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Summary 
This is the first thesis to explore sleep problems in young people with 22q11.2 Deletion 
Syndrome. This thesis includes both subjective and objective methods of sleep assessment 
which have contributed to furthering academic knowledge of sleep problems in 22q11.2DS.  
Firstly, the prevalence, nature and severity of sleep problems in a sample of young people 
with 22q11.2DS compared to their unaffected siblings was determined. The prevalence of 
sleep problems was high in young people with 22q11.2DS (~60%) and that the high 
preponderance remained stable in small subsamples of toddlers, adolescents and adults. The 
nature of sleep problems in the young people with 22q11.2DS was elucidated, showing that 
more sleep problems associated with poorer psychopathology and cognitive impairment.  
Building on the foundations of the subjective assessment of sleep, objective measures were 
introduced to begin to explore the physiology of sleep in these young people. A pilot study 
with a small typically developing sample of young people was conducted to assess the 
feasibility of an overnight sleep study. Resultantly, an overnight sleep study was developed in 
a subsample of young people with 22q11.2DS and their unaffected siblings which included 
polysomnography (PSG), two-week actigraphy assessments with a sleep diary and validated 
sleep questionnaires. Actigraphy-derived sleep parameters were compared between 
22q11.2DS and siblings showing some differences, in addition to differences in sleep 
parameters between the objective and subjective methods of assessment. Investigations into 
sleep architecture were few and small but provided a basis to build from when exploring the 
neurophysiology of sleep in young people with 22q11.2DS. Overall, the results from this thesis 
could have important implications for understanding sleep and its relationship with the 
neurodevelopmental phenotype in 22q11.2DS. 
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Chapter 1 – Introduction: 22q11.2 Deletion Syndrome 
1.1 Copy Number Variation 
Variability in the human genome is fundamental for evolution. The DNA sequences of any two 
human individuals are nearly identical with 99.9% comparability (National Human Genome 
Research Institute, 2018), yet it is the variation of the genome that contributes to the vast 
gene pool and diversity of the human race. There are around 20,000 genes in the human 
genome, and several mechanisms that underlie individual differences in genomic structure 
and function.  
Mutation is a term which can be interpreted both as a verb and a noun. As a verb, mutation 
can be a process of change whereas as a noun a mutation is used to define variants with a 
minor allele frequency of >1% (Loewe and Hill, 2010). Variants with a minor allele frequency 
of >1% include single nucleotide polymorphisms (SNPs). There are ~3 million SNPs identifiable 
in the human genome (Barreiro et al., 2008). A SNP can occur in any position throughout the 
genome: the position of the SNP influences the effect that it can have on encoding aberrant 
proteins and increasing the susceptibility to developing a certain disease. An example of this 
is the ApoE encoding protein increasing likelihood of Alzheimer’s disease (Hyman et al., 1996). 
They can also be benign, for example a SNP in the melanocortin-1 receptor on chromosome 
16 that gives rise to red hair.  
Mutational events can also affect multiple genes; these multi-genic changes are also 
abundant across the genome. Variations of a multi-genic nature are more likely than 
mutations in a single gene to impact many different cell types, tissues and organ systems.  
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Copy number variation (CNV) is an example of multi-genic variation in the genome. A CNV 
refers to a duplication, deletion or translocation of a segment of DNA that is 1 kilobase (kb) 
or larger (Thapar and Cooper, 2013). The affected section of DNA appears at a variable copy 
number: there are either more or fewer sections of DNA compared to the baseline human 
genome. A CNV can be detected as a more simple duplication of a segment of DNA or as a 
more complex change such as deletions or duplications of homologous DNA sequences at 
different sites across the genome (Redon et al., 2006). CNVs can be found in allosomes and 
autosomes alike, occurring in any of the 23 pairs of chromosomes in humans. For example 
where an additional ‘X’ allosome is present in the genome of males in Klinefelter Syndrome 
(Bhartia, Ramachandran and Ramachandran, 2012); an example of a CNV syndrome resulting 
in multi-system changes, especially in skeletal and endocrine systems. Changes to the genome 
including deletions and duplications tend to be detected less frequently than aneuploidies 
(Feuk, Carson and Scherer, 2006) (changes in the total number of chromosomes, for example 
trisomy 21 which is Down syndrome). However, CNV events are rarer in the human genome 
than smaller, individual nucleotide changes. The rarer events tend to have greater impacts 
such as aberrant protein expression and haploinsufficiency, where one chromosome in a 
chromosome pair is deleted and the remaining intact chromosome has to compensate 
(Prasad, Howley and Murphy, 2008).  
CNVs are present in every human and can occur across the whole genome. There are areas of 
the genome known as ‘mutation hotspots’ where CNVs occur most frequently. Highly 
homologous sequences of DNA known as low copy repeats (LCRs) (Shaikh et al., 2000) are 
present at these hotspots. When there are two copies of LCRs within 10 megabases of each 
other, there is a greater change of misalignment of paired chromosomes during meiosis. 
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When this occurs, typical genomic recombination is disrupted, resulting in deletion or 
duplications of the DNA region between the LCRs (Rosenberg and Pascual, 2015). This process 
is known as non-allelic homologous recombination (NAHR). 
Some CNVs can result in elevated risk for debilitating disorders and are therefore considered 
pathogenic. For instance, the deletion on chromosome 3q29 is the largest known biological 
risk factor for the development of schizophrenia (Kirov et al., 2012; Szatkiewicz et al., 2014). 
Genetic syndromes caused by a CNV impact an individual unpredictably. This so-called 
pleiotropy suggests that the phenotypic outcome is modified by other genetic or 
environmental factors. 
1.2 22q11.2 Deletion Syndrome Background 
22q11.2 Deletion Syndrome (22q11.2DS) is a relatively common microdeletion syndrome, 
characterised by the hemizygous deletion of ~50 genes (Swillen and McDonald-McGinn, 2015) 
on the long (q) arm of chromosome 22. The prevalence of 22q11.2DS is uncertain with 
estimated rates varying from 1 in 2,000-4,000 live births (Wilson, Cross and Wren, 1994; 
Tezenas du Montcel et al., 1996; Swillen and McDonald-McGinn, 2015). Some studies have 
reported rates as high as 1 in 992 in in utero testing (Grati et al., 2015). 22q11.2DS can be 
tested for using array comparative genomic hybridisation (CGH) (Theisen, 2008). Array CGH 
is a method for detecting genomic CNVs using fluorescence marking, for example a green 
fluorochrome, of a DNA base. A reference DNA sample is tagged with the opposite 
fluorochrome (red fluorochrome) and therefore, once the DNA extract is processed, the 
arrays can be imaged and the fluorescence can be measured. Based on the ratio of the 
fluorescence, CNVs can be detected (Ahn et al., 2015). Indicators for clinical testing could be 
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a new-born presenting with cardiac abnormalities prenatally or soon after birth (M.-Y. Lee et 
al., 2014) or the presentation of cleft palate (Driscoll et al., 1992). Another indication is 
developmental delay, which would generally be established somewhat later in childhood 
(Miller et al., 2010).  
Within the 22q11.2 region there are four LCRs in which deletions can occur. In ~86-90% of 
individuals with 22q11.2DS there is a ‘typical’ 3-megabase (Mb) deletion between LCR22A 
and LCR22B (Edelmann, Pandita and Morrow, 1999); there are approximately 7-10% that have 
a 1.5-Mb region (Amati et al., 1999) and ~3% of individuals have an atypical deletion at the 
loci on chromosome 22 (Emanuel, 2008). The 1.5-Mb deletion has helped to define a ‘critical 
region’ for the behavioural phenotype in 22q11.2DS based on the 28 genes within this smaller 
region. The critical region could be smaller still but more work is needed to define this 
(Williams, 2011).  
Individuals that have the smaller 1.5-Mb deletion have been shown to share a common 
proximal breakpoint with individuals with the 3-Mb deletion. However, it is the nested distal 
deletion breakpoint that distinguishes the deletion (Funke et al., 1999). Evidence suggests 
that the shared critical region from both deletion sizes presents as a decreased gene dosage 
which is associated with craniofacial abnormalities, conotruncal heart defects and has shown 
to associate with learning disabilities (Funke et al., 1999).  
The majority of cases of 22q11.2DS, ~93%, are de novo (McDonald-McGinn et al., 2001), 
occurring spontaneously during meiosis. The remaining 7% are inherited from a parent with 
22q11.2DS. This does not necessarily suggest that the parent was aware that they had 
22q11.2DS. The 22q11.2DS adult study at Cardiff University (https://www.cardiff.ac.uk/ 
neuroscience-mental-health/research/projects/the-wellcome-trust-strategic-award-define-
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grant) found that some adults did not receive their diagnosis until after their child was 
diagnosed with 22q11.2DS. Due to the variable phenotype, some adults might experience 
only minor features of 22q11.2DS and never realise they carry the CNV until they are screened 
because their child is diagnosed. The understanding of how varied the phenotype of 
22q11.2DS is remains limited. Many adults may still remain without a diagnosis, especially if 
the individual was born before particular symptoms could be identified, which prompts for 
further testing (McDonald-McGinn et al., 2001). For example, older individuals may have 
presented with congenital heart problems or developmental delay in their childhoods, 
however at the time of presentation, clinical understanding and capacity to refer these 
individuals to genetic clinics for genetic testing would have been limited. Techniques for the 
identification of CNVs would also have been limited. There was and currently is no routine 
testing for 22q11.2DS and existing clinical guidelines for treating individuals with 22q11.2DS 
are focussed on children, therefore prompting the development of adult-specific clinical 
practice guidelines (Fung et al., 2015).  
The varied phenotype has historically caused difficulty in diagnosing 22q11.2DS. There are 
over 180 distinct clinical manifestations that have been associated with 22q11.2DS (Furuya et 
al., 2015). These variable outcomes amongst individuals contributes to confusion and to begin 
with different disorders were suspected. Initially certain clusters of outcomes that presented 
in conjunction with each other such as heart defects with facial dysmorphia were recognised. 
For instance, a collection of features including conotruncal heart defects (interrupted aortic 
arch and tetralogy of Fallot for example), calcium deficiency, immune suppression due to 
thymus gland defects and occasionally a cleft palate was described as ‘DiGeorge syndrome’ 
(Demczuk and Aurias, 1995). Conotruncal anomaly face syndrome (CTAF) featured typical 
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facial appearances in patients with conotruncal heart abnormalities; Velocardiofacial 
syndrome (VCFS) or Shprintzen syndrome linked CTAF diagnoses with DiGeorge syndrome 
diagnoses resulting in the commonly used term VCFS. When overlaps were subsequently 
found between VCFS and DiGeorge syndrome it became clear that most patients with VCFS 
had a deletion at 22q11.2 suggesting the same genotype to DiGeorge syndrome patients. This 
resulted in DiGeorge and VCFS becoming the same diagnosis, but other chromosome 22 
deletion syndromes remained separate from this combined diagnosis. Other disorders unified 
by a 22q11.2 deletion include CTAF, autosomal dominant Opitz G/BBB syndrome, Cayler 
cardiofacial syndrome and Sedlackova syndrome. In the field of genetic research, the term 
22q11.2DS is now used to represent a syndrome characterised by the underlying genetic 
lesion rather than the collection of symptoms (McDonald-McGinn et al., 2015).  
Inconsistent presentation of the syndrome and the number of different phenotypic features 
can still affect timely diagnoses. There are characteristic physical features that are most 
commonly used as the indicators for genetic testing at birth. Not all individuals have these 
features, yet those that do often have such physical manifestation as cleft palate, hypotonia, 
facial dysmorphisms and conotruncal cardiac defects, particularly tetralogy of Fallot to name 
but a few (McDonald-McGinn, Emanuel and Zackai, 1993).  
Many individuals with 22q11.2DS have thickened keratinous features such as voluminous hair 
and rapidly growing nails. The extracellular differences in structures are also clear in the facial 
dysmorphisms and skeletal problems for which leg splints and walking aids are often needed. 
The facial features can include malar flatness, fullness of eyelids, tubular nose, round ears, 
broad nasal tip, thick helix and low-set ears (Skarsdttir et al., 2008). Many of the physical 
manifestations such as cleft palate can be surgically repaired, usually during childhood and 
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early adolescence. Septal heart defects are often repaired as a neonate. The earlier the 
intervention, the earlier other associated traits such as speech and language development 
can be corrected.  
In some individuals, the prevalence of physical manifestations is high suggesting that physical 
assistance might be required including wheelchairs and/or crutches, and continuous positive 
airway pressure (CPAP) machines. In other individuals, physical problems present in 
combination with a psychiatric phenotype, which can include developmental problems and 
possibly neurological conditions including seizures and epilepsy. Epilepsy and seizures are 
neurological features of 22q11.2DS with rates of childhood seizures above the typical rates 
(Vestergaard and Christensen, 2009). One study found that 7% of participants had 
unprovoked epileptic seizures (Kao et al., 2004), but another reported a rate as high as 15.2% 
(Kim et al., 2016). Seizures have a range of different underlying causes and many are present 
in 22q11.2DS: hypocalcaemia; adverse effects of antipsychotic drug use; hyperthyroidism and 
hypothalamic temperature dysregulation resulting in high fever.  
Much of the work currently conducted on the neuropsychiatric manifestations of 22q11.2DS 
is focussed on longitudinal assessment. Following of children from a young age over time can 
show the development of pathologies and morbidities. These critical periods are vulnerable 
to increased risk of psychiatric morbidity, which through the investigation of the adolescent 
period, can lead to a greater understanding of the developmental trajectory of 22q11.2DS. 
Neurology and physiology of individuals with 22q11.2DS is under-represented in current 
research, although a large-scale neuroimaging study focusing on the use of fMRI has begun 
to reveal neuroanatomical changes (Sun et al., 2018). More work in the field of 
neurophysiology and neuroanatomy will help to develop an understanding of the underlying 
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neural changes that are hypothesised as the foundation of the manifestation of some of the 
developmental, cognitive and psychiatric deficits seen in 22q11.2DS. Creating a complete 
description of the variable phenotype in 22q11.2DS can help in the understanding of 
individual variation and possible treatments and interventions throughout life.  
1.3 The Neurodevelopmental Phenotype of 22q11.2DS 
Neurodevelopment is a term which can broadly include a wide range of disorders and 
problems: there is much debate around what the term itself includes and defines. In this 
thesis, the phrase ‘neurodevelopmental phenotype’ is being used to define a broad group of 
disorders which involve disruption to brain development. The disorders which are namely 
defined by the term ‘neurodevelopmental’ are Attention-deficit hyperactivity disorder 
(ADHD), Autism spectrum disorders (ASD), Developmental coordination disorder (DCD) and 
learning disorders (cognitive impairments) (Thapar, Cooper and Rutter, 2017).  
However, there is evidence to suggest that the term can be used more broadly to define other 
related problems. These include rare genetic syndromes and as a result of this, it is this 
perspective that has been adopted throughout this thesis. This thesis uses the phrase 
‘neurodevelopmental phenotype’ to include ADHD, ASD, DCD and cognitive impairments, in 
addition to commonly occurring childhood psychiatric disorders including anxiety disorders, 
oppositional defiant disorder (ODD) and conduct disorder (CD) (Ollendick et al., 2008).  
The definition in this thesis recognises the psychiatric and cognitive morbidities common in 
22q11.2DS as part of the ‘neurodevelopmental phenotype’ (ADHD, ASD, DCD, anxiety 
disorders, CD and ODD and intellectual disability).  
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It is important to add that I recognise that including the psychiatric morbidities in the 
definition of the neurodevelopmental phenotype is not necessarily a widely used definition. I 
have taken the approach to use ‘neurodevelopmental phenotype’ in a broader and wider 
sense to be able to use it consistently throughout this thesis in reference to the young people 
with 22q11.2DS. 
Evidence derived from the paper by Mullin, A.P. et al. (Mullin et al., 2013) explores the 
definition of neurodevelopmental disorders and the contributions from the genome and 
specifically the genotype which is of relevance to the 22q11.2DS population in this thesis. 
Further evidence explored by Thapar, A. et al. outlines that the term neurodevelopmental has 
been used to broadly define a group of disabilities which commonly have not been regarded 
as a neurodevelopmental disorder including neurological, psychiatric and cognitive problems 
(Thapar, Cooper and Rutter, 2017).  
For this thesis, the definition has been formulated based on the underlying genetic 
predisposition to these morbidities and can be used to simplify matters when referring to the 
number of different morbidities which are often compared throughout this thesis. 
There are many psychiatric morbidities in 22q11.2DS which often create a complex 
presentation. Psychiatric morbidities such as anxiety disorders can be coupled with 
developmental problems such as ADHD as well as cognitive impairments and learning 
disability. Comorbid diagnoses are common in individuals with 22q11.2DS with 54% of 
children meeting diagnostic criteria for one or more psychiatric disorders (Niarchou et al., 
2014).  
   
10 
 
The multitude of problems follow varying trajectories over time. There is evidence to suggest 
that the prevalence of mood disturbance increases in adolescence (Gothelf, Penniman, et al., 
2007), the incidence of ADHD decreases with age (Niarchou et al., 2018) and that psychotic 
symptoms emerge in adolescence and early adulthood (Chawner et al., 2019). Many of the 
following problems feature in the psychiatric phenotype of 22q11.2DS, often presenting 
comorbidly. This section outlines those psychiatric and neurodevelopmental morbidities with 
most relevance to sleep problems. 
1.3.1 Anxiety Disorders 
Anxiety disorders are a collection of a number of diagnoses including generalised anxiety 
disorder (GAD), obsessive compulsive disorder (OCD), specific phobias, social phobias and 
separation anxiety and panic disorder (Barton et al., 2014). Rates of anxiety disorders in 
typically developing young people range from 9% to 32% (Essau and Gabbidon, 2012; 
Creswell, Waite and Cooper, 2014). Symptoms of anxiety can refer to significant worrying, 
unpleasant feelings and thoughts but will differ dependent on the diagnosis. Anxiety 
symptoms in research can be recorded from self-reports and semi-structured interviews 
(Angold et al., 1995). 
Anxiety disorders are commonly diagnosed in young people with 22q11.2DS with rates 
ranging from 40-76% (Niarchou et al., 2014; Schneider et al., 2014). Rates of anxiety disorders 
in 22q11.2DS were consistently higher than the unaffected sibling controls. A recent literature 
review identified that anxiety disorders in 22q11.2DS are found to have an average 
prevalence of ~39% of individuals. This review showed specific phobia as the most frequent 
type of anxiety disorder followed by generalised anxiety disorder (Bertrán, Tagle and 
Irarrázaval, 2018).  
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Anxiety and the propensity for mood changes can worsen with age and during puberty 
(Romeo, 2013). There is dysregulation of the endocrine system in 22q11.2DS shown by the 
elevated presence of hyperthyroidism and hypocalcaemia. These hormonal imbalances could 
potentially contribute to the elevated prevalence of neurodevelopmental disorders (NDDs) 
and anxiety for young people with 22q11.2DS (Swillen and McDonald-McGinn, 2015). There 
has also been evidence in the general population of pronounced gender differences in rates 
of internalising disorders which become pronounced during puberty, showing higher rates of 
affective disorders in females than males, suggesting hormonal changes could be a 
contributory factor (Hayward and Sanborn, 2002). 
Young people with 22q11.2DS and comorbid anxiety have a six-times higher risk of 
schizophrenia when compared to young people with 22q11.2DS without a comorbid anxiety 
disorder (Schneider et al., 2014; Bertrán, Tagle and Irarrázaval, 2018). Anxiety disorders in 
22q11.2DS differ from schizophrenia as they are present at high rates in young people 
whereas the high preponderance of psychotic symptoms is apparent in adolescence/early 
adulthood. There is evidence showing that the level of anxiety symptoms in childhood is 
associated with continued anxiety and severe chronic mood disorder across the lifespan 
(Gothelf, Feinstein, et al., 2007; Fabbro et al., 2012). Anxiety symptoms can have an impact 
on well-being, educational attainment, daily routines and impairment of social performance 
and ability to function in a family and/or school setting (Debbané et al., 2006). In individuals 
without 22q11.2DS, these symptoms are significant in themselves with anxiety causing 
substantial disruption to day-to-day routine and debilitating symptoms in typical individuals 
(Devine, Kempton and Forehand, 1994).  
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However, these problems are exacerbated in young people already at elevated risk for 
developmental delay, social and communication impairment and behavioural problems. One 
study of a small cohort of young people with 22q11.2DS (n=62) showed that anxiety was 
identified in 62.2% of individuals. Specific phobia was the highest represented anxiety 
disorder across all age groups and was diagnosable in 66.7% of adolescents in the study 
(Fabbro et al., 2012). 
In young people with 22q11.2DS, parents routinely report anxiety in their children. Assessing 
symptoms of anxiety against the DSM-IV-TR guidelines, many different anxiety disorders can 
be identified. These include GAD, specific phobias, social phobias and separation anxiety 
(Baker and Skuse, 2005; Niarchou et al., 2014; Schneider et al., 2014). The anxieties can 
manifest differently in young people with 22q11.2DS leading to outcomes such as withdrawal, 
avoidance, excessive worry or through self-harming including cases of trichotillomania and 
skin-picking (Tang et al., 2015).  
The aetiology of anxiety disorders in 22q11.2DS remains unknown. One problem that is often 
reported by parents is that young people with 22q11.2DS frequently go to hospital (Bassett 
et al., 2011), may have to undergo one or more surgeries and have numerous medical tests 
and immunisations. This can contribute to unstable home and school lives. Anecdotal 
evidence suggests that there are two groups of young people with 22q11.2DS: those who 
have become familiar with hospital surroundings and seemingly do not mind having medical 
tests and those young people who have an overwhelming phobia of the sight of blood, 
injections and being in the vicinity of a hospital. These situations themselves can cause or 
exacerbate anxieties with physiological and psychological stress at a young age as a marker 
for later onset of psychological problems and behavioural problems (Bonn, 1994).  
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Furthermore, a longitudinal study across two time points showed that the presence of anxiety 
symptoms in childhood is associated with the later emergence of psychotic experiences in 
adolescence (Chawner et al., 2019). Cross-sectional assessments outlined more about the 
comorbid nature of anxiety disorder diagnoses; 90% of young people with 22q11.2DS and an 
anxiety disorder diagnosis had comorbid Developmental Coordination Disorder (DCD) in 
(Cunningham et al., 2017). In cross-sectional analysis, the young people with poorer scores 
on the DCD questionnaire also reported more anxiety symptoms (Cunningham et al., 2017).  
1.3.2 Attention-Deficit Hyperactivity Disorder (ADHD) 
ADHD is one of the more common neurodevelopmental disorders and is considered to affect 
around 1.4-3% of children (Thapar and Cooper, 2016) in the general population. The diagnosis 
rate is often skewed dependent on geography with higher rates of diagnosis in western 
societies and also has a higher preponderance amongst boys (Taylor et al., 2016). Despite 
ADHD being diagnosed most commonly in childhood, it can be a lifelong disorder and persists 
into adulthood (Watters et al., 2017) with one study suggesting that 41% of individuals with 
ADHD experienced symptoms into young adulthood (Sibley et al., 2017). There is evidence 
showing the continued presence of ADHD into adulthood despite a reduction in the symptom 
severity (Eyre and Thapar, 2014).  
Previously portrayed as a behavioural manifestation of poor parenting and general insolence 
from a child seen as ‘naughty’ (Timimi and Leo, 2009), the perception of young people who 
are diagnosed with ADHD has changed in the 21st century. Gene-environment interactions 
were identified through behavioural genetic and molecular genetic studies (Faraone et al., 
2005) with evidence of genetic associations with ADHD in the dopaminergic, serotonergic and 
noradrenergic neurotransmitter systems. These studies suggested that genetic and non-
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genetic factors (Faraone et al., 2005) were important in the development of ADHD. Twin 
studies were used to explore the heritability of ADHD (Thapar et al., 2000) with high 
heritability evidence from parent reports, which alongside teacher-rated categories, also 
provided evidence for shared environmental effects. Wider heritability studies ultimately 
provided evidence of the mean heritability estimate of 76% demonstrating ADHD was one of 
the most heritable psychiatric disorders (Faraone et al., 2005).  
On recognising that there was a genetic aetiology and disposition for the manifestation of 
ADHD, it was important to identify what genetic lesions were contributing to the 
manifestation of ADHD. Genome-wide analysis studies of ADHD showed large, rare copy 
number variants were identified in children with ADHD at a higher rate than typically 
developing controls (Williams et al., 2010). This provided evidence for enrichment of genetic 
lesions in young people with ADHD but in particular rare genetic lesions as evidence for 
common genetic variants already existed and has continued to be built upon (Demontis et al., 
2017). Ongoing investigations have shown the importance of studying the gene-environment 
interactions and contributions from both genes and the environment (N. M. Williams et al., 
2012).  
ADHD is characterised by three subtypes: 1) inattentive which includes difficulty in 
concentrating and organising tasks and making careless mistakes, 2) hyperactive-impulsive 
which includes restlessness and acts like they are ‘driven-by-a-motor’, 3) and combined, 
where the latter indicates the presence of symptoms of both the inattentive and hyperactive-
impulsive subtypes (Graeta et al., 2001). In 22q11.2DS, the rate of ADHD has been reported 
to range between 12-68% (Schneider et al., 2014) and the inattentive subtype of ADHD is the 
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most prevalent in 22q11.2DS (Schneider et al., 2014; Niarchou, J. Martin, et al., 2015; 
Niarchou et al., 2018).  
The rates of ADHD in young people with 22q11.2DS were found to reach ~37.1% in the 
International Brain and Behaviour Consortium (IBBC) and continued incidence of ADHD into 
adulthood was shown, with evidence of 15.6% of adults in the consortium having diagnosable 
ADHD (Schneider et al., 2014; Niarchou, J. Martin, et al., 2015; Niarchou et al., 2018). ADHD 
in 22q11.2DS shows a male preponderance (Schneider et al., 2014) reflecting what is seen in 
the general population (Boat et al., 2015)  
In non-genotyped (idiopathic) ADHD, there is a high comorbid rate of conduct disorder (Boat 
et al., 2015). This is not reflected in individuals with 22q11.2DS: fewer individuals have 
comorbid diagnoses of conduct disorder (CD) and oppositional defiant disorder (ODD) but 
despite this, there are higher rates of comorbid anxiety disorders (Niarchou, J Martin, et al., 
2015; Niarchou et al., 2018) in young people with 22q11.2DS compared to the non-genotyped 
ADHD population. This distinction suggests that ADHD in 22q11.2DS presents differently to 
idiopathic ADHD. This can also be reflected in the treatments for ADHD in the idiopathic 
population compared to 22q11.2DS.  
There are a small number of studies investigating the efficacy of methylphenidate medication 
for the symptoms of ADHD in 22q11.2DS. A randomised controlled trial in 34 young people 
with 22q11.2DS with a comorbid ADHD diagnosis showed that methylphenidate treatment 
could be safe and effective after a six-month treatment schedule. This trial showed a 
reduction of 40% in ADHD parent-reported symptomology of the young child with 22q11.2DS 
(Green et al., 2011). Another study showed that behavioural and cognitive impairments 
improved substantially after treatment with methylphenidates, with minimal adverse effects 
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(Gothelf et al., 2003). The study sample sizes and time-scales limit interpretation, suggesting 
further studies are required to examine the use of stimulants to treat ADHD symptoms in 
22q11.2DS (Niarchou et al., 2018).  
A cross-sectional study showed that 41% of the 22q11.2DS cohort had an ADHD diagnosis 
(Niarchou et al., 2014). An association between risk for psychopathology (including an ADHD 
diagnosis) and IQ was shown via a reduction in IQ to elevated risk of psychopathology. The 
longitudinal course of ADHD prevalence, showing a reduction in prevalence in individuals with 
22q11.2DS with age, aligns with the typical idiopathic population (Langley et al., 2010). Study 
into the long-term persistence of ADHD into the adult population with 22q11.2DS will help to 
develop more appropriate and targeted treatments. 
1.3.3 Autism Spectrum Disorders (ASD) 
Autism spectrum disorder (ASD) in the general UK population has an estimated prevalence of 
about 1.1% with a higher preponderance in males (Reid and Ayris, 2011). ASD covers a range 
of diagnoses that, before the release of The Diagnostic Statistical Manual of Mental Disorders, 
Fifth Edition (DSM-5) (Kocsis, 2013), were classified as separate NDDs (DSM-5 Criteria | 
Autism Speaks, 2013). The diagnosis is inclusive of pervasive developmental disorder and 
Asperger’s syndrome and ties together the diagnoses because of their overlapping morbidity 
and symptomology. ASD is often considered to consist of subdomains which better explain 
the difficulties individuals have: social interaction impairment, communication deficits and 
restrictive and repetitive behaviours (Bishop, 2003). An ASD diagnosis can be determined 
by gold-standard diagnostic tools such as the Autism Diagnostic Interview-Revised (ADI-R) 
(Rutter et al., 2005) and the Autism Diagnostic Observation Schedule (ADOS) (Lord et al., 
2002). These techniques involve a clinician or trained health professional interviewing the 
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parent of the child in the case of the ADI-R or observations of the child as well as interviews 
with the parents in the case of the ADOS. The tools are dependent on inter-rater consensus. 
In 22q11.2DS, rates of ASD range from 10 to 50% (Niklasson et al., 2001; Vorstman et al., 
2006). However, there is a debate in the literature about whether autism spectrum disorder 
traits in 22q11.2DS are indicative of an ASD diagnosis, or because of the wide-range of 
comorbidities in 22q11.2DS, the symptoms themselves could be associated with an ASD 
phenotype but not indicative of an ASD diagnosis. For example, poor communication could 
be indicative of ASD or other morbidities that present in 22q11.2DS such as intellectual 
disability, selective mutism and developmental delay (Fine et al., 2005; Vorstman et al., 2006; 
Antshel et al., 2007; Ousley et al., 2017).  
One study that included the ADI-R showed that 42% of the 22q11.2DS sample (n=41) met 
diagnostic criteria for ASD (Antshel et al., 2007) whereas another study with a sample size 
twice as large (n=98) showed elevated ASD symptoms in 20% of children with 22q11.2DS and 
only 11.2% (n=11/98) were deemed to have a clinically accurate diagnosis of ASD despite 
14.3% (n=14/98) being established to have a diagnosis of autism from the ADI-R (Fine et al., 
2005).  
One study showed that in young people with 22q11.2DS and ASD, 94% had a co-occurring 
psychiatric disorder compared to a rate of 60% in young people with 22q11.2DS without ASD 
(Antshel et al., 2007). However, another study suggested that the high prevalence of ASD was 
inaccurate and that comorbidities like anxiety disorders need to be accounted for when 
diagnosing ASD. Furthermore, diagnostic variability among studies results in no common 
universal diagnostic tool or scale which is comparable and routinely used (Angkustsiri et al., 
2014). 
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Additionally, studies have investigated whether autistic traits in childhood could predict risk 
for development of psychotic traits in adulthood. A cohort of young people with 22q11.2DS 
(n=60) showed that 26.7% of those with ASD later developed psychotic symptoms (Vorstman 
et al., 2006).  
1.3.4 Developmental Coordination Disorder (DCD) 
Developmental Coordination Disorder (DCD) is defined by the American Psychiatric 
Association (APA) as a disorder including features associated with impaired development of 
motor coordination (both gross and fine). Such impairments in motor movements can be 
identified through motor assessments undertaken by neurologists. There are particular 
indicators which can suggest that an individual could have DCD. Such indicators can include 
the absence of meeting particular milestones throughout development. Delayed milestones 
can include achieving standing and walking at a later age compared to a normative 
distribution of children (Kirby and Sugden, 2007). Presentations of impaired performance in 
activities requiring hand-eye coordination such as sporting activities, as well as poor 
handwriting can also be indicative of DCD. Problems pertaining to DCD can often manifest in 
impaired academic performance for the young person. 
DCD rates in children have been shown to reach 4-5% in one population-based study involving 
the Movement ABC Battery (Wright and Sugden, 1996) and up to 6% when accounting for the 
APAs diagnostic criteria (Kirby and Sugden, 2007). Much like young people with 22q11.2DS, 
children with DCD have been shown to have a range of neurodevelopmental comorbidities 
such as ADHD (Kirby and Sugden, 2007). 
DCD can be assessed by the Movement ABC Battery, an objective tool which is the most 
widely used. The Movement ABC identifies and defines impairments on motor performance 
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of children and adolescents with comparative norms. This is done by exploring the fine and 
gross movements of a child such as assessing their ability to catch a small beanbag on two 
feet, then introducing different parameters such as on one foot.  
Functional MRI has shown anatomical changes in the brains of individuals with 22q11.2DS. 
There is evidence for widespread neurological changes in young people with 22q11.2DS that 
include increased cortical surface area in the sensorimotor cortex (Sun et al., 2018) and 
reduced cerebellum size showing association with motor function. These changes could be 
associated with the motor deficit shown in 22q11.2DS individuals. 
The parent-completed Developmental Coordination Disorder Questionnaire (DCDQ) is a 
screening tool used for DCD. This 15-item scale includes questions asking about whether the 
young person has reached milestones including tying their own show laces or fastening their 
buttons. The scale is reversed and therefore, scoring high on the DCDQ correlates with better 
coordination and fewer motor problems. In a cross-sectional study of indicative DCD 
symptoms, motor coordination problems were identified in 80% of young people with 
22q11.2DS in this cohort (Cunningham et al., 2017). It was also seen that DCD presents 
comorbidly with the neurodevelopmental phenotype showing that poorer coordination was 
associated with elevated symptoms of anxiety, ADHD and ASD. Looking at the young people 
with ADHD and 22q11.2DS, 100% met criteria for indicative DCD (Cunningham et al., 2017). 
Poorer sustained attention was associated with motor coordination also, resulting in a 
complex presentation. 
1.3.5 Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD) 
Oppositional Defiant Disorder (ODD) is characterised by oppositional behaviour including rule 
breaking, disobedience, annoying behaviour, vindictive behaviours and promise breaking. 
   
20 
 
Oppositional behaviours tend to be relatively ‘low-level’ problems that can often be 
controlled. These behaviours include often and easily losing one’s temper and deliberately 
annoying or upsetting people which is found in DSM-5 criteria (American Psychiatric 
Association, 2013). Violence is not common in ODD but can be indicative of Conduct Disorder 
(CD). CD is characterised by symptoms including deception and activities involving violence 
such as vandalism, arson or violence enacted towards someone or something such as fighting 
or cruelty to animals.  
Rates of ODD and CD in young people in the general population are estimated to occur at a 
rate of below 4% for both disorders (Boat et al., 2015). Cross-sectional analysis of a cohort of 
young people with 22q11.2DS showed that 18.8% of young people with 22q11.2DS had an 
ODD diagnosis compared to 0% with a CD diagnosis (Niarchou et al., 2014). This reflects 
similar evidence suggesting the prevalence of CD is lower than ODD in typical young person 
populations without 22q11.2DS (National Institute for Health and Care Excellence, 2017).  
ODD and CD can present comorbidly, with the individual demonstrating symptoms of both 
disorders (Costello et al., 2003). Furthermore, individuals with ADHD can present comorbidly 
with CD and/or ODD (Biederman et al., 2008). A study of young people with 22q11.2DS 
showed that 30% of the young people presenting with ODD also had symptoms of ASD 
suggestive of a diagnosis demonstrating comorbidity (Niarchou et al., 2014). This is a high rate 
of comorbidity and sets the precedent for further evidence of the comorbid nature of ODD in 
22q11.2DS.  
Another ECHO study-based project looked at the clinical presentation of ADHD in 22q11.2DS 
and showed that 34% of young people with 22q11.2DS and ADHD had an ODD diagnosis yet 
none had a CD diagnosis. Compared to a clinical idiopathic (non-genotyped) ADHD sample, 
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both of these rates were lower with 46% of the clinical ADHD sample having an ODD diagnosis 
and 21% having a CD diagnosis (Niarchou, J. Martin, et al., 2015). Consistently, there were 
fewer symptoms of ODD and CD in 22q11.2DS and ADHD compared to the clinical ADHD 
sample even when controlling for gender and IQ scores. However, there are elevated 
symptoms in 22q11.2DS than in population-based samples (Owens and Hoza, 2003). 
1.3.6 Cognitive Deficits  
Cognition involves high level processing of information such as through thinking, memory 
consolidation, perception, language processing and skilled motor movements. Learning and 
memory are fundamental processes in cognition, which assessment of these two domains 
through hippocampal memory tasks or abstract reasoning, can allow for recognition of 
cognitive deficits (Karpicke and Roediger, 2008). Impaired information processing, recall, 
ability to pay attention, initiation of speech and critical thinking can all indicate potential 
cognitive deficit (Trivedi, 2006).  
Decline in cognitive development in children with 22q11.2DS has been shown in a 2012 study 
where a decline in full-scale IQ was found across time points between 5.5 years to 9.5 years. 
An absolute decline in cognitive scores was found in n=10 young people (15%) of the cohort 
(Duijff et al., 2012). However, wide variability in cognitive function has been determined in 
young people with 22q11.2DS with divergent cognitive trajectories between studies (Swillen, 
2016). 
One study included assessments of working memory, executive function, attention and 
information processing and IQ allowing for investigation of cognitive deficits in young people 
with 22q11.2DS. Cognitive deficits are widely reported in young people with 22q11.2DS with 
the average IQ estimated to be ~30 IQ points lower than in typically developing children 
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(Niarchou et al., 2014) and deficits in cognitive function including reaction time, sustained 
attention, processing speed, spatial working memory and executive functioning have also 
been documented (Hooper et al., 2013; Niarchou et al., 2014). ~31% of young people with 
22q11.2DS have mild intellectual disability (ID) (53-69 full-scale IQ (FSIQ)), 31% borderline ID 
(70-79 FSIQ) and 39% an average IQ score (81-109 FSIQ) (Niarchou et al., 2014). Longitudinal 
study of cognitive function in n=75 young people with 22q11.2DS showed deficits in all 
cognitive domains. However the overall decline over time from time point 1 to 2 showed a 
similar group trajectory to the sibling controls suggesting that the decline in cognitive function 
reflects a normative developmental change rather than a specific 22q11.2DS cognitive deficit 
of decline (Chawner et al., 2017) 
 
The following morbidities have been reported in young people with 22q11.2DS however they 
are not prevalent in the sample described in this thesis. This is as a result of the age range of 
the young people with the prevalence of schizophrenia and mood disorders increasing in later 
adolescence and early adulthood (Schneider et al., 2014). 
1.3.7 Schizophrenia  
Reported at a lifetime prevalence of 1-2% in the general population, schizophrenia (SCZ) is 
considered to be one of the less common psychiatric disorders (Kirkbride et al., 2012). A 
debilitating disorder, SCZ is associated with chronic disability and experiences of positive 
(hallucinations and delusions) and negative (social withdrawal) symptoms as well as 
impairment in cognitive function (Owen, Sawa and Mortensen, 2016). SCZ tends to present 
during late childhood, adolescence and early adulthood when there is great plasticity and 
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neurological changes happening (Kolb and Gibb, 2011). It is not often a feature recognised in 
childhood yet psychotic experiences and episodes can be reported (Poulton et al., 2000). 
SCZ is a polygenic disorder and 108 distinct genetic loci were linked to risk of SCZ in a genome-
wide association study (Consortium et al., 2014). 22q11.2DS is one of the strongest known 
biological risk factors for SCZ (Rees et al., 2011, 2014; Kirov et al., 2014) with a 25-30% 
elevated risk for the development of SCZ. This rate is substantially larger than the typically 
developing population, and the risk for psychotic disorder is even higher at around 38% and 
with an estimated rate of psychotic experiences reaching 50% (Schneider et al., 2014). Rates 
of psychotic disorder can reach up to 41% in individuals over 25 years with 22q11.2DS (Bassett 
et al., 2008; Schneider et al., 2014).  
A cross-sectional cohort of n=137 young people with 22q11.2DS showed an association 
between the total ADHD symptom score and overall levels of subthreshold psychotic 
symptoms, with inattentive symptoms at a higher prevalence in 22q11.2DS with subthreshold 
psychosis compared to non-deletion with subthreshold psychosis (Niarchou et al., 2018). A 
longitudinal study showed that anxiety symptoms at the first time point were associated with 
the emergence of psychotic experiences at a later time point as well as differential 
development of cognitive domains such as the attention-executive domain (Chawner et al., 
2019). 
1.3.8 Mood Disorders 
Mood disorders are affective, emotional disorders. Depressive disorders are often 
characterised by loss of interest, low self-worth, disturbed sleep, tiredness and loss of 
concentration including many forms such as unipolar depression (World Health Organisation 
(WHO), 2018). Bipolar affective disorders typically include both depressive episodes and 
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manic episodes where elevated or irritable mood is exhibited alongside decreased need for 
sleep, over-activity and inflated self-worth (Lewis et al., 2017). The World Health Organisation 
(WHO) states that there are 300 million people affected by depression and 60 million by 
bipolar affective disorder globally (World Health Organisation (WHO), 2018).  
Mood disorders commonly present comorbidly in individuals with co-occurring psychiatric 
disorders such as anxiety disorder (Hirschfeld, 2001). One study showed that depression and 
anxiety disorder in young people with 22q11.2DS were predictors of later onset of psychiatric 
experiences with evidence of childhood depression and anxiety predicting 61% of the 
variance in the severity of psychosis assessed in later life (Gothelf, Feinstein, et al., 2007). The 
same research group published another study showing mood disorders, in the overall sample 
group including young people and adults, were present in 15.1% of the cohort; rates of mood 
disorder in young people under 12 were 9%, with 4.5% having major depressive disorder. In 
adults with 22q11.2DS, 40.7% scored for major depressive disorder; a higher rate than 
psychotic disorder in that sample (32.1%) (Green et al., 2009).  
In young people with 22q11.2DS, mood disorders are shown to be amongst the least frequent 
psychopathologies. Nonetheless, they can have debilitating and significant effects especially 
with regards to symptomology such as suicidal ideation. Mood disorder can impact upon 
social and emotional communication as well as general functioning including educational 
attainment.  
1.4 Summary 
This chapter has comprehensively outlined the features of the neurodevelopmental 
phenotype in 22q11.2DS. It has demonstrated the multiple complexities of the syndrome and 
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the number of different problems that can present. 22q11.2DS is associated with a range of 
physical and neurodevelopmental problems, with elevated preponderance for ADHD, ASD, 
anxiety disorders and an increased risk for schizophrenia. Rates of mood disorders, CD and 
ODD are shown to have lower prevalence’s in 22q11.2DS however there is great overlap in 
the shared symptomology. There is strong evidence of indicative DCD and learning disability, 
with impairments in cognition present in many individuals. The variability of the presentation 
in each individual complicates the understanding of 22q11.2DS further for medical 
professionals suggesting all hospital disciplines should be interested in the syndrome. 
In the next chapter, I will discuss the overarching theme of this thesis and a common symptom 
reported in many of the developmental, psychiatric and cognitive problems addressed in this 
chapter: sleep problems. 
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Chapter 2 – An Introduction to Sleep  
2.1 Key Principles of Sleep 
A third of a human’s life is spent asleep (National Institute of Neurological Disorders and 
Stroke, 2018), and is therefore is one of the most common activities undertaken by humans. 
Sleep has been preserved throughout evolution and as a result, these factors contribute to 
the suggestion that sleep serves an important role in human development (Lee and Rosen, 
2012).  
Sleep is an intricate and complex process that relies on the interaction between the brain and 
the body (Lu and Zee, 2006; Walker and Stickgold, 2006). Healthy sleep can be recognised 
through the detection of normative changes in the brain’s electrical activity and subsequent 
changes in the body’s activity. However, sleep can be vulnerable to disruptions that are acute 
or those that can become chronic. Chronic sleep disruption can have both detrimental 
physical and psychological impacts including elevated risk for type 2 diabetes and obesity 
(Gottlieb et al., 2005) as well as depression and anxiety (Johnson, Roth and Breslau, 2006; 
Roenneberg and Merrow, 2016; Freeman et al., 2017). Sleep deprivation impairs cognitive 
clarity and can impair daily tasks for example, driving a car and concentrating on work (Alhola 
and Polo-Kantola, 2007; Killgore, 2010).However, activities such as going to bed late in the 
evening resulting in tiredness can sometimes be unavoidable. 
There is no single definitive reason for why we sleep however, there are four theories that 
have evidence to support their claims (‘Why do we sleep?’, 2000): 1) for rest and 
recuperation; 2) for recall, cognitive learning and memory consolidation (Gais et al., 2000; 
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Maquet, 2000; Stickgold, James and Hobson, 2000); 3) it is an evolutionarily retained 
behaviour and 4) to undertake extracellular clearance in the brain, acting as a mechanism for 
removing toxic by-products assisted by the expansion of glial cells in the brain (Xie et al., 
2013).  
This section of the thesis, Key Principles of Sleep, addresses sleep in the wider literature, 
paediatric literature and what we know about sleep with regards to the neurodevelopmental 
phenotype including neurodevelopmental disorders (NDDs) and psychiatric disorders. Sleep 
problems that have been identified in genetic syndromes are included. The focus of this 
chapter is to outline the neurophysiology of sleep and provide a background to what is 
currently known regarding brain activity during sleep in the neurodevelopmental phenotype, 
explained in section 1.3 (page 8). This is in order to better understand Chapter 7 later. 
2.1.1 Background to the Sleep Literature 
The sleep-wake cycle is a balanced mechanism regulated by two processes: process circadian 
(process C) and process sleep-wake homeostasis (process S) (Borbély, 1982; Borbély et al., 
2016), illustrated by Figure 1.  
 
 
 
 
 
Figure 1 The two-process model of sleep adapted from the Borbély model published in 1982  
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Process S signifies the sleep-wake homeostatic pressure which increases throughout the day. 
Process S can be modified by the activities an individual undertakes during the day and by the 
substances ingested for example, caffeine (Silver and Rainbow, 2013). Contrastingly, process 
C is the circadian pattern which acts to counterbalance process S until the evening where 
there is a peak in the endogenous hormone melatonin. This is where the ‘sleep-gate’, a 
dominance of process S over process C, results in the increased pressure for sleep and the 
ultimate goal of sleep onset (Kotagal and Pianosi, 2006). Throughout the day and night, 
process C and S remain synchronous and balanced in a healthy individual. Changes to the 
balanced processes can result in clinical problems with the sleep phase. This refers to the 
timings of sleep onset and wake. For example, an advanced sleep phase results in an earlier 
than typical sleep onset time whereas a delayed sleep phase would be identified by a later 
sleep onset from the normative time (Barion and Zee, 2007). These processes are relevant to 
the later chapter (Chapter 6) where standardised sleep questionnaires have been adopted to 
try and acquire evidence of sleep phase disorders.  
Sleep loss is evidenced to contribute to elevated risk for disease (Hanis et al., 2016; Krysta et 
al., 2017) but overall, the amount of sleep someone needs is dependent on the individual and 
their preferences for sleep timings (Vitale et al., 2015). The amount of sleep needed changes 
across the life-course and new-borns do not establish a circadian rhythm until four months of 
age (Armstrong, Quinn and Dadds, 1994). In new-borns, brain plasticity and neurogenesis are 
vital and reflected in an average of 14-17 hours of sleep/day (Parmelee, Schulz and Disbrow, 
1961). The architecture of sleep varies across a lifetime; there are differences in the 
percentage of time spent in the stages of sleep in young children compared to adolescences 
and adults (Baker et al., 2016). Over the first year, a typical diurnal pattern of sleep-wake 
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starts to develop but with some daytime naps present and there is a shift in REM sleep 
dominance to non-REM (NREM) (Anders and Keener, 1985). For pre-school aged children, 10-
13 hours is recommended, down to 9-11 for school age and 8-10 for teenagers. It isn’t until 
18 years old that a sleep duration of 7-9 hours is recommended and after the age of 65, sleep 
recommendations reduce to 7-8 hours (Berry et al., 2016). 
2.1.2 Sleep Problems in the Typically Developing Paediatric Population 
Typically developing children experience sleep problems with reported rates ranging from 25-
50% (Owens and Mindell, 2011). These problems are likely to be transient: rates of 
sleepwalking are ~40% and night terrors 1-7% in young children (Gertner et al., 2002).  
Given the four theories for sleep (see section 2.1, pages 25-26), the universal importance of 
sleep in brain development, metabolism and cognition is recognised, which suggests that it is 
essential for young children to maintain healthy sleep (Cirelli and Tononi, 2017). In younger 
children, there is a high degree of brain plasticity, neurological development and building of 
new neural circuits. This means that the consequences of sleep deprivation are more likely to 
be problematic in younger children than older individuals (Jan et al., 2010; Bonuck and Grant, 
2012). Having said that, sleep deprivation and poor sleep quality at any age can elevate risk 
of neuronal dysfunction, and impaired neurogenesis and memory (Bonnier, 2008). However, 
sleep problems from a young age can contribute to a heightened risk of cognitive impairment 
and poor psychiatric outcomes (Dorris et al., 2008; Krystal, 2012) that can persist into 
adolescence and adulthood (Dahl, 2007; Kahn-Greene et al., 2007; Limoges et al., 2013; Rasch 
and Born, 2013; Krause et al., 2017).  
Sleep hygiene is a clinical tool that can be used to improve sleep behaviours especially 
surrounding the night time and sleep onset (Barion and Zee, 2007). These behaviours include 
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the development of a night time routine. Blue light however can be used in therapies to 
promote melatonin suppression in individuals with advanced sleep phases, depression or 
trouble with waking (Figueiro, Plitnick and Rea, 2014).  
Sleep is a prevalent topic in the paediatric literature. There is evidence to suggest that studies 
demonstrating the preponderance of sleep problems in young people have contributed to 
changes in health services and the media, aiming to encourage better sleep in young people. 
Mobile phone applications providing self-help for poor sleep such as ‘Sleepio’ (Espie, 2016; 
Elison et al., 2017) and parent-led monitoring of their child’s sleep habits and patterns 
through ‘Kids Dr Sleep’ (Gringras, 2015), are leading the way in encouraging conversations 
about children’s sleep and how to maintain healthy practice. 
2.1.3 Sleep Problems and the Neurodevelopmental Phenotype 
The neurodevelopmental phenotype as referred to in Chapter 1, section 1.3 (page 8) is being 
used to define the neurodevelopmental problems (Attention-deficit hyperactivity disorder, 
and Autism spectrum disorders predominantly) and other psychiatric morbidities (anxiety, 
conduct and oppositional defiant disorders and schizophrenia) based on the underlying 
genetic predisposition to these morbidities. This definition is derived from the paper by 
Mullin, A.P. et al. (Mullin et al., 2013) which explores the definition of neurodevelopmental 
disorders and the contributions from the genome and specifically the genotype which is of 
relevance to the 22q11.2DS population in this thesis. 
This thesis includes neurodevelopmental disorders (NDDs), psychiatric disorders and 
cognitive deficits. There are disorders discussed that can be defined as neurodevelopmental, 
psychiatric and possibly behavioural, such as Attention-deficit hyperactivity disorder (ADHD). 
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Throughout, reference to the collection of disorders as a group that is outlined in this section 
of the thesis will be done so as the ‘neurodevelopmental phenotype’.  
2.1.3.1 Sleep in Neurodevelopmental Disorders (NDDs) 
NDDs are characterised by impaired emotional, psychological and physical development and 
can include communication disorders and learning disabilities. One of the most common 
features of NDDs is sleep problems, which have a reported prevalence as high as 86% (Wiggs, 
2001; Malow et al., 2006; Johnson and Malow, 2008; Reynolds and Malow, 2011). Sleep 
problems feature in the diagnostic criteria for developmental disorders, including Angelman 
syndrome (Owens and Palermo, 2008; Robinson-Shelton and Malow, 2016).  
Features such as inattention can present as behavioural symptoms of NDDs, but could be a 
consequence of an underlying sleep problem, or both (Owens, 2009). It can be difficult to 
determine the aetiology of certain symptoms and to determine whether sleep problems are 
consequential or causative of behavioural problems. 
A vicious circle of behavioural problems that are exacerbated by the sleep problems, which in 
turn themselves, further increase the risk of poor behaviour as a result of poor sleep (Corkum, 
Tannock and Moldofsky, 1998; Esbensen et al., 2017). Behavioural and sleep problems are 
inherently intertwined, for example bedtime resistance and anxiety-related problems 
(Iwadare et al., 2015) are prevalent in NDDs. 
Attention-Deficit Hyperactivity Disorder 
There is a large literature regarding sleep problems in ADHD with reported rates ranging from 
25-50% (Wiggs, 2001; Robinson-Shelton and Malow, 2016) regardless of the particular 
subtype of ADHD whether symptoms of hyperactivity-impulsivity or inattentiveness are 
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dominant, or a combination of both presenting as the combined subtype. Parental reports, 
as well as objective assessment of sleep such as actigraphy, have been used in cohorts of 
young people with ADHD, with findings showing consistent disturbance (Corkum et al., 2001; 
Owens, 2008): shorter total sleep times from these objective studies with evidence of wake 
after sleep onset and fragmentation of sleep have been shown. These symptoms and reports 
of sleep disorders in ADHD including restless legs syndrome and periodic limb movements, 
sleep-disordered breathing and hypersomnia (Silvestri et al., 2009) suggest sleep 
interventions are required.  
In ADHD, there is the added problem of controlling the hyperactive-impulsive behaviours 
through medication such as methylphenidates (O’Brien et al., 2003) which adversely affect 
sleep by stimulating the young person and can mean that melatonin is prescribed in many 
children with ADHD to promote sleep (Van der Heijden et al., 2007; Cortese et al., 2013). 
Autism Spectrum Disorders 
Elevated rates of sleep problems of ~40-80% in young people with ASD (Souders et al., 2009) 
have been identified since the nineteen-nineties (Richdale and Schreck, 2009) with problems 
including restless sleep parasomnias, bedtime resistance, insomnia and daytime sleepiness 
(Johnson and Malow, 2008; Souders et al., 2009).  
Different sleep problems required different treatments: melatonin is commonly used in ASD 
to mitigate sleep problems. In some young people with ASD, a deficient melatonin profile is 
identified (Melke et al., 2007) leading to a chaotic sleep-wake cycle. Medication is the most 
effective treatment in these young people however not all individuals with ASD have a 
melatonin-deficiency and behavioural programmes and parent-based sleep education can 
prove to be effective (Malow et al., 2014). Sleep hygiene is used as a behavioural intervention 
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for many children experiencing sleep problems. This intervention is shown to work in children 
with NDDs (Blackmer and Feinstein, 2016). The idea of sleep hygiene is that routines are 
developed around bedtime and an environment is constructed to be conducive to sleep such 
as no phone in the bedroom, a comfortable bed and a window kept ajar (Hiscock et al., 2015).  
Each child responds to treatment differently so the possibility of a range of options in young 
people with NDDs such as sleep hygiene practices, cognitive behavioural therapy and 
medication can give each child the best chance of improving their sleep problems.  
2.1.3.2 Psychiatric Disorders and Sleep Problems 
Studies of REM sleep in individuals with psychiatric disorders such as post-traumatic stress 
disorder have shown reactivation of memories and replaying traumatic events, but in a state 
of sleep where biochemical responses and stress hormone levels are supressed (Lipinska et 
al., 2014). This theory suggests that physiological responses to the traumatic events can 
reduce over time (van der Helm et al., 2011) but other studies suggest that sleep deprivation 
after a traumatic event prevents consolidation of the memory which is better for long-term 
health and recovery (Harvey, Talbot and Gershon, 2009; Pace-Schott, Germain and Milad, 
2015). Nonetheless, there is substantial evidence linking sleep and emotion, and resultantly 
sleep to mental health. This section reviews sleep problems in psychiatric disorders. 
Anxiety disorder and depression 
Sleep problems are considered ‘core symptoms’ of depression (Nutt, Wilson and Paterson, 
2008) with around 75% of adults with depression having insomnia, and there are reports of 
hypersomnia in up to 40% of young depressed individuals (Nutt, Wilson and Paterson, 2008). 
Depression often presents comorbidly with anxiety (Hirschfeld, 2001) with ~24-36% of 
individuals with insomnia and ~27-42% with hypersomnia having an anxiety disorder (Ford 
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and Kamerow, 1989; Breslau et al., 1996; Staner, 2003). There is evidence of reduced latency 
to the first REM stage of sleep in depression and anxiety (Spiker et al., 1978; Papadimitriou, 
Linkowski, et al., 1988; Wilson and Argyropoulos, 2005) and prolonged REM sleep with more 
sleep fragmentation (Nutt, Wilson and Paterson, 2008). This can result in increased tiredness 
resulting in more daytime naps and sleepiness (Breslau et al., 1996). 
Conduct (CD) and oppositional defiant disorder (ODD) 
As disruptive behavioural disorders, young people with CD and ODD have shown to have a 
high prevalence of sleep problems resulting in a reduction in total sleep time and reduced 
sleep efficiency when compared to age-matched children (Aronen et al., 2014). Elevated 
prevalence and severity of externalising problems including physical aggression are 
characteristic of CD, and other symptoms such as temper tantrums that present in CD, 
associate with more sleep problems (Paavonen et al., 2002; Lycett et al., 2015). The reported 
frequency of other externalising problems indicative of CD such as bullying and aggressive 
behaviours have been shown to be elevated in individuals that are at an elevated risk for 
sleep-disordered breathing compared to young people not at risk for sleep problems. 
Associations between the conduct symptoms and restless legs syndrome and periodic limb 
movements, both pathological sleep disorders, was also demonstrated in the same study 
(Chervin et al., 2003). 
Schizophrenia 
Insomnia-like sleep disturbance occurs in approximately 80% of individuals with a SCZ 
diagnosis (Wulff et al., 2012) with experience of delayed sleep onset as well as heightened 
nocturnal activity (Foster and Kupfer, 1975). Profound circadian misalignment, circa-bidian 
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rhythms (around-48-hours) (Hofstetter, Lysaker and Mayeda, 2005) as well as other non-24-
hour rhythms have been shown in SCZ (Pritchett et al., 2012; Zanini et al., 2013).  
Sleep problems and symptoms of the neurodevelopmental phenotype are intertwined with a 
perpetual cycle of poor sleep exacerbating symptoms. Balancing the treatment of sleep and 
psychiatric, behavioural or cognitive symptoms is required for the optimal prognosis.  
2.1.4 Copy Number Variants and Sleep Problems  
Sleep problems can be one of the possible consequences of carrying a CNV associated with 
high risk of neurodevelopmental disorder. The sleep problems can be a direct consequence 
of aberrant protein expression caused by the genetic lesion, or an indirect result, where they 
are linked to the comorbidities arising from the genetic lesion. The literature on sleep 
problems in CNV carriers is quite sparse, however, some syndromes have received a degree 
of research attention.  
2.1.4.1 Smith-Magenis Syndrome  
Smith-Magenis syndrome (SMS) is characterised by a deletion or mutation on/at 
chromosome 17 at locus p11.2 and is associated with prominent sleep and circadian rhythm 
disruption (SCRD) reported in up to 98% of individuals (De Leersnyder, 2012). A missense 
mutation in the retinoic acid 1 gene (RAI1) disrupts circadian CLOCK gene function giving rise 
to an inversion of the melatonin circadian rhythm profile. Individuals with SMS do not entrain 
to their environment shown by a delay in the melatonin peak which is observable at 4 a.m. in 
typically developing individuals (De Leersnyder et al., 2001).  
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2.1.4.2 Angelman Syndrome 
Angelman syndrome (AS), caused by a number of different genetic abnormalities that occur 
on chromosome 15 at the loci q11-13 which is a locus susceptible to genomic imprinting 
(Clayton-Smith and Laan, 2003), is also associated with prominent sleep problems such as 
reduced total sleep time, disrupted sleep architecture with reduced REM sleep, and nocturnal 
limb movements (Goldman, Bichell, et al., 2012; Robinson-Shelton and Malow, 2016). 
Atypical neurodevelopment in AS also suggests that dysregulation of GABA-mediated 
inhibition in thalamocortical interactions disrupts sleep-wake regulation in these individuals. 
2.1.4.3 Williams Syndrome 
Williams syndrome (WS) is characterised by the deletion of 26 to 28 genes at locus q11.23 on 
chromosome 7. Sleep problems present in up to 97% of young people with reports of greater 
bedtime resistance, sleep anxiety, nocturnal awakenings and daytime sleepiness as well as 
poorer sleep efficiency and more respiratory-related nocturnal arousals compared to children 
without pathogenic CNVs (Mason et al., 2011; Ashworth et al., 2013). Hyperhidrosis, excessive 
sweating during sleep, is also seen in these individuals (Santoro et al., 2016), as are abnormal 
melatonin and cortisol (defined as the ‘stress hormone’ is a glucocorticoid steroid) circadian 
profiles. These profiles show more shallow troughs of cortisol concentrations and dampened 
increases in melatonin concentrations at bedtime compared to controls, and higher cortisol 
levels at bedtime maintaining wakefulness (Sniecinska-Cooper et al., 2015). 
These three examples show that sleep problems are a common feature of at least some 
pathogenic CNVs. For the majority of CNV syndromes, the exact reason for sleep problems 
remains unclear. Understanding the aetiology in CNV carriers affected by sleep problems is 
an important first step towards best practise for interventions and treatments. 
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2.2 Sleep Problems in 22q11.2DS 
There are currently no published systematic assessments of sleep in 22q11.2DS. This is in leu 
of considerable anecdotal evidence, based on parental reports to doctors, to researchers and 
through charities and social media.  
Mentioned in section 1.2 (pages 3-8) 22q11.2DS is commonly screened for due to the 
detection of cardiac abnormalities in utero and in new-borns (Lee et al., 2014; McDonald-
McGinn et al., 2015) or as a result of developmental delay in later childhood (Bassett and 
Chow, 1999; Swillen and McDonald-McGinn, 2015). In childhood, these problems are 
dominant and families seek advice and guidance from numerous professionals to provide 
support for their child with many individuals requiring numerous assessments early in 
childhood (Bassett et al., 2011).  
In young people regardless of psychiatric disorders, sleep problems can be disruptive to the 
individual and family, acting negatively on daytime behaviours (Stores, Wiggs and Campling, 
1998). However, having disturbed sleep in addition to a predisposition to a psychiatric 
disorder, cognitive impairment, behaviour difficulties and physical problems adds to a more 
complex phenotype. This section of the thesis aims to explore the scant literature regarding 
sleep problems in 22q11.2DS, highlighting the need for further understanding.  
Anecdotally, parental reports have shown consistently high rates of sleep problems in 
22q11.2DS, however the literature is scant other than report of sleep-related breathing 
disorders (SRBD), especially obstructive sleep apnoea (OSA) (Spruijt et al., 2012; Crockett et 
al., 2014; Kennedy et al., 2014; Silvestre et al., 2014a). The incidence of OSA is estimated at 
~10% of young people with 22q11.2DS, compared to only 2-4% in typically developing 
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children (Chang and Chae, 2010; Kennedy et al., 2014). OSA is characterised by an obstruction 
or occlusion in any part of the upper airway (Waters, Suresh and Nixon, 2013), reducing the 
capacity for air to enter the lungs and making breathing difficult, especially when lying down. 
Individuals with 22q11.2DS commonly have high arched palates and cleft palate that is 
present in 9-11% of individuals (Heike et al., 2007; Crockett et al., 2014; Kennedy et al., 2014), 
and narrowed airways (Bassett et al., 2011) elevating the risk for OSA (Kennedy et al., 2014). 
Hypotonia can result in OSA, where there is reduced muscular tone leading to lack of support 
and stability in the neck and jaw (Crockett et al., 2014). Hypoplasia and small occluded 
airways, as well as airways prone to collapse, also factor into the risk for OSA and all of which 
are common in 22q11.2DS. Another factor contributing to risk for OSA is the presence of 
hypertrophic adenoids and tonsils in children with 22q11.2DS (McDonald-McGinn, Emanuel 
and Zackai, 1993).  
The physical phenotype of OSA leads to subsequent problems such as effected breathing 
during sleep. It is also important to understand how impaired breathing during sleep can 
influence the behaviour and cognitive phenotype of an individual, whether they are a young 
person with 22q11.2DS (Heike et al., 2007; Kennedy et al., 2014)or an individual without a 
genetic lesion (Bourke et al., 2011). There is evidence of OSA and cognitive impairment in the 
wider literature that is not isolated to childhood (Lal, Strange and Bachman, 2012).  
There is a literature base focussing on the behaviours and problems that manifest as a result 
of SRBD and OSA: ADHD-like symptoms are common with increased inattentive and excessive 
daytime sleepiness (Gaultney, Terrell and Gingras, 2005; Wiggs, Montgomery and Stores, 
2005) for example. Often the problems which manifest from OSA can be interpreted as 
behavioural or neurodevelopmental problems with one study showing attentional deficits in 
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up to 95% of individuals with OSA and an incidence of 20-30% of OSA in clinical ADHD-
diagnosed individuals, supporting the interlinking diagnoses and symptomology (Youssef et 
al., 2011).  
To assess sleep-related breathing, a gold-standard diagnostic sleep assessment called a 
polysomnography (PSG) is required. This requires an individual to attend a sleep clinic and 
have physiological measures such as pulse oximetry, limb movements and respiratory rate 
and pressure assessed. There have been a small number of studies that using PSG in 
individuals with 22q11.2DS. One study included 21 individuals with 22q11.2DS who 
underwent a PSG with the results showing that 48% scored for SRBD and within those 
individuals, 43% reporting sleepiness (Moraleda-Cibrian et al., 2014). Similarly, another 
patient cohort study, including 26 individuals with 22q11.2DS, showed that young people with 
22q11.2DS were at the highest risk for a positive OSA outcome compared to other individuals 
with similar syndromic cleft palate including Pierre Robin Sequence. 50% of the young people 
with 22q11.2DS scored for SRBD in the Paediatric Sleep Questionnaire (PSQ)-SRBD scale 
(Silvestre et al., 2014a). 
The only report of sleep problems in 22q11.2DS outside of OSA forms part of a wider study of 
the phenotype of 22q11.2DS where sleep problems were mentioned, yet there was no 
emphasis on the issue. Higher scores on the Child Behaviour Checklist (CBCL) (Achenbach, 
1992) for sleep problems in girls compared to boys with 22q11.2DS were identified (Briegel, 
Schneider and Schwab, 2008) yet only four questions regarding sleep problems are included 
in the CBCL, so this must be taken with caution.  
This thesis will be the first to identify and report sleep problems in these young people, 
hopefully instigating further research into sleep problems in 22q11.2DS. 
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2.3 The Neurophysiology of Sleep  
The process of falling asleep can be defined as ‘-a link between two general states of 
consciousness, wakefulness and sleep’ (pages 157-185) (Cvetkovic and Cosic, 2011). This 
quote suggests that there are different states of consciousness between daytime activity and 
sleep. Therefore, it is not naïve to derive that wakeful neurophysiology is different from sleep 
neurophysiology.  
The state of sleep itself is comprised of two general stages defined as non-rapid eye 
movement (NREM) sleep and rapid eye movement (REM) sleep. NREM is composed of stages 
1, 2 and 3 which are characterised by differences in the waveforms and physiology presented. 
During sleep, different percentages of time are spent in different stages and across a lifetime, 
the composition of a night’s sleep changes. Neonates spend ~50% of time in NREM and 50% 
in REM sleep, with 50-minute sleep cycles whereas adults spend on average 18-25% of a 
night’s sleep in REM with a full-sleep cycle equating to around 90-minutes (Foster et al., 1976).  
The following section will briefly highlight the fundamentals of typical sleep physiology. In 
Chapter 7 (pages 202-214) comprehensive descriptions of the detected neurophysiology that 
are required for the scoring and recognition of each stage of sleep is outlined to allow for 
interpretation of the results. 
2.3.1 Wake 
Sleep initiates with wake and the physiology of wake is important with regards to the 
transition into sleep. The sleep-wake cycle aligns with the light-dark cycle illustrating a 
circadian pattern of alignment to the environment based on biological cues such as light 
(Roenneberg and Merrow, 2016). The neurophysiology of wake is distinctive to sleep yet 
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there are overlapping waveforms present in both. Wake activity comprises of gamma, beta 
and alpha waveforms. Gamma is detectable at the highest frequency range (25 to 100 Hz), 
commonly at 40 Hz and originates from the thalamus but is traceable across the cortex (Başar-
Eroglu et al., 1996). Beta activity is often 13-25 Hz, with some literature reporting up to 30 Hz 
(Groppe et al., 2013). This activity characterises a state of high alertness and focus in an 
individual during wake (Kamiński et al., 2012). Alpha activity (8-14Hz) centralises to the 
occipital cortex and is present in quietened and relaxed wakefulness (Blume, 2006) and is the 
dominant waveform detected when eyes are closed. Alpha activity can continue into sleep as 
background activity. 
2.3.2 Non-Rapid Eye Movement Sleep (NREM) - Stage 1  
Stage 1 features high frequency and low voltage activity, but can be identified mostly by low-
amplitude mixed frequency (LAMF) waveforms, slow eye movements and a transition from 
alpha activity into theta frequencies (4-8 Hz) (Biswal et al., 2010). Theta waves are not isolated 
to sleep and have been evidenced in situations of stress in adults during wake however 
detection of theta is most prominent in stage 1 where the frequency proliferates (Singh et al., 
2015).  
In addition, sharply contoured waves called ‘vertex sharp waves’ are seen in the transition to 
stage 1 from other stages of sleep and are dominant across centralised regions of the brain. 
This waveform acts as a marker for the transition of stages, a process that can be difficult to 
detect from an EEG (Stern et al., 2011). 
Stage 1 transition from wake at the beginning of the night can be defined as a ‘hypnagogic’ 
state. This first stage 1 of the night in children can feature ‘hypnagogic-hypersynchrony’ which 
is high-amplitude, sinusoidal, 3-4 Hz paroxysmal bursts of waves seen globally but mainly in 
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frontocentral regions of the cortex. This activity is only detectable in young children and as a 
result, highlights some differences in brain activity between adults and children, with the 
stabilisation of most wave forms occurring around 11 years old (Berry et al., 2016).  
2.3.3 NREM - Stage 2 
Stage 2 of NREM sleep is characterised by the dominance of theta waveforms (4-8 Hz) and 
symbolic features called ‘K-complexes’ and ‘sleep spindles’ (Caporro et al., 2012).  
K-complexes in stage 2 are negative, sharp waves followed immediately by a positive 
induction. The positive induction is apparent from the background EEG and will occur in 
isolation of arousal or artefacts (Berry et al., 2012). K-complexes are measured maximally 
across the frontal cortex and last for a duration of at least 0.5 seconds. K-complexes are 
particularly interesting to study with regards to evoked-potentials (Colrain and Campbell, 
2007). K-complexes can contribute to the slow wave frequency band range (0.5-0.9 Hz) and 
the characteristic shape of K-complexes has been used to prove that they contribute to the 
1-4 Hz frequency band and therefore the delta band range (Steriade and Amzica, 1998).  
Sleep spindles are lengths of sinusoidal waveforms lasting for at least 0.5 seconds, detectable 
at 11-16Hz but most commonly at 12-14Hz (Iber, 2007; Berry et al., 2012). Spindles are a 
defining feature of stage 2 sleep but can occur during stage 3 also however their presences 
can be obscured by slow-wave oscillations (Cox et al., 2017).  
Sleep spindles can be divided into two classifications: slow (~10 Hz) and fast spindles (~13 Hz) 
based on the theory that slow and fast spindles serve distinct functional roles (Tamaki et al., 
2008; Hoedlmoser et al., 2014). Sleep spindles derive from the thalamus (Steriade et al., 1987) 
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and slow spindles are detected more densely in the frontal cortex whereas fast spindles are 
seen more centrally and parietally.  
 
 
 
 
 
 
Sleep spindles are important in exploring the role of sleep in cognitive processing and learning 
with the detection of sleep spindles indicative of sleep-dependent learning (Gais et al., 2002). 
By completing memory or motor tasks pre- and post-sleep can allow for spindles to be 
analysed in relation to the cognitive task performance (Walker et al., 2002).  
2.3.4 NREM - Stage 3 
Stage 3 is characterised by slow-wave oscillations at frequencies ~0.5-2Hz and delta 
frequencies which include the slow-wave oscillation but include higher frequencies ranging 
from 0.5-4Hz. These oscillations can be best measured by EEG locally at the frontal cortex of 
the brain. Stage 3 of NREM sleep can be defined as the period of ‘deep-sleep’ (Fujitani and 
Hosogai, 1983) or consolidative sleep and is the stage characterised with the lowest frequency 
waveforms. 
 
Figure 2 An example of a fast sleep spindle averaged from the central electrodes on an EEG 
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Slow-
waves oscillations originate from and are modulated in the neocortex (Achermann et al., 
1993). Synchronised coupling of slow-wave oscillations with sleep spindles provides evidence 
of sleep-dependent memory consolidation (Rasch and Born, 2013).  
Across a single night, the duration of slow-wave sleep per 90-minute sleep cycle will 
depreciate (Achermann et al., 1993). This is mirrored by the progressively increasing duration 
of REM sleep throughout the night with the longest time spent in REM in the early morning 
of the sleep period (Endo et al., 1981).  
2.3.5 Rapid Eye Movement (REM) Sleep  
REM sleep is characterised by rapid eye movements and ‘saw tooth waves’ which present as 
sharply contoured trains of waves that appear serrated and occur at 2-6 Hz (Berry et al., 2012). 
The neurophysiology of REM sleep is comparable to wake activity and can be difficult to 
detect on EEG traces when not coupled with other physiological markers (see Chapter 7). 
The purpose of REM sleep remains unknown however one theory suggests that REM is 
responsible for emotional processing and disconnection. Communication between the 
amygdala and the ventromedial prefrontal and dorsolateral prefrontal cortex can contribute 
emotional disconnection in healthy humans, dampening emotional responses to memories 
and thoughts (Walker and van der Helm, 2009).  
Figure 3 Examples of averaged slow-waves featuring delta across fronto-central-occipital regions of 
an EEG 
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2.4 Neurophysiology of Sleep in the Neurodevelopmental Phenotype 
There is limited work in the paediatric literature regarding sleep EEG. Where there is 
literature, the investigation of epileptiform activity dominates with scant literature regarding 
the significant of sleep physiology in the neurodevelopmental phenotype. This limits the 
understanding of interactions between brain mechanisms and sleep such as motor learning 
and sleep in young people (Walker et al., 2002). There are however more studies regarding 
adults and their electrophysiology including sleep EEG in adults with NDDs.  
Nonetheless, the small number of studies investigating sleep electrophysiology in the 
neurodevelopmental phenotype in young people are outlined in this section.  
2.4.1 Neurophysiology of ADHD 
The number of overnight EEG studies that have been conducted with young people with 
ADHD are limited. However, there are studies that include small samples of individuals where 
sleep-EEG was conducted to cross-validate other objective measures such as actigraphy or 
subjective measures of sleep in these individuals such as sleep questionnaires and sleep 
diaries/logs.  
One study conducted overnight polysomnography (PSG) including sleep-EEG and additional 
cardiorespiratory measures in young people with ADHD (O’Brien et al., 2003). This study 
included n=47 individuals with ADHD recruited from a clinic, n=53 individuals with ADHD 
recruited from a community sample and n=49 controls. The young people wore the sleep-EEG 
measures for 12 hours over a single night and showed that there were substantial differences 
between groups in the REM onset latency and the percentage of time spent in REM sleep. 
The clinical ADHD groups showed lower spontaneous arousals than both other groups and 
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there were a higher number of periodic limb movement arousals in the ADHD young people 
compared to the controls. Objective investigation of sleep in ADHD showed the prevalence of 
disturbance. This was further supported by other studies that investigated disturbed sleep in 
young people with ADHD with objective methods. A smaller n=55 investigation of young 
people with ADHD only (mean age of 8.9 years old), used overnight video-polysomnography 
coupled with a subjective behavioural assessment and structured sleep interview to assess 
sleep in ADHD. Many of the individuals had a hyperactive-impulsive or combined subtype of 
ADHD (n=39); n=16 with inattentive ADHD subtype. An abnormal EEG was evident for 23.6% 
(n=13) of the sample when assessing the overnight video-PSG, and 40% (n=22) of the sample 
were objectively assessed to have periodic limb movements during sleep (Silvestri et al., 
2009). 
Crabtree et al. studied a sample of young people identified from two sources: a paediatric 
sleep medicine centre and a community survey sample in the USA. The young people that 
were sourced from the sleep centre completed a single night of PSG. From this sample of 
young people, those individuals identified to have periodic limb movement disorder (PLMD) 
were allocated into one group. Among this group, the individuals were further divided into 
individuals with ADHD and those without ADHD (PLMD only). Therefore, there was one group 
with PLMD and ADHD, and another group of young people with PLMD only.  
The parents of the young people from the community control sample completed a detailed 
sleep habits questionnaire. The questionnaire contained questions regarding ADHD-like 
activities. Where the parents reported no ADHD or snoring (PLMD only), these young people 
from the community sample were invited to participate as a control group.  
   
47 
 
There were n=90 young people identified to have PLMD by the PSG and n=40 of these young 
people with PLMD also presented with ADHD. The young people with PLMD and ADHD were 
shown to spend a smaller percentage of the night in REM sleep compared to the group with 
PLMD only, and the controls. Additionally, the PLMD and ADHD group recorded a higher 
apnoeic-hypopneic index and spontaneous arousal index throughout the night compared to 
the PLMD only and control groups, suggesting that the young people with PLMD and ADHD 
presented with a more severe sleep phenotype compared to the PLMD only group (Crabtree 
et al., 2003). 
There is a scant literature regarding sleep-EEG investigation in young people with ADHD 
however those studies that are present do show consistent reports of disturbed 
neurophysiology but do not provide electrophysiological or waveform analyses.  
2.4.2 Neurophysiology of ASD 
Epileptiform activity is commonly identified by EEG in young people with ASD in the absence 
of clinical seizures (Chez et al., 2004). Daytime EEG can provide an assessment of 
neurophysiology during wakefulness however to reliably measure epileptiform activity, the 
hypnagogic and hypopneic brain activity needs to be accounted for. These two states occur 
as an individual is falling asleep (hypnagogic) and when an individual is waking up (hypopneic) 
and therefore transitioning between sleep and wake (Harvey and Barnes, 1996). Seizure-
related activity is not isolated to sleep in ASD individuals, yet it shows a preponderance during 
sleep (Chez et al., 2006). Therefore, 24-hour EEG is required to comprehensively assess brain 
activity incorporating sleep neurophysiology. Overnight ambulatory EEG discovered 
abnormalities in brain activity during sleep in young people with ASD (Chez et al., 2004).  
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Overnight EEG demonstrates abnormalities in slow-wave and delta activity during NREM 
sleep in young people with ASD and reductions in delta activity compared to a typically 
developing control group (Rochette et al., 2018). This reduced delta power focussed over the 
parieto-occipital region and contributed to findings that suggest abnormalities in the 
thalamocortical system in individuals with ASD. This study was further supported by 
additional findings in a small (n=13) sample of young male participants with ASD (Lehoux, 
Carrier and Godbout, 2018). Slow-wave oscillations in this sample were shown to have fewer 
and smaller differences in the slow-wave density, amplitude and frequency across the cortex 
when compared to typically developing age-matched controls.  
ASD is an overarching diagnosis which includes a broad range of individuals that have variable 
intellectual functioning. One study of high-functioning individuals with ASD showed reduced 
beta activity during REM sleep over the temporal-occipital regions compared to typical 
controls (Daoust et al., 2004). Elevated absolute theta however was observed over the frontal 
cortex compared to controls suggesting atypical physiology in the frontal cortex in ASD 
compared to controls and contributes to the literature suggesting atypical thalamocortical 
mechanisms in ASD.  
Accessibility to 24-hour assessments and investigation into atypical sleep physiology in ASD 
contributes to a better understanding of brain activity abnormalities throughout the 24-hour 
period showing a persistent problem during wake and sleep that is not isolated to daytime 
activity and wakefulness. 
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2.5 Neurophysiology of Sleep and Psychopathology 
This section will focus on the neurophysiology of sleep in psychiatric disorders relevant to the 
neurodevelopmental phenotype of 22q11.2DS.  
2.5.1 Neurophysiology of Anxiety Disorders  
Widespread sleep disturbance is common in individuals with anxiety disorders. According to 
the DSM-5 criteria for the diagnosis of generalised anxiety disorder (GAD), tiring easily, more 
fatigued than usual and difficulty sleeping (insomnia-related) are incorporated into the 
physical problems assessed (Kocsis, 2013). This demonstrates the inter-relationship of sleep 
and anxiety and suggests that objective assessment of sleep neurophysiology is of importance 
to understanding the relationship better.  
Sleep studies that include sleep EEG assessments have shown reduced number of awakenings 
and transitions between stages during the night’s sleep, in addition to prolonged REM latency 
but a shortened duration of REM sleep (Papadimitriou, Kerkhofs, et al., 1988) in individuals 
with anxiety disorder. Individuals with GAD showed a longer sleep onset latency, taking longer 
to transition from wake into sleep and a shorted total sleep time and time spent in stage 2 of 
NREM sleep when compared to control individuals.  
Additional studies have suggested that disturbed sleep stage transitions and differing lengths 
of time in sleep stages compared to typically developing controls is common. A young person 
sample of individuals with anxiety disorders showed elevated nocturnal awakenings 
compared to individuals with major depressive disorder, in addition to prolonged sleep onset 
latency compared with both the MDD and control groups (Forbes et al., 2008; Alfano et al., 
2013).  
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There is consensus in the literature that sleep EEG studies have shown consistency in their 
objective measurements: prolonged sleep onset latency and differences in the transitions into 
REM sleep and time spent in REM relative to stage 3 suggesting increased REM sleep which is 
of higher frequency and reduced time spent in stage 3 where slow-wave oscillations dominate 
and lower frequency neurophysiology is detected. These variable durations spent in stages of 
sleep compared to typically developing individuals can be coupled with dysregulation of 
neurotransmitter concentrations especially serotonin in anxiety disorders with extracellular 
concentrations of serotonin contributing to changes in slow-wave (stage 3) and REM ratios 
during a night’s sleep (Portas, Bjorvatn and Ursin, 2000).  
Anxiety disorders are highly preponderant in 22q11.2DS and one study showed that 
psychotropic medications in young people with 22q11.2DS were effective in treating anxiety 
diagnoses with high tolerability (Dori et al., 2017). The presence of medication in young 
people with 22q11.2DS should be considered when assessing the relationship of anxiety 
disorders and sleep.  
2.5.2 Neurophysiology of Schizophrenia 
Deficient sleep spindles (see section 2.3.3, page 41) characterised by a reduced number, 
amplitude and density have been identified in medicated and non-medicated individuals with 
SCZ (Manoach et al., 2016). Studies have shown similarities in spindle amplitude between the 
first-degree relatives of individuals with SCZ and healthy controls suggesting spindles are 
representative of a genetic lesion in SCZ (Manoach et al., 2016; Cosgrave, Wulff and Gehrman, 
2018). 
Additionally, deficient slow-wave oscillations hypotheses exist. The thalamic reticular nucleus 
(TRN) (Lewis et al., 2015) relays signals to the thalamus and cortex resulting in the production 
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of slow-wave oscillations. Disturbance to the TRN in SCZ could contribute to the decrease in 
delta-power and reduced frequency, amplitude and abundance of slow-wave oscillations 
(Keshavan et al., 1998). 
2.6 22q11.2DS Neurophysiology  
There are few studies investigating neurophysiology in 22q11.2DS and those studies including 
EEG as a technique have focussed on assessments for seizures and epilepsy (Eaton, C.B. et al. 
in submission) and assessment of motor dysfunction (Biria et al., 2018). Despite no report of 
sleep neurophysiology in 22q11.2DS, these studies are important as they confirm that there 
is aberrant brain physiology in individuals with 22q11.2DS.  
Impairments in source activations and reduced amplitudes of waveforms involved in visual 
processing (Biria et al., 2018) have been reported as well as spike-wave complexes having 
been identified in 22q11.2DS. The rate of epilepsies is higher than the general population with 
one study suggesting 15.2% of the sample experienced epileptic seizures, higher than the 
prevalence of developmental delay (Kim et al., 2016). There are also different types of 
epilepsy seen in 22q11.2DS, with one review showing out of n=88 individuals with epilepsy, 
44% of patients with epilepsy reported focal epilepsy and 27% generalised epilepsy 
(Mudigoudar et al., 2017). These potential epileptiform discharges in 22q11.2DS further 
support the claim of aberrant neurophysiology in 22q11.2DS and further support the 
investigation of sleep physiology in 22q11.2DS to see whether the wake abnormalities are 
also detectable during sleep. 
Neuroanatomical differences in 22q11.2DS compared to typically developing controls such as 
a reduced hippocampal volume could be relevant to sleep as sharp-wave ripple activity 
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originates in the hippocampi (Eschenko et al., 2008). Abnormalities in the volume of the 
hippocampi and reports of hippocampal mal-rotation in 22q11.2DS could suggest disruption 
of the translation of short-term stored memories from the limbic system to the neocortex 
during slow-wave sleep (Andrade et al., 2013).  
There are widespread neurological changes in young people with 22q11.2DS including 
increased cortical surface area in the sensorimotor cortex (Sun et al., 2018), reduced 
cerebellum size, reduced cerebellar grey matter and white matter in the frontal lobe 
(Campbell et al., 2006) linking neuroanatomical changes in 22q11.2DS to sleep. Sleep 
deprivation in addition can effect brain physiology by promoting inflammatory processes 
which change the brains sensitivity to hormones like insulin and leptin (Suarez, 2008). There 
is already poor homeostatic regulation of the endocrine system in 22q11.2DS so the additive 
impact of sleep deprivation could potentially have further impact on brain anatomy. 
There is currently no known origin for sleep problems in 22q11.2DS. Beginning to explore the 
sleep neurophysiology of individuals with 22q11.2DS could help to better understand what is 
happening at a fundamental neurological level during a night’s sleep. To do this, an overnight 
sleep EEG is required. This thesis aims to describe the first study to systematically assess sleep 
in this high-risk population.  
2.7 Aims of Thesis 
The main aim of the thesis is to better understand sleep problems in young people with 
22q11.2DS as well as explore the links with their other problems such as within the 
neurodevelopmental phenotype. These aims are based on the information outlined in the 
introductions in Chapters 1 and 2.  
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To address this main aim, there were three aims developed with objectives.  
1. The first aim was to understand the prevalence, severity, nature and type of sleep 
problems in young people with 22q11.2DS by conducting comparisons with their 
unaffected sibling controls. To achieve this, primary carer reports of sleep problems 
from the semi-structured Child and Adolescent Psychiatric Assessment (CAPA) 
interview were compared between groups and assimilated into factors which best 
described the patterns of sleep problems reported in 22q11.2DS. 
2. The second aim was to describe the associations between the sleep problems and 
neurodevelopmental phenotype within young people with 22q11.2DS. The objective 
was to use the derived patterns of sleep problems from the first aim to further explore 
associations with the neurodevelopmental phenotype including psychiatric outcomes, 
neurodevelopmental disorder and cognitive deficits. 
3. Aim three worked to better understand the physiology of sleep problems in young 
people with 22q11.2DS, by conducting comparisons with their unaffected sibling 
controls. To achieve this, an ambulatory sleep study was developed to assess the 
neurophysiology of participants using electroencephalography (EEG); 
cardiorespiratory measures and 24-hour sleep-wake activity using actigraphy watches 
with a complementing sleep diary. The aimed outcomes to be derived from the 
measures are: hypnograms and basic measures of sleep stages from the objective EEG 
analysis (for example percentages of the night spent in each sleep stage); objective 
nocturnal activity from the actigraphy watches in addition to sleep parameters such 
as sleep onset latency and sleep timings, analysed using a standardised protocol and 
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subjective measures of sleep from the validated sleep questionnaires and the sleep 
diary.  
It was predicted that:  
1. for aim one, the prevalence and severity of sleep problems in 22q11.2DS would be 
elevated compared to the unaffected control siblings and the typically developing 
paediatric population, and that sleep problems would be related to each other, 
therefore one dominant factor would encompass the different sleep problems. This is 
based on the evidence for a high preponderance of sleep problems across CNV genetic 
syndromes, neurodevelopmental disorders and psychiatric disorders (see section 1.3, 
pages 8-23);  
2. for aim two, that elevated symptoms of sleep problems would be associated with 
higher symptoms of the neurodevelopmental phenotype and with cognitive deficit;  
3. and for aim 3, differences in the percentage of time spent in sleep stages in 22q11.2DS 
compared to siblings, with longer periods of REM in 22q11.2DS and shorter NREM 
Stage 2 and 3 when analysing the EEG was expected. Elevated nocturnal activity was 
expected to be identified objectively in the 22q11.2DS young people compared to 
their siblings when analysing the actigraphy data, and sleep parameters to show 
prolonged sleep timings and increased sleep disturbances throughout the night such 
as increased wake after sleep onset compared to siblings. The sleep questionnaires 
were hypothesised to subjectively agree with the sleep problems reported by parents 
in the CAPA and would show concordance with some objective measures, but namely 
there would be differences in the parent reports compared to the objective measures, 
suggesting that multiple methods of sleep assessment are required to 
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comprehensively assess sleep in the 22q11.2DS population and the typically 
developing sibling control group. It is important to note, that there is no analysis of 
individuals sleep architectural markers such as sleep spindles or slow waves. These 
markers were measured and are available for future analyses and investigation of the 
underlying sleep physiology in young people with 22q11.2DS. 
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Chapter 3 General Methodology  
The general methodology refers to the samples that have been used throughout this thesis. 
Therefore, the specific methodologies required for Chapters 5, 6 and 7 are not included in 
this chapter. The samples used throughout the thesis however are all outlined in this chapter 
for clarity.  
The ECHO Study (see section 3.1 and Appendices 1 and 2) and the IMAGINE-ID study (see 
section 3.2 and Appendices 1 and 2.) are the overarching studies where the young people 
with 22q11.2DS and the sibling control groups were recruited from to undertake sleep 
phenotyping and exploring the association between sleep problems and the 
neurodevelopmental phenotype (see Chapter 4, section 4.2.3). 
Young people from the typically developing population included in the Pilot Sleep Study (see 
Chapter 5, section 5.4) were recruited from the general population and colleagues with 
children at Cardiff University.  
The cohort of young people who wore actigraphy watches and completed sleep diaries as part 
of the Sleep Study (see Chapter 6, pages 162-164) were recruited from either the ECHO Study 
(see section 3.1) or the IMAGINE-ID Study (see section 3.2) as part of a follow-up assessment.  
The young people that undertook the polysomnography were individuals that were recruited 
as part of the same follow-up from the ECHO and IMAGINE-ID studies. There were fewer as 
this additional part of the sleep study was more invasive and considered problematic for some 
young people and parents. The cohort of individuals who undertook the polysomnography 
sleep study are outlined in Chapter 7, pages 217-220. 
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The different investigations were all cross-sectional: all analyses were conducted at a single 
time point. The only exception to this is the small sample longitudinal analysis which is 
included in Chapter 4.  
A subsample of adults is included in this thesis to demonstrate the prevalence of sleep 
problems in a separate adult sample. These individuals were taken from the DEFINE study 
(see section 3.3). The sample of toddlers were recruited through the ECHO Toddler Study (see 
page 3.10 and Appendices 1 and 2.) and were used in this thesis to show presence of sleep 
problems from a young age. Ultimately, the different sub-samples were used to demonstrate 
the persistence and maintained prevalence of sleep problems regardless of age of the 
individual with 22q11.2DS. 
For a diagrammatic explanation of how the ECHO Study works in conjunction with other 
studies mentioned in this thesis, see Appendices 1 and 2 (pages 327-329). How the samples 
were derived from the different studies are also included in the appendices. 
3.1 The ECHO Study 
The ECHO Study was designed to assess young people with CNVs with elevated risk for 
psychopathology and intellectual disability, with notable focus on 22q11.2DS. The aim was to 
understand their lifetime trajectories with regards to their psychological, intellectual and 
biological development.  
3.1.1 Recruitment  
Young people with 22q11.2DS were recruited through NHS Medical Genetics clinics in the UK, 
British 22q11.2DS charities (Max Appeal! 22qCrew and Unique) and social media 
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advertisements and family networks including ‘22qAwarenessDays’. Where available, a 
sibling control closest in age to the child with the deletion was also invited to take part in the 
ECHO Study. Carriers of the deletion and sibling controls were aged 6 or older and the 
presence (in carriers) or absence (in sibling controls) of the deletion was confirmed either by 
a Medical Genetics laboratory providing a medical genetics report, and/or a microarray 
analysis in the MRC Centre for Neuropsychiatric Genetics and Genomics laboratory at Cardiff 
University. There was no discrimination of the length of genetic lesion required to participate 
in the ECHO Study: individuals with both the 1.5 and 3-Mb deletions (see Chapter 1) on 
chromosome 22 were included in the analyses in this thesis.  
Consent was obtained prior to participation from carers who consented for all participants. 
Additional consent was obtained from participants aged ≥16 years with capacity, and assent 
was obtained from young people aged <16 years and children aged ≥16 years without 
capacity. The protocols used in the ECHO Study were approved by NHS South East Wales 
Research Ethics Committee. Additional ethics was required for the sleep and EEG Study and 
this was in the form of an amendment to the ECHO Study as it required additional measures 
that had not previously been used (see Chapters 6 and 7). 
3.2 The IMAGINE-ID Study  
The IMAGINE-ID Study is a collaborative project coordinated by researchers from Cardiff 
University, University College London and the University of Cambridge, as well as the UK rare 
chromosomal support charity, Unique. The IMAGINE-ID Study focusses on understanding 
genetics, intellectual disability and the behavioural phenotype, with the aim of understanding 
the lifetime trajectories and interactions of CNV genetic syndromes. This aligns with the aims 
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of the ECHO Study; however, the IMAGINE-ID Study focuses on a broader spectrum of CNVs 
specialising in CNV genetic syndromes with an elevated risk for intellectual disability. The 
IMAGINE-ID Study includes the recruitment of individuals with 22q11.2DS including young 
people and adults. Participants are not required to have completed assessments with the 
ECHO Study, however there are some individuals that have been seen cross-sectionally and 
followed-up by the IMAGINE-ID Study. 
3.2.1 Recruitment 
The IMAGINE-ID Study works cooperatively with UK NHS Genetics Clinics where many 
individuals are initially informed about participation. Cambridge University is responsible for 
the initial recruitment of the individuals and assimilation of the data. The Cardiff team are 
responsible for visiting the families and conducting similar assessments regarding psychiatric 
outcomes and cognition to the ECHO Study. Individuals participating in the IMAGINE-ID Study 
can also have participated in the ECHO Study or can consent to receiving additional 
information regarding other research studies including information about the Sleep Study. 
For further information regarding the overlap of the different studies, please refer to 
Appendices 1 and 2.  
3.3 The DEFINE Study 
The DEFINE Study aims to integrate basic and clinical neuroscience with animal, cellular and 
human studies to investigate high-penetrance mutations conferring risk for psychopathology. 
Of relevance to this thesis, the human aspect of the DEFINE Study assesses individuals over 
the age of 18 that have a CNV genetic syndrome conferring risk for psychopathology, including 
22q11.2DS. Phenotypic and behavioural assessments are conducted which are like those 
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undertaken by the ECHO Study. Neuroimaging and electrophysiological methods are also 
included in the DEFINE Study.  
A small subsample of individuals from the DEFINE Study (see Chapter 4) are included to 
explore the continued prevalence of sleep problems in individuals with 22q11.2DS into 
adulthood.  
3.4 The Study Samples  
This thesis includes multiple samples. These samples have been outlined in flow charts in 
Appendices 1 and 2 (pages 327-329). For methodology of the different investigations 
undertaken using the samples see the following chapters: Chapter 5 for the Pilot Study; 
Chapter 6 for the Actigraphy, Sleep Diaries and Sleep Questionnaires analyses and Chapter 7 
for the Polysomnography. 
3.5 Psychiatric Assessments 
The semi-structured Child and Adolescent Psychiatric Assessment (CAPA) (Angold et al., 1995) 
was conducted with the primary carer by trained psychologists for the assessment of young 
people aged 6-18 years old. Sections of the CAPA regarding mood and anxiety disorder were 
conducted with young people over the age of 12 to gain their perspectives and the psychotic 
experiences section of the CAPA was conducted with young people from age seven. This was 
only conducted if the individual was assessed to have capacity to answer and understand the 
questions. Primary carer and child self-report were both assessed for positive outcomes. The 
primary carer and the participant were asked to provide responses to the CAPA questions 
that were relevant to the past three months prior to the assessment date.  
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All interviews were audio recorded and research DSM-IV diagnoses were obtained. The CAPA 
assessments were all double-diagnosed with the individual completing the second diagnosis 
blind to the first assessors’ diagnostic opinion. When a particularly difficult case was 
presented to a researcher, review meetings led by a child and adolescent psychiatrist were 
held to ensure consistency and accuracy of diagnoses. 
The CAPA was used to obtain ADHD, anxiety, oppositional and conduct symptom counts as 
well as sleep problems. The presence of a symptom was counted if an individual scored one 
or two on the relevant question. Dichotomising such scores allowed for easier interpretability 
of the outcomes when summed to generate symptom scores for analyses and therefore, 
where there were individuals scoring ‘two’, ultimately these individuals were combined with 
the individuals scoring ‘one’ on the same item. On most items, the scoring was arbitrary and 
referred to a timescale of symptomology which was not explored in this thesis. 
3.5.1 Attention-Deficit Hyperactivity Disorder 
The overall ADHD symptom score included hyperactivity-impulsivity and inattentive 
symptoms and therefore, a separate score for hyperactivity-impulsivity and inattention 
symptoms could be derived. Where there was evidence of ADHD Diagnostic and Statistical 
Manual for Mental Disorders Fourth Edition (DSM-IV-TR) (Association and Association, 2000; 
Valo and Tannock, 2010) criteria of presence of symptomology before the age of 7, a research 
diagnosis could be derived.  
3.5.2 Anxiety 
The anxiety disorder symptom score included symptoms of generalised anxiety disorder, 
social phobia, specific phobia, separation anxiety, panic disorder with and without 
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agoraphobia, agoraphobia and obsessive-compulsive disorder. If any of these research 
diagnoses were scored for, the individual was given a classification of ‘any anxiety disorder’.  
3.5.3 Oppositional and Conduct Symptoms 
Oppositional Defiant Disorder (ODD) and Conduct Disorder (CD) symptoms were assessed by 
two subscales: oppositional behaviour and deception for ODD, and acts involving violence and 
violence against persons for CD. The two symptom scores overlap and literature suggests that 
many of the symptoms co-occur. As a result, a single research diagnosis indicative of CD and 
ODD can be given for use in research.  
3.6 Sleep Problems  
Sleep problems experienced over the past three months were established through the sleep 
section of the CAPA. There are thirteen questions included in this section (see Table 1). 
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Table 1 Sleep items in the CAPA 
Sleep items (CAPA) Description Scoring 
Insomnia Composite insomnia score 0, 1, 2 
Initial Insomnia Trouble initiating sleep 0, 1 
Middle Insomnia Trouble maintaining sleep 0, 1, 2 
Early Insomnia 
Early morning awakening without being 
able to return to sleep 
0, 1 
Medication for Insomnia Melatonin use 0, 1 
Hypersomnia 
Excessive daytime sleepiness and 
extended sleep duration 
0, 1, 2 
Restless sleep 
An inability to sleep comfortably and 
remain rested through the night 
0, 1 
Inadequately rested Lack of restorative and maintained sleep 0, 1 
Fatigability 
Difficulty in performing to the same 
standard as previously experienced day-
to-day 
0, 1 
Tiredness 
Tiredness for at least half the day and 
more than usual 
0, 1 
Nightmares 
A distressing event that can be recalled 
and occurs regularly; the individual will 
be conscious of their nightmare 
0, 1 
Night terrors 
Distressing, unconscious events without 
recall or recurrence 
0, 1 
Sleepwalking  Walking activity whilst remaining asleep 0, 1 
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These sleep items (see Table 1) assess problems rather than clinical diagnoses yet could be 
indicative of underlying sleep disorders and suggestive of further exploration of the sleep 
phenotype.  
Items were coded “0 = absent” or “1 = present”, except for insomnia, middle insomnia and 
hypersomnia, which were originally coded on a three-point scale so were dichotomised. Out 
of the 13 items, 11 were used to obtain an overall sleep problem score. The two items that 
were excluded were a closed question regarding melatonin use over the past three months 
and a composite insomnia score, dependent on a score for either initial, middle or early 
insomnia.  
The overall insomnia score was based on the responses from the initial, middle and early 
questions but the CAPA required the total accumulative time spent awake to reach a 
threshold of 1 hour or more. Some individuals did not reach the threshold to score for the 
main insomnia item, however they did report the presence of insomnias illustrated by 
responses to middle insomnia, where a specific time threshold was not specified. This 
resulted in positive scores for middle insomnia not always contributing to the overall insomnia 
outcome. Therefore, despite an individual scoring for middle insomnia set out by the CAPA, 
this positive score might not contribute to an overall positive score for insomnia. Therefore, 
it was important to explore the prevalence of insomnia-related problems but exploring the 
individual insomnias rather than a composite score which could have excluded some 
individuals who were reporting positive symptoms. The three questions provided a more 
comprehensive understanding of the types of insomnia experienced by the young people. 
Each of the 11 items were summed to obtain an overall sleep problem score. The sleep 
problems symptoms could range from 0-11.  
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3.7 Social Communication Questionnaire (SCQ) 
ASD symptoms were screened for by the Social Communication Questionnaire (SCQ) (Rutter, 
Bailey and Lord, 2003) completed by the primary carer. The total indicative ASD score 
comprised subscales: social interaction, communication, and restrictive and repetitive traits. 
The total score ranged from 0 to 39 with a score of 15 or higher suggestive of putative autism 
spectrum disorder (ASD) (Berument et al., 1999).  
3.8 Developmental Coordination Disorder Questionnaire (DCDQ) 
Indicative DCD was established by the Developmental Coordination Disorder Questionnaire 
(DCDQ) (Wilson et al., 2009) completed by the primary carer. The DCDQ screens for motor 
coordination impairments with scores ranging from 15 to 75. Lower scores indicated greater 
coordination problems and discrimination thresholds dependent on age were used 
(Cunningham et al., 2017).  
3.9 Cognitive Assessments  
3.9.1 Full-scale IQ (FSIQ), Performance and Verbal IQ (PIQ and VIQ) 
Intelligence was assessed by the Wechsler Abbreviated Scale of Intelligence (WASI) 
(Wechsler, 1999) at all waves of assessment as well as in the adults with 22q11.2DS. The 
selection of subtests used as part of the WASI in the ECHO and IMAGINE-ID studies included 
two subtests for assessing performance IQ (PIQ) and two subtests for the assessment of 
verbal IQ (VIQ). PIQ is a measure of nonverbal ability and can be conceptualised as fluid 
intelligence, whereas VIQ is a measure of verbal ability and considered as acquired crystallised 
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intelligence. PIQ is assessed by block design and matrix reasoning whereas VIQ is assessed by 
the vocabulary and similarities subtests. 
The four subtests are summed, generating subtest raw scores which are converted to T-scores 
using the WASI T-score conversion tables. To get the PIQ T-score, the block design and matrix 
reasoning T-scores are added, and similarly, the vocabulary and similarities T-scores are 
summed to generate a T-score for the VIQ. Combining the PIQ and the VIQ T-scores results in 
the generation of the FSIQ T-score. Using this score, a WASI IQ equivalent is generated. The 
WASI was double-rated to ensure consistency in the ratings (Heaton et al., 1993; Wechsler, 
1999).  
3.9.2 Wisconsin Card Sorting Test (WCST) 
The Wisconsin Card Sorting Test (WCST) (Heaton et al., 1993) was used to assess executive 
functioning including strategic planning, organised searching, abstract reasoning ability and 
ability to shift cognitive strategies in response to feedback and contingency. The WCST 
assesses behaviour directed towards achieving a goal and used to modulate impulsive 
responding (Kohli and Kaur, 2006). 
The WCST consists of four stimulus cards and sixty-four response cards which depict different 
figures where the shape, colour and form is manipulated. The underlying principle of the 
WCST was to assess whether the participant was able to determine that a pattern of card-
matching changes periodically throughout the assessment. This is demonstrated by the 
individual changing the method of matching the cards according to the negative or positive 
response of the assessor. The participant is asked to match each response card to one of the 
four stimuli cards and they only receive recognition as to whether their positioning of the card 
is correct or incorrect; the reason is not revealed to the individual and therefore, they remain 
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unaware to the principle which is enacted until they personally determine it. Ten consecutive 
correct matches results in the principle of matching changing but the participant remains 
unaware of this unless they recognise the pattern.  
A perseverative error is scored when the incorrect principle is matched by the participant. For 
example, a perseverative error is scored when the response cards are continually matched to 
the incorrect stimulus card but the participant has a reason for matching these cards such as 
matching the form, despite the matching principle being colour. The outcome measure used 
in Chapters 4, 6 and 7 is a standard score: a higher standard score, the fewer perseverative 
errors.  
A nonperseverative error is scored however where the response card is placed by a stimulus 
card without reason and without matching of the colour, shape or form. Nonperseverative 
total errors is also used as an outcome measure in this thesis in Chapters 4, 6 and 7.  
3.9.3 Cambridge Neuropsychological Test Automated Battery (CANTAB) 
The Cambridge Neuropsychological Test Automated Battery (CANTAB) (Cambridge Cognition 
Ltd, 2006) is a sensitive and validated cognitive research tool which provides objective 
measures of cognitive function which has been evidenced to correlate with neural networks 
(Robbins et al., 1994; Cambridge Cognition, 2019). The CANTAB software was used to assess 
neurocognitive domains using different tasks. All tasks chosen as part of the ECHO Study and 
IMAGINE-ID battery had been verified for use in similar populations. Barnett, J.H. et al. 
(Barnett et al., 2010) showed that the tests that were adopted in the ECHO and IMAGINE-ID 
studies were sensitive to psychopathology, especially deficits which are present in 
schizophrenia and therefore, ultra-high-risk populations such as 22q11.2DS are an 
appropriate model for identifying schizophrenia-related deficits. Gur, R.E. et al. (Gur et al., 
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2014) used tests that were adopted in the ECHO Study and showed that there is a specific 
neurocognitive profile in 22q11.2DS young people compared to typically developing young 
people and age-matched developmental delay groups. Standard scores were used for each of 
the CANTAB tests other than the MTS total score where no normative score is available.  
3.9.3.1 Rapid Visual Processing (RVP) 
Visual sustained attention was assessed by Rapid Visual Processing (RVP).  
Participants are asked to press a press-pad when they notice a sequence of ‘3, 5, 7’ appear on 
the tablet screen in front of them. This sequence is hidden within a list of digits from 2-9. 
There are different levels to the assessment and the ‘3,5,7’ sequence is initially underlined 
and bold, helping the participant. As each level is completed it becomes less obvious when 
the sequence is to appear and when to press the button. 
The outcome measure used in this thesis is that of the RVP A’ prime which is the signal 
detection measure of the sensitivity to the target sequence (3,5,7). This score ranges from 0 
to 1, with 1 the highest.  
3.9.3.2 Match to Sample Visual Search (MTS) 
Match to Sample Visual Search (MTS) is a measure of visual attention by the number of correct 
target items distinguished from distractor stimuli. An abstract pattern stimulus is presented 
in the middle of the screen. Several abstract patterns are then presented in surrounding boxes 
circling the target stimulus. The participant must then match the target pattern in the middle 
of the screen with the same pattern on the outer-edge as quickly as possible.  
The outcome measure refers to the percentage of correctly discriminated target items: the 
higher the percentage the better.  
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3.9.3.3 Five Choice Reaction Time (RTI) 
Processing speed was measured by reaction times in milliseconds on the Five-choice reaction 
time (RTI) task.  
The participant holds down the press-pad, only letting go of the press-pad when a yellow spot 
appears on the screen. Then the participant must respond as quickly as possible and tap the 
yellow spot displayed on the tablet.  
The outcome measure used in this thesis relates to the time it takes to release the press-pad 
and tap the yellow spot: the quicker the time, the better reaction time.  
3.9.3.4 Stockings of Cambridge (SOC) 
The spatial planning aspect of executive function is assessed by the Stockings of Cambridge 
(SOC) task. 
On the screen, there are two scenes where three coloured balls are stacked in stockings 
suspended from a beam. The participant must use the balls in the lower scene to recreate 
and copy how the balls are displayed in the upper scene. The balls can only be moved one at 
a time, and balls at the bottom of the ‘stocking’ cannot be moved until the balls stacked on 
top of them are removed and placed elsewhere.  
The number of problems that were solved in minimum moves was used as an outcome 
measure in this thesis. A higher score is better. 
3.9.3.5 Spatial Working Memory (SWM) 
The Spatial Working Memory (SWM) task is used to assess spatial working memory as an 
aspect of higher executive function.  
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Several coloured boxes appear on the screen. The aim for the participant is to locate the 
darker blue tokens which are hidden in the coloured boxes. Once a dark blue token is found 
in the coloured box, there 
will never be another dark 
blue token under that box. 
The number of coloured 
boxes presented on the 
screen increases from four 
to eight as the participant 
progresses through levels.  
 
The outcome measure of SWM is ‘between-errors’. This is the number of times a participant 
returns to a box in which they have already found a token. Therefore, the lower the score, 
the better the performance.  
3.10 Subsamples  
This thesis includes smaller cohorts of individuals, longitudinal, toddler and adult samples, 
which are derived from larger studies. These studies and how they are associated with the 
ECHO Study and the primary cohort of young people with 22q11.2DS is outlined in 
Appendices 1 and 2 (pages 327-329).  
Figure 4 An example of the SWM task on CANTAB. 
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3.11 Correcting for Multiple Comparisons  
Multiple comparisons have been corrected for in the results outlined in Chapters 4, 6 and 7, 
where there is a comprehensive explanation of the technique used to correct for the False 
Discovery Rate. To correct the analyses for multiple comparisons, we used a Benjamini–
Hochberg false discovery rate (FDR) rate of 10% and 5% (Benjamini and Hochberg, 1995). The 
10% application is applied in Chapter 4 whereas the 5% application to the data in Chapters 6 
and 7. The reason for the different thresholds is that Chapter 4 was the initial analyses 
undertaken in young people with 22q11.2DS with regards to sleep problems. Therefore, the 
intention was to keep lines of enquiry open to explore associations with the 
neurodevelopmental phenotype. This work has been accepted for publishing in Psychological 
Medicine journal (April 2019).  
However, once the initial work had been conducted it was deemed appropriate to align the 
remaining data with the typical 5% FDR, which is comparable to the 95% CI and p=0.05 in 
typical analyses. There were many tests completed in Chapters 6 and 7 and therefore, the 
smaller FDR seemed to be most appropriate for focussing in on the sleep phenotype in 
22q11.2DS. 
The Benjamini-Hochberg method ranks the individual p-values from smallest to largest, with 
the smallest p-value ranking as 1. By comparing each individual p-value to the Benjamini-
Hochberg critical value, ((rank/total number of tests) * FDR (i.e., 5%)), if the largest p-value in 
our analyses before correction is smaller than its critical value, it is considered significant. Any 
p-values smaller than the largest p-value, that has a p-value smaller than its own critical value, 
are also interpreted to be significant even if the p-values themselves are not less than their 
own Benjamini-Hochberg critical value.  
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For the pre-processing of the EEG data, a standardised early-stage EEG processing 
pipeline (PREP) (Bigdely-Shamlo et al., 2015) (see Chapter 7) was conducted. As part of the 
pipeline, multiple testing was corrected for.  
The results have been corrected for multiple comparisons. The exploratory nature of this 
work allows for some leniency in the interpretation, however by controlling for multiple 
testing, the potential for over-interpretation of the findings from the exploratory 
investigations has been limited.  
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Chapter 4 – Sleep Problems and the Neurodevelopmental Phenotype 
in 22q11.2 Deletion Syndrome 
4.1 Overview of Chapter 
A lack of focus on sleep problems in 22q11.2DS has resulted in scant literature thus far. There 
is a small pool of literature regarding sleep-related breathing disorders (SRBD), especially 
obstructive sleep apnoea (OSA). The literature includes case studies and small samples of 
22q11.2DS as well as some larger studies of individuals with syndromic craniofacial 
abnormalities that include 22q11.2DS (Moraleda-Cibrian et al., 2014; Silvestre et al., 2014b). 
The physical problems of 22q11.2DS such as velopharyngeal insufficiency (VPI), cleft palate 
and narrow airways increase the risk for OSA and adds to the clinical interest in sleep-related 
breathing problems in this population (Heike et al., 2007).  
Individuals with 22q11.2DS have a broad phenotype (see Chapter 1) but how sleep problems 
feature in this phenotype has yet to be investigated. Sleep problems have been overlooked 
(see section 2.2) and at the current time of writing, there have been no studies exploring the 
prevalence and nature of sleep problems in this population of young people. It is not known 
what type of sleep problems are common in 22q11.2DS despite anecdotal parent reports of 
restlessness, insomnias (particularly initial and early), and daytime tiredness in their children. 
The topic of Sleep medicine is broad; the literature includes studies on the prevalence of sleep 
problems in young people and adults in typical populations and there is also expanding 
literature about sleep problems in neurodevelopmental disorders (Johnson, 1996; Wiggs, 
2009; Robinson-Shelton and Malow, 2016). Sleep research in genetic syndromes, however, is 
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sparse, especially in syndromes where there is a strong biological risk for psychiatric disorders 
and intellectual disability. The studies reported in the literature tend to focus on Smith 
Magenis Syndrome and Williams’s Syndrome where genetic causes have been attributed to 
the high preponderance of sleep problems (see Chapter 2, section 2.1.4) (De Leersnyder et 
al., 2001; Goldman et al., 2009). An underlying genetic aetiology can help to better 
understand the sleep and circadian problems seen in specific conditions, but in 22q11.2DS 
there is currently no known genetic cause to sleep problems.  
Once sleep problems in 22q11.2DS have been better understood, relationships between sleep 
problems and other symptoms can be examined, for example how sleep relates to the 
neurodevelopmental phenotype. There is variability in the definition of neurodevelopment 
but in this thesis, the neurodevelopmental phenotype is defined as the psychiatric, 
neurodevelopmental and neurocognitive domains that are present in 22q11.2DS and outlined 
in Chapter 1, section 1.3, and Chapter 3, section 3.5-3.9. The physical phenotype could also 
play a role in the manifestation of sleep problems especially in individuals with cardiac, 
respiratory and skeletal problems. Understanding the severity and persistence of sleep 
problems in 22q11.2DS is clinically important and can contribute toward developing the most 
appropriate treatments and interventions.  
This chapter aims to examine the prevalence and nature of sleep problems in young people 
with 22q11.2DS and their siblings, cross-sectionally exploring the relationship between sleep 
problems and the neurodevelopmental phenotype of 22q11.2DS.  
To gain further insights into the persistence of sleep problems in 22q11.2DS, this chapter 
includes the results of longitudinal analysis based on data collected from a follow-up 
assessment. Additionally, I present sleep problem data collected from the ECHO toddler study 
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and data on the rates of sleep problems and disorders from adults with 22q11.2DS to gain 
evidence of the lifetime persistence and clinical importance of sleep problems in 22q11.2DS. 
4.2 Part One - Cross-sectional analysis of sleep in young people with 
22q11.2DS and sibling controls  
4.2.1 Introduction  
Sleep is pivotal in healthy brain development, metabolism, cognition and general well-being 
(Cirelli and Tononi, 2017) and sleep problems from a young age can seriously affect these 
important mechanisms. Moreover, sleep deprivation and poor sleep quality at any age can 
elevate risk of neuronal dysfunction (Bonnier, 2008).  
There is a high degree of brain plasticity during childhood as changes to neuronal circuitry 
allow for reorganisation and development of neural pathways (Mundkur, 2005). This period 
of development however leaves the brain vulnerable to injury and therefore, processes which 
disturb neuroplasticity such as disturbed sleep, can have a larger impact in children compared 
to adults (Jan et al., 2010; Bonuck and Grant, 2012). There is increasing evidence that sleep 
deprivation and inadequate sleep quality is robustly associated with cognitive impairment 
and poor psychiatric outcomes (Dorris et al., 2008; Krystal, 2012). This indicates that young 
people may be at higher risk of poor outcomes that may persist into adolescence and early 
adulthood (Dahl, 2007; Kahn-Greene et al., 2007; Limoges et al., 2013; Rasch and Born, 2013; 
Krause et al., 2017).  
In the typical paediatric population rates of sleep problems range from 25-50% (Owens and 
Mindell, 2011) (see Chapter 2, section 2.1.2). The wide range could arise from the use of sleep 
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measures that have not been systematically evaluated; sleep questionnaires are frequently 
used as the only parameter of assessment in paediatric sleep studies however the variety of 
questionnaires include different assessment criteria making comparability of studies more 
difficult (Spruyt and Gozal, 2011b).  
Nonetheless, subjective sleep questionnaires remain the most common tool of assessment 
and can provide a wealth of data regarding the types of sleep problems experienced, 
signposting the problem to address. Parasomnias (nightmares, night terrors and 
sleepwalking) have been identified to be the most prevalent in typical populations. One study 
showed that 35% of children at the age of one-and-a-half have experienced night terrors; 
these are one of the more common sleep problems in children under the age of 13 with 56% 
having experienced night terrors at least once (Moreno, 2015).  
Young people with neurodevelopmental disorders (NDD) are at particular risk of sleep 
problems (see Chapter 2, section 2.1.3) with an estimated prevalence as high as 86% (Wiggs, 
2001; Robinson-Shelton and Malow, 2016). More specifically 40-80% of children with ASD 
have been reported to have sleep problems, ADHD 25-50%, anxiety disorders 88% and 
intellectual disability 26-86% (Wiggs, 2001; Staner, 2003; Souders et al., 2009). Furthermore, 
individuals with NDD who suffer with sleep problems are reported to be at increased risk of 
impairments in cognitive function and motor coordination (Thapar et al., 2012; Lloyd, 
MacDonald and Lord, 2013; Ren et al., 2016). 
As NDDs are a core feature of 22q11.2DS, impairments in cognitive function are prevalent 
(see Chapter 2.9) regardless of sleep problems. The average IQ is estimated to be ~30 IQ 
points lower than typically developing children (Niarchou et al., 2014) and deficits in cognitive 
function including: reaction time, sustained attention, processing speed, spatial working 
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memory and executive functioning have been documented (Hooper et al., 2013; Niarchou et 
al., 2014). Additionally, deficits in motor coordination are common in NDDs (Vasserman, 
Bender and Macallister, 2014) and are highly preponderant in 22q11.2DS with over 80% of 
young people having been reported to have motor coordination problems (Cunningham et 
al., 2017). These problems may potentially be linked to some of the widespread brain 
abnormalities that have been observed in these patients, including increased cortical surface 
area in the sensorimotor cortex and reduced cerebellum size (Sun et al., 2018).  
Sleep in 22q11.2DS remains an understudied area of research despite reports of associations 
between sleep problems and a range of neurodevelopmental impairments in other 
populations (Wiggs, 2001; Johnson and Malow, 2008; Robinson-Shelton and Malow, 2016). 
4.2.2 Methodology  
Participants were part of the ongoing Experiences of CHildren with cOpy number variants 
(ECHO) study (Niarchou et al., 2014; Chawner et al., 2017; Cunningham et al., 2017). For 
further information regarding the study see Chapter 3, section 3.1 and Appendices 1 and 2.  
The current investigations focussed on 140 children with 22q11.2DS (x ̅age = 10.1, range = 6 
years 3 month–17 years 1 month, s.d. = 2.45, 45.0% females) and 65 age-matched sibling 
controls (x ̅ age = 10.8, range = 6 years 1 month –16 years 7 months, s.d. = 2.26, 43.1% 
females). Family income information was obtained from primary carer questionnaires and 
can be found together with information of the age and gender of the participants in Table 2.
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Table 2 Demographic information on participating families 
 
% 
Family ethnic background 
 European 85.9 
 Mixed 4.23 
 Non-European 2.11 
 Unknown  7.76 
Highest maternal education qualification 
 No qualifications  8.57 
 Low: O-levels or GCSEs 22.9 
 Middle: A-levels/Highers or vocational training 23.6 
 High: University degree and/or other higher 
postgraduate qualification 
36.4 
 Other 3.52 
 Unknown  3.57 
Family annual income (£) 
 £≤19,999 20.4 
 £20,000-39,000 23.9 
 £40,000-59,000 18.3 
 £≥60,000 23.9 
 Unknown 13.4 
Age, years: mean (s.d.) range p 
 Probands 10.1 (2.46) 6.02-17.1 Siblings 10.8 (2.26) 6.29-16.6 0.04 
Gender, n (%)  
 Probands 63/140 F (45%) Siblings 28/65 F (43.1%) 0.796 
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In the 22q11.2DS cohort, 17 young people were on melatonin for sleep problems; one young 
person was on antipsychotic medication aripiprazole for psychotic experiences; one was on 
risperidone for mood disorder and none were on ADHD medication. 10.7% (15/140) of the 
young people with 22q11.2DS were reported to have experienced seizures during their 
lifetime or have an epilepsy diagnosis with one person receiving sodium valproate for 
epilepsy. No unaffected control siblings were medicated for sleep problems, seizure-related 
problems or epilepsy. Prior to recruitment, primary carers consented for all participants and 
additional consent was obtained from participants aged ≥16 years with capacity. The 
protocols used in this study were approved by NHS Wales Research Ethics Committee 1.  
4.2.2.1 Assessments 
Psychopathology and neurodevelopmental assessment 
The semi-structured Child and Adolescent Psychiatric Assessment (CAPA) (Angold et al., 1995) 
was conducted with the primary carer by trained psychologists. Information regarding the 
following can be found at the stated locations: psychiatric assessments (section 3.5), sleep 
problems section of the CAPA (section 3.6), cognitive assessments (section 3.9) and parental 
questionnaires including the SCQ (section 3.7) and DCDQ (section 3.8). The DCDQ was 
introduced later in the ECHO Study accounting for the fewer questionnaires completed 
compared to the other measures.  
The assessments undertaken were completed by different sample sizes as a result of the 
completeness of tasks and introduction of questionnaires into the wider study. ADHD and 
anxiety symptoms were available for all n=140 individuals with 22q11.2DS; CD and ODD 
symptoms for n=134; SCQ total scores for n=128 and the DCDQ score was available for n=97 
individuals with 22q11.2DS. All young people had sleep problem scores.  
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Covariates (age, gender, family socio-economic status and physical outcomes) 
Family income information was obtained from questionnaires completed by the primary carer 
and can be found together with information of the age and gender of the participants in Table 
2 (page 76). Physical health problems were also assessed in the parental questionnaire.  
4.2.2.2 Aims of the Subjective Cross-Sectional Analyses 
The primary aims were: 
1. To identify the prevalence of sleep problems in young people with 22q11.2DS 
compared to their unaffected siblings; 
2. To determine patterns of sleep problems in young people with 22q11.2DS; 
3. To investigate links between patterns of sleep problems and the neurodevelopmental 
phenotype.  
4.2.2.3 Statistical Analysis 
The statistical analyses refer to the aims stated in section 4.2.2.3. 
For aim 1, chi-squared tests were used to explore differences in the ages, and t-tests were 
used to investigate the differences in gender between the two groups. Gender was not used 
as a covariate as there was no difference in proportions between groups (p=0.967) but there 
were differences in age (p=0.04) (Table 2, page 76). Differences in overall sleep problem 
scores (sum of positively endorsed sleep items) between the two groups were assessed using 
logistic regression analysis including age as a covariate.  
For aim 2, exploratory factor analysis (EFA) (Conway and Huffcutt, 2003) was used to establish 
the number of factors underlying the structure of the responses to the CAPA sleep section for 
the children with 22q11.2DS. Statistically, combining items that represent a single underlying 
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construct is important as it reduces the number of comparisons that would be conducted if 
each individual item was analysed separately and enhances the robustness of the measured 
concept. Clinically, it is important to understand whether sleep problems group into particular 
patterns and have different associations with other outcomes such as psychopathology as this 
could have implications for interventions.  
To conduct the EFA appropriately, pre-processing of the data was required. Initially, two-by-
two tables were constructed for each of the different combinations of the sleep variables 
derived from the CAPA. This was followed by a tetrachoric correlation (Pearson, 1900) which 
is a suitable type of correlation matrix and analysis for dichotomous variables that assume an 
underlying normal distribution, with the theory of continuous latent variables to explain 
variance (Ledesma, Macbeth and Valero-Mora, 2011).  
The two-by-two tables suggested that some combinations of variables were highly correlated 
and there were some tables that showed positive endorsement that equalled zero. This was 
apparent for parasomnia items and several other items: night terrors and hypersomnia, sleep 
walking and hypersomnia; night terrors and tiredness; night terrors and fatigability; 
nightmares and fatigability; and sleep walking and fatigability. As a result, no correlation 
coefficients could be calculated for these combinations. In addition, there were other two-
by-two tables that showed very low cell count and positive endorsement, with many of these 
correlations including sleep walking as a variable: sleep walking with initial insomnia (r=-
0.036); sleep walking with early insomnia (r=-0.002); as well as fatigability with middle 
insomnia (r=-0.01). The parasomnia items were problematic when combined with the other 
variables however, they didn’t show improved correlations between each other: sleep 
walking with nightmares (r=0.06, p=0.620); sleep walking with night terrors (r=0.04, p=0.490), 
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except for nightmares and night terrors (r=0.400, p<0.001). Sleep walking was the only sleep 
item in the CAPA that was asked dependent on lifetime history suggesting that it might not 
reliably present the rates of sleep walking in the current cohort. The parasomnia items also 
did not differ significantly between young people with 22q11.2DS and control siblings (Table 
3, page 84), indicating that they do not represent sleep problems that are specific to young 
people with the deletion. Therefore, the parasomnia items were removed from the analysis. 
Furthermore, of the remaining items, hypersomnia, tiredness and fatigability correlated quite 
strongly (hypersomnia with tiredness r=0.510; hypersomnia with fatigability r=0.370; 
tiredness with fatigability r=0.560). Therefore, these variables were combined into a single 
score capturing tiredness-related sleep problems. Similarly, the items early and middle 
insomnia also correlated quite strongly (r=0.522, p<0.001) and were combined (into an item 
capturing mid/early insomnia). By combining these variables, the very low cell counts and 
positive endorsement were accounted for and the almost zero correlation between middle 
insomnia and fatigability was corrected. Item combination was as follows: a dichotomous 
variable was created where a positive score on any of the items translated into a positive 
score on the combined variable. 
This produced a 5-item tetrachoric correlation matrix which was the basis for exploratory 
factor analysis (EFA) (Conway et al. 2003) to determine the patterns of sleep problems in 
young people with 22q11.2DS. A tetrachoric correlation matrix is a special type of polychoric 
correlation which estimates the correlation between two hypothetical parametric continuous 
latent variables that have been derived from two actual observed ordinal variables (Drasgow, 
1986). The tetrachoric correlation is special as the observed variables are dichotomous. The 
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two-by-two infers Pearson correlation, but with the assumption of bivariate normality 
(Günther and Höfler, 2006). 
The number of factors retained was based on the scree plot of eigenvalues (values ≥0.6) and 
interpretation of meaningful patterns (Gorsuch, 1983). The factor solution was rotated using 
a promax method of rotation. A promax rotation is a type of oblique solution used to 
maximise interpretation. An oblique rotation allows for the factors to be correlated. In this 
study, it is rationalised that a young person with 22q11.2DS with sleep problems relating to 
insomnia also has sleep problems relating to tiredness suggesting that the factors should be 
correlated (Gorsuch, 1983). The oblique rotation of the axes for the distribution of the data 
accommodates the correlating data better than an orthogonal rotation which keeps the axes 
at right-angles reducing the interpretability of the data (IBM, 2018). The rationale was based 
on the literature supporting overlap of insomnia-related problems with restlessness and 
tiredness (Staner, 2003). Often problems with initiating and maintaining sleep can co-occur 
with restlessness especially in individuals with an anxiety disorder (Sheehan, Ballenger and 
Jacobsen, 1980).  
The sleep patterns were calculated by summing the binary sleep items that loaded on each 
factor (“1” = ≥1 positive item; “0” = no positive items) for use in further analysis. Spearman 
correlation analysis was used to determine the patterns of sleep problems interrelationship. 
To explore aim 3, hierarchical logistic regression analyses were used to examine links between 
the patterns of sleep problems (presence or absence of a pattern) and the children’s age (step 
1), with the addition of psychiatric disorder symptoms (ADHD, ASD, anxiety, CD and ODD) and 
DCD, and cognitive performances (IQ, spatial working memory, sustained and visual 
attention, spatial planning and executive function) each individually (step 2). The patterns of 
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sleep problems were investigated in relation to potentially confounding factors such as 
maternal education level and melatonin use. Sensitivity analyses were conducted accordingly. 
Other potential confounders (e.g., other medication use) were not evaluated because of low 
sample prevalence. 
To correct for multiple comparisons, the Benjamini–Hochberg correction of false discovery 
rate (FDR) applying a 10% FDR was used (Benjamini and Hochberg, 1995) (see section 3.11) . 
All analyses that survived FDR correction are denoted in tables by an asterisk (*). Statistical 
analysis was carried out using STATA (version 13.1) (https://www.stata.com/stata-
news/news28-4/stata13.1) and R (version 3.5.0) (R: The R Project for Statistical Computing, 
2018). 
4.2.3 Results 
In this sample, the individuals with 22q11.2DS were younger than sibling controls (t=2.09, 
p=0.04) but there was no difference in the gender proportions (p=0.796).  
4.2.3.1 Prevalence of Sleep Problems in 22q11.2DS (Aim 1)  
There were 60% of young people with 22q11.2DS with at least one sleep problem out of the 
11 sleep items outlined in the sleep problems section of the CAPA (see Table 3) (22q11.2DS 
median=1 (range 0-7)). This prevalence was compared to 23.1% of sibling controls (controls 
median=0 (range 0-5)) (OR=5.00 p=<0.001) (Figure 5, Table 3). Analysis of the 11 CAPA items 
showed that children with 22q11.2DS had higher rates of insomnias, restless and 
inadequately rested sleep but no differences with sibling controls for hypersomnia, 
fatigability and parasomnias (Table 3).  
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Figure 5 Prevalence of sleep problems in 22q11.2DS and siblings 
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Table 3 Prevalence of sleep problem items in young people with 22q11.2DS and sibling 
controls 
Sleep items, n 
(%) 
22q11.2DS Siblings OR 
95% Cl for 
means/medians 
differences 
p 
At least one 
sleep problem 
84/140 
(60) 
15/65 
(23.1) 
5.00 2.56-9.76 <0.001 
Overall total 
number of 
sleep problems  
84/140 
(60) 
15/65 
(23.1) 
1.86 1.34-2.57 <0.001 
  Total, n (%)   
Insomnias      
 Initialb 32 (22.9) 7 (10.8) 2.46 1.02-5.91 0.045 
 Middleb 23 (16.4) 1 (1.54) 12.6 1.66-95.3 0.014 
 Earlyb 13 (9.29) 0 (0) -  - 
Hypersomniaa 8 (5.71) 1 (1.54) 3.88 0.475-31.7 0.206 
Restless sleepa 45 (32.1) 4 (6.15) 7.22 2.47-21.1 <0.001 
Inadequately 
resteda 
27 (19.3) 1 (1.54) 15.3 2.03-115 0.008 
Tirednessa 15 (10.7) 1 (1.54) 7.68 0.992-59.4 0.051 
Fatigabilitya 7 (5.00) 1 (1.54) 3.37 0.406-28.0 0.261 
Parasomnias      
 Nightmares 16 (11.4) 6 (9.23) 1.27 0.472-3.41 0.637 
 Night terrors 8 (5.71) 2 (3.08) 1.91 0.384-9.25 0.422 
 Sleepwalking 11 (7.86) 4 (6.15) 1.30 0.398-4.25 0.664 
The sleep items denoted with a capture the tiredness-related sleep pattern and those with b capture 
the insomnia-related pattern of sleep problems best. 
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In the subsample of 22q11.2DS children with a participating sibling control no correlation 
between the number of sleep problems each sibling experienced was found (r=0.080, 
p=0.704). 
4.2.3.2 Patterns of Sleep Problems in 22q11.2DS (Aim 2) 
Table 3 shows the absence of a difference in the rates of parasomnias between 22q11.2DS 
and sibling controls further adding to the justification of removing the parasomnias from the 
tetrachoric correlation matrix in the EFA.  
The EFA is illustrated in Figure 6 showing that sleep problems in 22q11.2DS were captured 
best by two patterns: tiredness-related sleep (see Table 3 denoted a) and insomnia-related 
(see Table 3 denoted b). The patterns showed a modest correlation (r=0.252, p=0.003) 
reflecting that the children can have both problems. 
54.3% (76/140) of young people with 22q11.2DS scored on at least one sleep pattern. Of these 
76 individuals, 44.7% (34/76) scored positive for the tired-related sleep pattern only; 21.1% 
(16/76) on the insomnia-related sleep pattern only and 34.2% (26/76) on both patterns. 
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4.2.3.3 Links between Sleep Patterns and the Neurodevelopmental Phenotype (Aim 3) 
Rates of psychiatric disorder in 22q11.2DS are elevated compared to the typical paediatric 
population (see Chapter 1, section 1.3). Comparing rates of neurodevelopmental disorder 
diagnosis in young people with and without reported sleep problems can potentially provide 
a better understanding of the pathology of the neurodevelopmental phenotype and the sleep 
problems.  
Young people with 22q11.2DS who scored positive for the tiredness-related sleep pattern 
compared to those who did not had higher rates of ADHD, anxiety disorder, CD and ODD 
diagnoses (Table 4). No differences were found in the rates of diagnosis in those who scored 
positive on the insomnia-related sleep pattern compared to those who did not (Table 4).  
Table 4 Associations between the tiredness-related and insomnia-related sleep patterns and 
psychiatric disorder in young people with 22q11.2DS 
 
 Tiredness-related Sleep Insomnia-related Sleep 
Psychiatric 
Disorder 
Positive, n 
(%) 
Negative, 
n (%) 
p Positive, 
n (%) 
Negative
, n (%) 
p 
ADHD 
diagnosis  33 (55) 21 (26.3) 0.001 18 (42.9) 36 (36.7) 0.495 
Indicative 
ASD  25 (43.9) 20 (29.4) 0.094 18 (47.4) 27 (31.0) 0.080 
Any 
anxiety 
diagnosis  
20 (33.3) 15 (18.8) 0.049 12 (28.6) 23 (23.5) 0.523 
Indicative 
DCD  38 (88.4) 41 (76) 0.117 24 (88.9) 55 (78.6) 0.241 
CD/ODD 
diagnosis  17 (28.8) 8 (10.5) 0.007 11 (28.2) 14 (14.6) 0.065 
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Sample sizes were different as some CAPA interviews were incomplete: the CD and ODD 
sections were the final to be completed during the interview and therefore, remained 
incomplete on some occasions. The DCDQ was introduced later in the overall ECHO Study and 
the SCQ was part of the questionnaire pack which was sometimes incomplete or not returned 
by the participating primary carer.  
There was a subsample of 39.3% (18/46) of young people with 22q11.2DS who did not meet 
diagnostic criteria for a neurodevelopmental phenotype, but did score positively for sleep 
problems.  
Investigating the symptom scores of the neurodevelopmental phenotype provided an 
additional dimension to the findings. The tiredness-related sleep pattern was associated with 
increased symptoms of ADHD, indicative ASD, anxiety disorder, indicative DCD, oppositional 
disorder and conduct disorder, as well as a poorer performance on the sustained attention 
and set shifting ability (perseverative errors on the Wisconsin Card Sorting Task (WCST)) tasks 
(see Table 5). However, the association with sustained attention did not persist when 
correcting for multiple testing using the Benjamini-Hochberg 10% critical value for FDR.  
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Table 5 Associations between tiredness-related sleep pattern and psychopathology, IQ and cognitive 
function 
Psychopathology (symptom counts) OR S.E. 95% Cl p 
Attention–deficit hyperactivity disorder 1.16 0.047 1.07-1.25 <0.001 
Indicative autism-spectrum disorder 1.05 0.027 1.00-1.10 0.048b 
Anxiety disorder 1.10 0.039 1.03-1.19 0.006 
Developmental coordination disordera 0.968 0.014 0.940-0.996 0.023 
Conduct disorder 1.41 0.237 1.02-1.96 0.038b 
Oppositional defiant disorder 1.29 0.137 1.05-1.59 0.015b 
IQ OR S.E. 95% Cl p 
Full-scale IQ 0.980 0.0151 0.951-1.01 0.194 
Performance IQ 0.984 0.0156 0.953-1.01 0.296 
Verbal IQ 0.981 0.0137 0.955-1.01 0.175 
Cognitive processing OR S.E. 95% Cl p 
Processing speed (five-choice reaction 
time) 
0.938 0.096 0.769-13.14 0.525 
Sustained attention (rapid visual 
processing) 
0.832 0.076 0.696-0.995 0.044* 
Visual attention (match to sample) 0.997 0.026 0.948-1.05 0.900 
Spatial planning 0.950 0.192 0.640-1.41 0.800 
Spatial working memory 0.909 0.174 0.625-1.32 0.616 
Set shifting ability 0.973 0.001 0.954-0.993 0.008 
Errors on the Wisconsin Card Sorting 
Task 
1.02 0.010 0.998-1.04 0.074 
aDevelopmental coordination disorder is reversed scored. bAssociations did not persist during sensitivity 
analyses. *Correcting for the FDR of 10% meant that these associations did not reach the Benjamini-
Hochberg criteria. 
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Post-hoc analysis of the association between tiredness-related pattern of sleep problems and 
ADHD symptoms showed inattentive (OR=1.23, p=0.001) and hyperactive-impulsivity 
symptoms (OR=1.26, p=0.002) were associated with an elevated risk of tiredness-related 
problems. 
The insomnia-related sleep pattern showed associations with increased symptoms of anxiety 
disorder, indicative DCD and CD as well as impaired performance on the visual attention task 
(Table 6). The association with visual attention did not persist when controlling for multiple 
testing using the Benjamini-Hochberg 10% critical value for FDR.
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Table 6 Associations between insomnia-related sleep pattern and psychopathology, IQ and cognitive 
function 
Psychopathology (symptom counts) OR S.E. 95% Cl p 
Attention–deficit hyperactivity disorder 1.04 0.042 0.961-1.12 0.338 
Indicative autism-spectrum disorder 1.04 0.027 0.992-1.10 0.095 
Anxiety disorder 1.07 0.036 1.00-1.14 0.045 
Developmental coordination disordera 0.955 0.017 0.922-0.989 0.009 
Conduct disorder 1.53 0.278 1.07-2.18 0.020 
Oppositional defiant disorder 1.22 0.133 0.980-1.51 0.075 
IQ OR S.E. 95% Cl p 
Full-scale IQ 0.988 0.017 0.956-1.02 0.467 
Performance IQ 0.982 0.018 0.949-1.02 0.315 
Verbal IQ 0.992 0.015 0.963-1.02 0.595 
Cognitive processing OR S.E. 95% Cl p 
Processing speed (five-choice reaction 
time) 
1.15 0.157 0.881-1.50 0.303 
Sustained attention (rapid visual 
processing) 
0.995 0.061 0.882-1.12 0.941 
Visual attention (match to sample) 0.945 0.026 0.895-0.998 0.042* 
Spatial planning 1.21 0.277 0.771-1.89 0.410 
Spatial working memory 1.09 0.227 0.729-1.64 0.663 
Set shifting ability 0.989 0.010 0.970-1.01 0.301 
Errors on the Wisconsin Card Sorting 
Task 
1.01 0.010 0.989-1.03 0.381 
aDevelopmental coordination disorder is reversed scored. *Correcting for the FDR of 10% meant that 
these associations did not reach the Benjamini-Hochberg criteria. 
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Comorbid presentation of both sleep patterns with psychiatric symptoms was high. Of the 60 
young people who scored on the tiredness-related sleep pattern, 86.7% (52/60) had at least 
one psychiatric symptom as did 52.4% (22/42) of the young people scoring on the insomnia-
related sleep pattern. The most common presentation for the tiredness-related sleep pattern 
(18.6%) was in combination with symptoms of CD/ODD, anxiety disorder, indicative DCD and 
ADHD and the most common comorbid presentation for the insomnia-related sleep pattern 
(35.7%) was in combination with CD/ODD, anxiety and DCD.  
Sensitivity analyses 
No links between age (tiredness-related pattern, p=0.912; insomnia-related pattern=0.069), 
gender (p=0.493; p=0.970) nor gross family income (p=0.418; p=0.432) were found with either 
pattern of sleep problems.  
An association between highest maternal education and the tiredness-related sleep pattern 
(p=0.008) was found. Additionally, associations between melatonin use and both tiredness-
related sleep (p=0.003) and insomnia-related (p<0.001) sleep patterns were derived. As a 
result, sensitivity analyses were conducted by adding 1), highest maternal education and 2), 
melatonin use to the regression analyses to see if the findings changed and finally 3) the 
analysis of the links between sleep patterns and anxiety symptoms were rerun whilst 
removing sleep-related anxiety symptoms from the total anxiety symptom score. These items 
were: reluctance to sleep alone; sleeps with family member; rises to check on family 
members; avoidance of sleeping away from family; separation dreams; easy fatigability and 
restlessness.  
The findings showed that higher maternal education was associated with a reduced risk for 
the child with 22q11.2DS scoring positively on the tiredness-related sleep pattern (p=0.011), 
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but level of maternal educational attained was not associated with the insomnia-related 
pattern of sleep problems (p=0.866). A sensitivity analysis was then conducted to see if the 
associations found with the tiredness-related sleep pattern illustrated in Table 5 remained 
when introducing highest maternal education into the regression analyses as a covariate. The 
associations between tiredness-related sleep and indicative ASD (p=0.101), conduct 
symptoms (p=0.094) and oppositional symptoms (p=0.087) did not persist when controlling 
for highest maternal education.  
12% (17/140) of the children with 22q11.2DS were taking melatonin at the time of assessment 
and 94.1% of those (16/17) reported sleep problems. Children taking melatonin had higher 
levels of sleep problems (p<0.0001, x=̅3.12 and median=3) compared to those not taking 
melatonin (x=̅1.23 and median =1) with elevated rates of tiredness-related sleep (OR=5.26, 
p=0.006) and insomnia-related (OR=15.8, p<0.0001). 68.8% (11/16) scored on both patterns; 
18.8% (3/16) on the tiredness-related sleep pattern and 12.5% (2/16) on the insomnia-related 
pattern only. Melatonin use was a proxy for sleep problem severity in the sample, and 
therefore was not included in analyses as a covariate.  
On removing the sleep-related anxiety symptoms and repeating regression analyses no 
changes were found; links with both sleep problem patterns remained. 
4.2.4 Discussion 
This is the first study to systematically investigate subjective sleep problems in 22q11.2DS. I 
found high rates of sleep problems affecting around two-thirds of these young people 
compared to around a quarter of sibling controls. Two patterns of sleep problems were found 
in 22q11.2DS: tiredness-related sleep and insomnia-related sleep, which occurred at rates of 
43% and 30% respectively. Both patterns were associated with elevated symptoms of anxiety 
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disorder and indicative DCD. The tiredness-related sleep pattern was also associated with 
increased ADHD symptoms and impaired executive function, and the insomnia-related sleep 
pattern with conduct disorder symptoms.  
4.2.4.1 High Prevalence of Sleep Problems in 22q11.2DS  
Young people with 22q11.2DS showed a higher prevalence of sleep problems at 60% than 
reported for young people in the general population (Owens and Mindell, 2011). The findings 
add to a scarce literature of sleep problems in young people with genetic syndromes (De 
Leersnyder et al., 2001; Williams et al., 2006; Trickett et al., 2018). 23% of siblings reported 
sleep problems which is comparable to typical childhood rates at 25-50% (Owens and Mindell, 
2011). Paired analysis of children with 22q11.2DS and their siblings showed no correlation 
between the number of sleep problems reported. However, data was available from only 63 
sibling pairs and these analyses may have been underpowered.  
4.2.4.2 Patterns of Sleep Problems in 22q11.2DS 
Tiredness-related sleep and insomnia-related were identified as the two patterns of sleep 
problems in 22q11.2DS suggesting that it may be relevant to distinguish sleep problems 
dependent on their pattern in further research. 
4.2.4.3 Links between Sleep Patterns and the Neurodevelopmental Phenotype in 22q11.2DS 
The study showed that ADHD symptoms were linked to increased likelihood of scoring on the 
tiredness-related sleep pattern and these results are in line with genetically heterogeneous 
(Lycett et al., 2015) young people with ADHD showing that sleep problems including sleep-
related breathing disorders (Chervin et al., 1997; Karen Spruyt and Gozal, 2011) and restless 
legs syndrome (Chervin et al., 2002) are common in this group.  
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Previous work showing a higher incidence of inattentive ADHD subtype in 22q11.2DS 
compared to idiopathic ADHD populations (Niarchou et al., 2018) is supported by the finding 
that the link between ADHD symptoms and tiredness-related sleep is driven by inattentive 
ADHD. These results should be interpreted with caution as only three individuals in the 
22q11.2DS sample had the hyperactive-impulsive ADHD subtype. 
Symptoms of indicative ASD were associated with the tiredness-related sleep pattern 
complementing previous reports of sleep problems that are common in non-22q11.2 deletion 
young people with ASD (Reynolds and Malow, 2011; Cohen et al., 2014; Robinson-Shelton 
and Malow, 2016). These sleep problems are various and of different types including 
parasomnias, bedtime resistance, insomnia and daytime sleepiness (Johnson and Malow, 
2008; Souders et al., 2009). The association found in the study cohort did not persist in 
sensitivity analyses when accounting for the effects of maternal education; young people with 
22q11.2DS of mothers with higher educational attainment were less likely to have tiredness-
related sleep, explaining the association with ASD. 
Conduct and oppositional defiant disorder symptoms were associated with the tiredness-
related sleep pattern (Eastabrook et al., 2003) and conduct disorder symptoms also with the 
insomnia-related pattern. Children with CD and ODD are reported to have more sleep 
problems than typically developing children including increased nocturnal awakenings and 
delayed sleep onset, and conduct problems show particular links with sleep-related breathing 
disorders and periodic limb movements (Eastabrook et al., 2003). The associations between 
tiredness-related sleep pattern and symptoms of CD and ODD did not persist when 
accounting for the effects of maternal education. 
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Anxiety symptoms were associated with both the tiredness-related and insomnia-related 
sleep patterns and these links remained after removing sleep-related anxiety symptoms from 
the total symptom score. Insomnia is a common complaint in anxiety disorders (Vriend and 
Corkum, 2011) as is fatigue (Chorney et al., 2007) and prior studies have identified links 
between limb movements during sleep and generalised anxiety (Saletu et al., 2002; Staner, 
2003). The findings in this young high-risk population highlight the need for increased 
awareness of sleep problems (Benca et al., 1997; Staner, 2003; Turnbull, Reid and Morton, 
2013).  
As previously reported the rate of indicative DCD in 22q11.2DS is very high (80%) 
(Cunningham et al., 2017) and motor coordination problems are associated with both 
tiredness-related and insomnia-related sleep patterns. There are few studies reporting sleep 
problems in DCD with the exception of few reports outlining disturbed sleep patterns (Wiggs, 
Sparrowhawk and Barnett, 2016) including bedtime resistance and daytime sleepiness 
(Barnett and Wiggs, 2012) and impaired sleep quality (Wiggs, Montgomery and Stores, 2005). 
Investigating the mechanism linking sleep and impaired motor coordination in 22q11.2DS can 
add to the understanding of how sleep problems affect neurological processes.  
The tiredness-related sleep pattern was associated with poor executive function and 
sustained attention. The association with attention did not persist when correcting for 
multiple comparisons but the link with poor executive function remained. Cognitive flexibility 
of the frontal cortex is necessary for executive function with studies observing the 
detrimental impact of sleep deprivation on set-shifting ability using the WCST (Maddox et al., 
2009). Anatomical brain abnormalities in 22q11.2DS (Sun et al., 2018) could affect normative 
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frontal cortical functioning and potentially lead to atypical sleep neurophysiology (Muzur, 
Pace-Schott and Hobson, 2002).  
The insomnia-related sleep pattern was associated with impaired visual attention but this did 
not remain when correcting for multiple comparisons. The link between insomnia and 
impaired visual attention has been observed in sleep deprivation studies (Kendall et al., 2006). 
Cognitive models have shown that insomnia in young adults is associated with poor attention 
control and negative emotionality (Mitchell, Mogg and Bradley, 2012). Impairments in 
sustained attention, visual attention and sleep globally are reported in ADHD in young people 
(H. K. Lee et al., 2014). 
Longitudinal studies are required to investigate the relationship of sleep and psychosis as the 
current sample is too young to look at how sleep problems relate to risk of psychosis and 
schizophrenia (Ferrarelli et al., 2007; Pritchett et al., 2012; Wulff et al., 2012). Evidence from 
the Cardiff ECHO Study showed emergence of psychotic experiences in early adolescence in 
children with 22q11.2DS with an increase in the prevalence of reported psychotic experiences 
from 4% at the first assessment to 21% at the second time assessment (Chawner et al., 2019). 
Investigating sleep problems in this emerging cohort may be of interest.  
4.2.4.4 Sensitivity Analyses 
Highest maternal education associated with reduced Risk for Tiredness-related Sleep Pattern 
Higher maternal education level was associated with reduced risk of scoring on the tiredness-
related sleep pattern. There is some evidence that parents with higher education attainment 
may be better informed on practices that can improve the quality of a child’s sleep, with 
specific evidence of long-lasting effects in children with NDDs (Hiscock et al., 2015; 
Papadopoulos et al., 2015) including ASD (Trickett et al., 2017). There is clear evidence for 
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higher maternal education to be linked to fewer childhood ODD (Rydell, 2010) and CD 
symptoms (Etherington et al., 2016).  
Melatonin use in 22q11.2DS  
Melatonin is commonly prescribed in young people with insomnia-related problems as it 
mimics endogenous melatonin release, thought to positively influence sleep onset (Ivanenko 
et al., 2003). Of the individuals in the cohort on melatonin, all but one reported sleep 
problems. Sleep problems were higher in those on melatonin compared to those who were 
not hinting that melatonin was prescribed to individuals with the more severe problems. To 
understand the efficacy of melatonin in young people with 22q11.2DS, a randomised 
controlled drug trial is required (Appleton et al., 2012). Without systematic investigation of 
the utility of melatonin, evidence for its appropriate use in these young people is not 
definitive.  
4.2.5 Strengths and Limitations 
This is the first study to systematically investigate sleep problems in 22q11.2DS. The sample 
is large compared to previous studies, including a valuable sibling control group allowing for 
comparison to typically developing children. Available demographic and medication data 
allowed us to conduct sensitivity analyses.  
In this study the measures used, despite gold-standard research diagnostic psychiatric tools, 
did not include objective sleep monitoring or the young person’s own accounts of sleep 
problems. Parents might not be able to accurately report night-time activities and behaviours 
in older children so objective measures such as sleep electroencephalography (EEG) and 
cardio-respiratory polygraphy would help to further explore sleep problems in 22q11.2DS.  
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This study was cross-sectional so it is difficult to comment on whether sleep problems 
preceded or followed the emergence of other associated phenotypes. As a result, it is difficult 
to infer causal relationships between sleep disorders and other phenotypes. Longitudinal 
analysis would be required to investigate this further.  
The availability of demographics and medication data allowed for us to conduct sensitivity 
analyses, however as part of the study, there was no data on the rates and seriousness of 
sleep problems before melatonin use and if melatonin had been taken previously. With the 
availability of this data, it would be important to identify whether sleep problems have 
diminished in severity despite their persistence. For example, an individual on melatonin 
continues to report sleep problems however the melatonin has worked to lessen these 
problems. 
There are endocrine and neurological problems in young people with 22q11.2DS yet this 
study does not have data reflecting the melatonin profile in 22q11.2DS. Exploring the 
melatonin profile in individuals with a genetic syndrome could help to identify an endogenous 
deficiency in 22q11.2DS.  
In the literature, there is evidence of obstructive sleep apnoea in 22q11.2DS however these 
findings were unable to address the high rates of sleep apnoea reported clinically. Further 
information is also required regarding incidence of physical problems relating to disturbed 
sleep such as restless legs, pain in limbs during sleep, and periodic limb movements.  
The cause/s of sleep problems remains to be elucidated with sleep problems potentially 
manifesting in a number of ways that could include one or more of the following: unidentified 
genetic aetiology (S. R. Williams et al., 2012); or behavioural consequences of psychiatric and 
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cognitive deficits or atypical brain physiology (Flahault et al., 2012; Andrade et al., 2013; Scott 
et al., 2016; Sun et al., 2018). Imaging studies including use of electroencephalography (EEG) 
and functional magnetic resonance imaging (fMRI) may provide responses to these questions 
in the future as imaging will allow for physiological outputs to be assessed during sleep, 
focussing on objective physiological, anatomical and neurological reasoning. 
Similarly, young people with 22q11.2DS who use melatonin report more sleep problems than 
those not taking melatonin. This needs to be followed up with a longitudinal design to 
establish whether levels of problems change following the onset of use.  
There are a number of different factors which could contribute to the development of sleep 
problems including physical symptoms seen in 22q11.2DS such as endocrine problems and 
vascular abnormalities (Sonino and Fava, 1998). There is currently no evidence in this study 
or current cohort but there have been studies supporting the interaction of sleep problems 
and cardiovascular disease (O’Driscoll et al., 2009)  
4.2.6 Clinical Implications 
It is difficult to identify when sleep problems are no longer part of typical development and 
become long-term disturbances or indicators of underlying problems. Therefore, elevated 
rates in young people with 22q11.2DS warrants attention. The findings show sleep problems 
in 22q11.2DS are prevalent and strongly associated with neurodevelopmental problems.  
This study shows it is important to distinguish between the two sleep patterns especially 
when trying to manage neurodevelopmental problems and treat sleep problems. Identifying 
sleep problems early in 22q11.2DS is vital for intervention and management and there is a 
need for parents, teachers and clinicians to be aware of the severity of sleep problems and 
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the possible consequences that untreated sleep problems could have in a population at 
elevated psychopathological risk. 
4.2.7 Future Studies  
To further explore sleep in 22q11.2DS, physical problems should be assessed. This includes 
measuring limb movements during sleep to see whether the restlessness reported in sleep in 
22q11.2DS is derivative of periodic limb movement disorders (Provini et al., 2001). Further, a 
clinical study of sleep disorders in a sleep medicine facility is able to assess cardiac and 
respiratory sleep-related problems with rigor in a controlled environment (Heike et al., 2007; 
Kennedy et al., 2014; Moraleda-Cibrian et al., 2014). This physical assessment of sleep 
problems would complement the evidence this study has found of the prevalence of sleep 
problems and association with psychiatric and cognitive outcomes.  
4.3 Part Two - Description of Sleep Problems in 22q11.2DS through 
life 
4.3.1 Introduction 
The cross-sectional findings (section 4.2.3) show the incidence of sleep problems at a given 
time of assessment and helps to identify associated problems, yet the interpretation of 
development and change in sleep over time is limited.  
Anecdotal evidence from parents of young people in the ECHO study suggests that sleep 
problems occur at birth where issues with getting to sleep and maintaining sleep through the 
night are observed. Many of the parents have other children without 22q11.2DS and can 
compare the sleep behaviours, reporting more problematic sleep in comparison to unaffected 
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siblings. Anecdotal reports from adults with 22q11.2DS suggest that sleep problems continue 
into adulthood and can be identified as pathological problems resulting in sleep disorder 
diagnoses. 
The importance of investigating change over time and age in individuals with 22q11.2DS is 
highlighted by studies that have identified increased reports of psychotic experiences 
between assessment timepoints in young people (Chawner et al., 2019) and elevated reports 
of mood disorders in late adolescence compared to childhood (Gothelf, Feinstein, et al., 
2007). Variability in the prevalence of symptoms of the neurodevelopmental phenotype 
across age and development could indicate that sleep problems share a similar pattern in 
22q11.2DS. However, the occurrence of sleep problems from birth and persistence into 
adulthood has yet to be investigated.  
It is important to identify pathological sleep problems from a young age as they could affect 
neurological development (Walker and Stickgold, 2006) and could adversely affect attainment 
of milestones such as physical growth (Brand and Kirov, 2011). Early identification could 
potentially help to inform interventions that could lessen sleep problems throughout life and 
potentially have an impact on the neurodevelopmental phenotype in 22q11.2DS. 
4.3.2 Methodology 
The ECHO Study includes a longitudinal component aiming to assess change in the 
neurodevelopmental phenotype over time. Assessments by the ECHO Study at wave 2,3, and 
4 continue to collect data. Both wave 3 and 4 currently have insufficient cohort sizes for 
statistical analyses. As a result, these waves are not included in the analyses and this thesis 
refers to wave 1 (see section 3.1 and Appendix 2) and wave 2 (see section 3.10, Appendix 2).  
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Investigation of the neurodevelopmental phenotype across time and ages also included the 
assessment of toddlers and adults with 22q11.2DS. These two studies were cross-sectional 
studies exploring the phenotype of 22q11.2DS at different ages rather than a longitudinal 
assessment. Toddlers with 22q11.2DS and unaffected control siblings were investigated in the 
preliminary pilot study. The adults with 22q11.2DS were identified and assessed by the ECHO 
Study working collaboratively with the Intellectual Disability and Mental Health: Assessing the 
Genomic Impact on Neurodevelopment’ (IMAGINE-ID) study (see Chapter 3, section 3.2) and 
the ‘Defining Endophenotypes From Integrated Neurosciences (DEFINE)’ study (see Chapter 
3, section 3.3).  
4.3.2.1 Recruitment, Demography and Sample  
The wave 2 study focussed on 87 children with 22q11.2DS (x ̅age =12.6, range = 8 years ~8 
months – 17 years ~6 months, s.d. = 2.37, 42.5% females) and 39 age-matched sibling controls 
(x ̅age = 12.8, range = 6 years ~2 months – 17 years ~6 months, s.d. = 1.65, 48.7% females).  
The Toddler study focussed on 10 children with 22q11.2DS (x ̅age =4.19, range = 2 years ~4 
months– 5 years ~7 months, s.d. = 1.12, 70.0% females) and 3 age-matched sibling controls 
(x ̅age = 5.44, range = 2 years ~4 months – 5 years ~10 months, s.d. = 0.584, 66.7% females). 
The demographic data for this small cohort was not incorporated into analyses.  
The adult study focussed on 23 adults with 22q11.2DS (x ̅ age =37.5, range = 19 years ~6 
months– 67 years ~5 months, s.d. = 14.3, 69.6% females. There were no unaffected sibling 
controls in the adult study. Demographic data was not included in analyses of this cohort. The 
sample cohort is small (n=23) and as a result, reports of sleep problems were assessed only.  
   
106 
 
4.3.2.2 Assessments 
Wave 2  
The wave 2 longitudinal assessments match the cross-sectional methodology (see section 
3.10) to ensure consistency of the data collected across the waves and for cross-wave 
comparisons. Sleep problems were assessed by the Child and Adolescent Psychiatric 
Assessment (CAPA) (see section 3.6).  
The Toddler Study 
The Tayside Children’s Sleep Questionnaire (TCSQ) (McGreavey et al., 2005) was completed 
by the primary carer of the toddler reporting sleep problems. This questionnaire was not 
consistent with the CAPA sleep problems items: there were different questions, undertaken 
by different individuals and only a small sample completed such questionnaires.  
The Adult Study  
The sleep problems for adults were assessed using a validated semi-structured interview for 
adolescents and adults: Psychiatric Assessment Schedule for Adults with Developmental 
Disabilities (PAS-ADD) (Moss et al., 1998) (see Chapter 3, section 3.10). It is important to note 
that sleep apnoea is not assessed as part of the PAS-ADD. 
The Tayside Children’s Sleep Questionnaire and the sleep section of the PAS-ADD were not 
consistent with the CAPA sleep problems items: there were different questions, undertaken 
by different individuals and only a small sample completed such questionnaires. This needs 
to be considered when comparing these findings as part of the discussion.  
4.3.2.3 Aims of the Studies 
The aim of the wave 2 and longitudinal sleep analyses was: 
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1. to describe the prevalence of sleep problems at the follow-up assessment. 
It was hypothesised that in young people with 22q11.2DS, sleep problems would remain 
elevated across time and age, whilst sibling controls would experience fewer sleep problems 
across the same period. As there was no evidence to suggest trajectory of sleep problems in 
individuals with 22q11.2DS, this was an exploratory analysis of sleep problems across time 
points.  
The aim of exploring sleep in the Toddler study was: 
1.  To outline the preliminary prevalence of sleep problems in toddlers with 22q11.2DS 
compared to their unaffected control siblings, illustrating the presence of sleep 
problems from birth/early age.  
Evidence from the cross-sectional study suggested that sleep problems would be elevated in 
the toddlers with 22q11.2DS. It was hypothesised that elevated reports of sleep problems 
would also be evident in the Toddler study.  
The aim of the investigation of sleep problems in the adult data was: 
1. to describe the prevalence of sleep problems and sleep disorders in adults with 
22q11.2DS, showing the persistence of problems into older age.  
It was hypothesised that the rates of sleep problems in adults would reflect what is seen in 
adolescents and young people more generally.  
4.3.2.4 Statistical Analysis 
The prevalence of sleep problems at wave 2 for 22q11.2DS young people and sibling controls 
was outlined and differences between each of the 11-items from the sleep problem section 
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of the CAPA (see Chapter 3, section 3.6) were assessed using chi-squared tests and Fisher’s 
exact tests. The total sleep problem score was compared between groups using Mann-
Whitney U tests. Differences in the prevalence of sleep problems between wave 1 and wave 
2 for the 22q11.2DS young people and the sibling controls were assessed using a McNemar’s 
test.  
Descriptive statistics were used to assess the sleep problem findings from the Toddler Study 
and the Adult Study. The Adult Study did not include a control sample and therefore no 
comparisons could be made. Prevalence of sleep problems was determined and a comparison 
between the toddlers with 22q11.2DS and the sibling controls was determined used a Mann-
Whitney U test.  
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4.3.3 Results  
4.3.3.1 Wave 2 and Longitudinal Assessment 
The prevalence of sleep problems in young people with 22q11.2DS at the second time point, 
wave 2, was 57.5% compared to 20.5% of sibling controls (p=0.001). The 11-items of sleep 
problems were assessed between groups (see Table 7) showing elevated rates of initial and 
middle insomnia, as well as restless sleep in young people with 22q11.2DS compared to 
siblings.
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Table 7 Rates of the 11-items of sleep problems between 22q11.2DS and siblings 
Sleep items Wave 2, 
n (%) 22q11.2DS Siblings OR 
95% Cl 
mean/media
n differences 
p 
At least one sleep 
problem 
42/75 (56) 7/33 (21.2) 4.73 1.83-12.3 0.001 
Overall total 
number of sleep 
problems 
42/75 (56) 7/33 (21.2) 1.79 1.17-2.74 0.007 
Insomnias      
 Initial 21 (28) 2 (6.06) 6.03 1.32-27.5 0.020 
 Middle 16 (21.3) 1 (3.03) 8.68 1.10-68.5 0.040 
 Early 12 (16) 1 (3.03) 6.10 0.759-49.0 0.089 
Hypersomnia 2 (2.67) 0 1 / / 
Restless sleep 22 (29.3) 3 (9.09) 4.15 1.15-15.0 0.030 
Inadequately 
rested 
14 (18.7) 1 (3.03) 7.34 0.924-58.4 0.059 
Tiredness 5 (6.67) 1 (3.03) 2.29 0.256-20.4 0.459 
Fatigability 3 (4.00) 1 (3.03) 1.33 0.134-13.3 0.806 
Parasomnias      
 Nightmares 4 (5.33) 2 (6.06) 0.873 0.152-5.02 0.879 
 Night terrors 3 (4.00) 1 (3.03) 1.33 0.134-13.3 0.806 
 Sleepwalking 3 (4.00) 1 (3.03) 1.33 0.134-13.3 0.806 
   
111 
 
Longitudinal Assessment - Wave 1 to Wave 2 
The 11-items were then assessed in relation to the prevalence of each item at wave 1 
compared to wave 2 (see Table 8) showing that there was no overall difference in the total 
prevalence of sleep problems between the waves of assessment of individuals with 
22q11.2DS (p=0.835). Differences in the reported rates of initial insomnia (p=0.02) and early 
insomnia (p=0.05) however were demonstrated. There were n=10 young people with 
22q11.2DS whose sleep problems improved at wave 2. There was an equal amount (n=10) 
that developed a sleep problem at wave 2 however, resulting in no net change.  
Investigating the stability of the wave 1-derived patterns of sleep problems across waves 
showed that there were no substantial differences: the prevalence remained stable (p=1.00) 
for both tiredness-related sleep and insomnia-related sleep patterns. Pairwise correlations 
showed associations between the factors at wave 1 and wave 2: tiredness-related sleep 
(r=0.450, p<0.001) and insomnia-related (r=0.392, p=0.002). There were no differences in the 
rates of sleep problems in the sibling controls when comparing reports from wave 1 to wave 
2 (p=0.739) (Table 9). 
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Table 8 Comparing the 11-items of sleep problems from wave 1 to wave 2 in young people 
with 22q11.2DS 
Sleep items Wave 1 to 
Wave 2, n (%) 
Wave 1 Wave 2 
2 p 
Overall sleep problems 84/140 (60) 42/75 (56) 0.04 0.835 
Insomnias     
 Initial 32 (22.9) 25 (28.7) 5.00 0.02 
 Middle 23 (16.4) 17 (19.5) 0.20 0.655 
 Early 13 (9.29) 14 (16.1) 3.77 0.05 
Hypersomnia 8 (5.71) 2 (2.30) 0.00 1.00 
Restless sleep 22 (29.3) 45 (32.1) 1.38 0.240 
Inadequately rested 14 (18.7) 27 (19.3) 0.17 0.683 
Tiredness 15 (10.7) 0.564 0.459 0.564 
Fatigability 7 (5.00) 0.480 0.806 0.480 
Parasomnias     
 Nightmares 16 (11.4) 7 (8.05) 0.53 0.467 
 Night terrors 8 (5.71) 3 (3.45) 2.78 0.100 
 Sleepwalking 11 (7.86) 4 (4.60) 1.33 0.248 
Differences between the matched n=75 individuals with 22q11.2DS that were in both wave 1 
and wave 2 are illustrated in the table.  
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Table 9 Comparing the 11-items of sleep problems from wave 1 to wave 2 in sibling controls 
 
Sleep items Wave 1 to 
Wave 2, n (%) 
Wave 1 Wave 2 
2 p 
Overall sleep problems 
15/65 (23.1) 7/33 (21.2) 0.11 0.739 
Insomnias     
 Initial 
7 (10.8) 3 (7.69) 0.00 1.00 
 Middle 
1 (1.54) 1 (2.56) / / 
 Early 
0 (0) 1 (2.56) 1.00 0.317 
Hypersomnia 
1 (1.54) 0 (0) / / 
Restless sleep 
4 (6.15) 3 (7.69) 0.00 1.00 
Inadequately rested 
1 (1.54) 1 (2.56) 1.00 0.317 
Tiredness 
1 (1.54) 1 (2.56) 1.00 0.317 
Fatigability 
1 (1.54) 1 (2.56) 1.00 0.317 
Parasomnias     
 Nightmares 
6 (9.23) 3 (7.69) 0.00 1.00 
 Night terrors 
2 (3.08) 1 (2.56) 1.00 0.317 
 Sleepwalking 
4 (6.15) 1 (2.56) 1.00 0.317 
Differences between the matched n=33 sibling controls are illustrated in the table.  
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4.3.3.2 The Toddler Study  
The prevalence of sleep problems reported by the primary carer in toddlers with 22q11.2DS 
was 60% compared to 33.3% of unaffected control siblings (p=0.559). The total sleep 
problems symptom score showed 22q11.2DS toddlers had a median symptom score of 15.5 
(s.d.= ±11.8) and unaffected control siblings had a median score of 2 (s.d.= ±5.20) (p=0.127).  
In this current sample, there were no associations seen between the incidence of sleep 
problems and gender (p=0.266), age (p=0.180) or when including group status as a predictor 
(p=0.559). 
4.3.3.3 The Adult Study  
The prevalence of sleep problems reported for adults was 56.5% (13/23). There was a small 
group of n=3 individuals diagnosed with sleep disorders: slow-wave arousal disorder, early 
insomnia and restless legs syndrome. One individual was taking the sleep medication 
Zopiclone for their slow-wave arousal disorder. Two further individuals were considered to 
have situational initial insomnia with delayed phase sleep onset. This resulted in a total of n=5 
individuals either having a clinical diagnosis or a research-assessed diagnosis of a sleep 
disorder. 
In this sample, there were no associations between the incidence of sleep problems and 
gender (p=0.386) or age (p=0.364).  
4.3.4 Discussion  
The prevalence of sleep problems in young people with 22q11.2DS was shown to remain high 
and stable across time-points; 60% at wave 1 to 57.5% at wave 2. Similarly, sleep problems in 
unaffected control siblings were shown to be relatively stable from 23.1% to 20.5% yet the 
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proportion reporting sleep problems was consistently lower with fewer symptoms reported 
than in the young people with 22q11.2DS. These results help to illustrate the seriousness of 
sleep problems with maintenance of sleep problems over time. 
Sleep problems such as parasomnias are considered part of typical development (Siegel, 
2005). The preliminary findings suggest that in young people with 22q11.2DS the prevalence 
of sleep problems does not follow a typical pattern of sleep problems across time. 
Parasomnias were less prevalent in 22q11.2DS than insomnia-related and tired-related 
problems, yet the parasomnias were still more abundant than in the siblings. The siblings 
showed a typical trajectory of decline in parasomnias; fewer were reported over time and as 
a group, with increasing age.  
Group statistics showed that sleep problems decreased from wave 1 to wave 2 however not 
all individuals followed this trend. There were n=10 young people with 22q11.2DS who 
reported fewer sleep problems and therefore their sleep problems had improved whereas 
n=10 others developed sleep problems at the later time point. There was also a small 
subsample of young people with 22q11.2DS in the cross-sectional analysis that reported sleep 
problems but did not have a comorbidity (see section 4.2.4.3). This variability amongst 
individuals could suggest that there is no generic solution to treating sleep problems in 
22q11.2DS. The problem of sleep is not confined to a particular age or time of development, 
and personalised treatments and management of sleep problems could be required.  
In the Toddler Study, the preliminary results show that the toddlers have a similar incidence 
of sleep problems to the young people in the cross-sectional and longitudinal studies at 60%. 
Although the sample of n=13 is very small, the proportion of individuals that report sleep 
problems is something to note.  
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These preliminary findings suggest that sleep problems are elevated in individuals with 
22q11.2DS from birth and remain a persistent, stable and serious problem across time and 
development. In toddlers, neurophysiology is different to older individuals (Scholle, Wiater 
and Scholle, 2011) with different durations spent in stages of sleep for example. At a younger 
age, development of a bedtime routine is important and behaviour around sleep could be 
different suggesting that assessing sleep in this vulnerable developmental age might not 
provide substantial evidence for the high preponderance of sleep problems. However, the 
similar prevalence of sleep problems in the toddlers compared to the young people should 
be considered.  
The prevalence of sleep problems in the sample of adults with 22q11.2DS was 57%, showing 
comparative rates with the cross-sectional, longitudinal and toddler prevalence of sleep 
problems (see Chapter 4). This prevalence is shown to be higher than the reported typical 
rates of sleep problems in adults which range from as little as 10% up to 30% dependent on 
criteria of sleep problem and diagnosis (Leger et al., 2000; Morin et al., 2006). There were 
clinical diagnoses in n=3 individuals showing the seriousness of sleep problems in adulthood 
resulting in clinical diagnosis and medication in one instance. Interestingly, there were no 
clinical reports of sleep-related breathing disorders in this population despite elevated rates 
of sleep-related breathing disorders being the only reported sleep problems in 22q11.2DS in 
the literature. The PAS-ADD did not ask specifically about SRBD and therefore this could have 
reduced the likelihood of adults reporting this condition. However, a medical report was 
available for most individuals and this did not indicate the presence of SRBD in the sample in 
this thesis.  
   
117 
 
4.3.5 Strengths and Limitations 
The longitudinal analyses outlined the stability of the high incidence of sleep problems across 
waves providing evidence for the consistent issue of sleep across the lifespan and with time. 
The toddler sample provides preliminary evidence for the high incidence of sleep problems 
from a young age in 22q11.2DS. These reports are from the primary carer who is the most 
effective reporter in this young population; there are currently no objective measures of sleep 
in the toddler sample. The results from the three studies must be interpreted with caution 
due to the low sample sizes. However, the prevalence of sleep problems is comparable across 
the ages suggesting evidence of elevated sleep problems throughout life in individuals with 
22q11.2DS.  
A limitation to the toddler description is that their sleep is often not stable: their 
neurophysiology during a night’s sleep has yet to stabilise (Scholle, Wiater and Scholle, 2011) 
and their behavioural bedtime routine is inconsistent. The unaffected control sibling sample 
helps to disentangle whether sleep problems are unique to 22q11.2DS.  
There are different sleep questions asked among the samples; the CAPA sleep questions do 
not map directly onto the Tayside sleep questionnaires and similarly, do not agree with the 
sleep questions in the PAS-ADD. Furthermore, the PAS-ADD does not address sleep apnoea 
and as a result, information regarding any sleep-related breathing problems in the adults was 
not collected.  
4.3.6 Clinical Implications 
The sleep problem descriptions across the different ages suggests that there are persistent 
sleep problems throughout life in individuals with 22q11.2DS. Observing sleep problems as 
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part of these studies can show the prevalence of sleep problems at different ages. However, 
a longitudinal study into the trajectory of reported sleep problems from birth, through 
childhood and adolescence, and into adulthood of a group of individuals is needed to 
understand the sleep phenotype of 22q11.2DS better.  
The presence of sleep disorders in the adult cohort suggests that medical intervention and 
treatment for sleep in 22q11.2DS is important. The earlier the intervention, the higher 
likelihood there is of a better outcome in later life. Evidence of this needs to be provided in 
future study.  
4.4 Summary  
This chapter has shown the high preponderance of sleep problems across different ages in 
individuals with 22q11.2DS. The systematic assessment of sleep problems in the larger cross-
sectional sample of young people with 22q11.2DS showed a prevalence of 60% compared to 
23.1% in their unaffected siblings. The rates of sleep problems in individuals with 22q11.2DS 
was mirrored in the wave 2, toddler and adult sample cohorts studied. There isn’t an increase 
in prevalence shown in these studies but there is persistence of severity and high prevalence 
from birth into adulthood showing a consistent burden and need for early intervention.  
The results from the cross-sectional study showed two dominant patterns of sleep problems: 
tiredness-related sleep and insomnia-related sleep. Both patterns of sleep problems were 
associated with the neurodevelopmental phenotype with the tiredness-related sleep pattern 
associated with higher ADHD, anxiety disorder and indicative DCD symptoms as well as 
impaired executive function, and the insomnia-related pattern with higher anxiety, indicative 
DCD and conduct disorder symptoms.  
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However, there was a subsample of young people with 22q11.2DS that did not have a 
diagnosable comorbidity but did report sleep problems. This suggests that the presence of 
the neurodevelopmental phenotype might not explain all the sleep problems observed in 
22q11.2DS. However, it is probable that the comparison with diagnoses rather than the 
symptom scores reduced dimensionality of the analysis with the symptomology providing 
more reliable and comprehensive results.  
This thesis chapter provides evidence supporting the importance of recognising sleep 
problems in individuals with 22q11.2DS. Treatments targeted to the individual and their 
additional needs such as neurodevelopmental problems could be trialled and tested. Such 
therapies could be non-pharmaceutical such as cognitive behavioural therapy (CBT) (Espie et 
al., 2016), or pharmaceutical as long as a systematic assessment of the efficacy of melatonin 
was undertaken in these young people.  
The longevity of sleep problems is shown by the longitudinal assessment included matched-
pairs showing consistency across wave 1 and 2 in the severity of sleep problems. This 
supported what was found in the cross-sectional samples of the independent toddler and 
adult groups. Together, these findings provide evidence to support continued sleep problems 
throughout life for individuals with 22q11.2DS.  
This study begins to outline the nature of the sleep problems in 22q11.2DS and the 
associations that sleep problems have with the neurodevelopmental phenotype. This 
evidence warrants further study of sleep in 22q11.2DS to understand the underlying 
neurophysiology of sleep and sleep behaviours to build an evidence base for effective 
treatment.
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Chapter 5 - The Pilot Study and Training  
This chapter will outline the rationale behind the pilot study that was conducted prior to the 
main sleep study. The pilot was conducted to test the feasibility of the proposed protocol 
including the EEG setup. Therefore, problems could be identified and rectified prior to the 
development of the 22q11.2DS sleep and brain activity main study.  
Moreover, this chapter will comment on the training undertaken to ensure that the 
researchers could conduct the project suitably. This includes formal training courses as well 
as volunteering in projects and then on-the-job development and learning.  
This chapter provides a brief background to the methods used in the sleep study including 
electroencephalography and actigraphy. These methods are outlined in detail in Chapters 6 
(actigraphy) and 7 (polysomnography (PSG)).  
5.1 Background  
In the literature, a pilot study is defined as “A small-scale test of the methods and procedures 
to be used on a larger scale…” (Samet et al., 2009). The objectives of a pilot study should be 
outlined from the start ensuring that these work to understand and assess the feasibility of 
the measures in the study (Leon, Davis and Kraemer, 2011).  
The recruitment, protocol and implementation of novel procedures were assessed in the pilot 
study. As part of this, feedback from the participants was acquired. This could further help to 
develop and evolve the protocol. The participants were asked to comment on the study 
protocol and the equipment used. Combining the views of the participants with an objective 
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assessment of the protocol and equipment especially the method of EEG and its setup, the 
adherence to the study and equipment could be examined including tolerability.  
In summary, a pilot study is a necessary step in exploring novel applications of methodology 
and protocol in a new patient population.  
5.2 Rationale  
Currently there are no studies that have objectively assessed brain activity in young people 
with 22q11.2DS during sleep. The findings from Chapter 4 demonstrate that there is a high 
preponderance of sleep problems in young people with 22q11.2DS compared to their 
typically developing siblings. This investigation is novel in its focus on sleep problems and their 
association with the neurodevelopmental phenotype in 22q11.2DS. However, the evidence 
of sleep problems was obtained from a subjective assessment of sleep problems, related to 
the interviewer by the primary carer. Therefore, the interview itself confined the information 
that was reported in order to answer the questions, and the subjectivity of the responses 
does not allow for reliable conclusions to be made regarding the underlying physiology of 
sleep in young people with 22q11.2DS.  
The subjective assessment outlined in Chapter 4 cannot stand-alone as a comprehensive 
assessment of sleep problems in young people with 22q11.2DS: the CAPA is not a gold-
standard sleep questionnaire and it is limited in the information that it can acquire. To best 
understand sleep in these young people, it would be preferable to combine the primary carer 
reports that are subjective perspectives of sleep problems in their child/ren, with objective 
measures of sleep. As a result, a pilot study was conducted in order to develop an appropriate 
protocol, which utilises subjective and objective methods of assessing sleep problems in 
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young people with 22q11.2DS. The pilot study was undertaken in young people that were 
from the typically developing population to reduce any problems before conducting the 
protocol with a group of young people with 22q11.2DS and their siblings.  
The pilot study allowed for the trialling of the different subjective and objective measures 
which subsequently shape the themes and results of the following chapters: actigraphy, sleep 
diaries and sleep questionnaires (Chapter 6). These were tested and improved as part of the 
pilot study to show development in the protocol and appropriateness for the young people 
with 22q11.2DS. The polysomnography, particularly the technique and equipment used to 
acquire sleep EEG (Chapter 7), was closely examined during the pilot study to ensure the most 
appropriate equipment was used. This would allow for young people with 22q11.2DS to 
remain comfortable whilst gathering the most comprehensive dataset.  
In total, these foci would contribute to the main aim of the pilot study which was to assess 
the feasibility of the methodology and protocol that was developed.  
5.2.1 In-home Assessment and Logistics 
It was proposed that the polysomnography (PSG) should be conducted in the homes of the 
participants to normalise their experience in the main study. The protocol could have been 
undertaken in a sleep laboratory, however the disruption to the participants was considered 
too great. Undertaking the protocol in a constant environment for an individual with 
22q11.2DS was important as this removed added disruption to the individuals when moving 
them into an unfamiliar clinical setting. This is particularly pertinent as levels of anxiety are 
high which are linked to sleep disturbance (Babson et al., 2013; Swillen and McDonald-
McGinn, 2015).  
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However, to conduct the study in the homes of the participant, the protocol had to be 
applicable for a home environment with a contained and manageable EEG setup that was 
ambulatory. Having an ambulatory study resulted in logistical parameters having to be 
considered such as transportation, ensuring robustness of equipment and the financial 
impact of staying nearby to the family homes throughout the study. These factors needed to 
be considered when planning both the pilot and main studies.  
5.2.2 Objective Measures of Sleep  
To develop the most appropriate protocol for the high-risk 22q11.2DS population, two 
methods of EEG acquisition were compared in the pilot study: silver-chloride free cup 
electrode technique to the high-density geodesic EEG net application. In addition to the EEG 
acquisition, cardiorespiratory polygraphy was used to measure cardiac and respiratory 
outputs throughout the night’s sleep. This technique is routinely used in clinical sleep studies 
of sleep-related breathing disorders (Ruehland et al., 2011). 
Training was needed to learn how to use and interpret electrocardiography, respiratory 
induction plethysmography (RIP) belt, oxygen saturation, electrooculography and 
electromyography.  
5.2.2.1 Electroencephalography (EEG) – high-density 60-channel EEG net or traditional free 
electrode? 
Two methods of EEG acquisition were trialled during the pilot study to assess brain activity 
during sleep: the traditional 10-20 EEG, free cup electrode technique which used 21 silver-
chloride electrodes glued to the scalp, verses the 60-channel high density EEG geodesic net. 
The high-density geodesic net acquired brain activity from 60 different electrode locations on 
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the scalp which could help to accurately map brain activity across the cortex (Pisarenco et al., 
2014).  
The silver-chloride electrodes are traditionally used to measure brain activity during sleep as 
well as daytime multiple sleep latency tests (MSLTs) and assessing seizure-related brain 
activity clinically (Carskadon, 2011). The application of the electrodes however requires the 
use of collodion, a flammable and highly toxic nitrocellulose preparation that glues the 
electrodes onto the scalp. Acetone is also used to remove the glue which can also contribute 
to headaches. These mildly irritant substances would need to be handled and transported 
carefully as well as stored in secure units in the laboratory prior and after use (Young et al., 
1993). The pilot study trialled the use of such substances in the study.  
The two techniques required set-up in the evening and either removal in the morning or the 
following afternoon depending on whether the participant continued wearing the EEG setup 
for the 24-hour period.  
See section 5.5.2 for the methods used to measure sleep brain activity. 
5.2.2.2 Cardiorespiratory Measurements - Breathing and Cardiac  
The limited literature regarding sleep and 22q11.2DS refers to the elevated prevalence of 
obstructive sleep apnoea (Heike et al., 2007). As a result, 
it was important to monitor breathing during sleep in 
these individuals. This was completed using a nasal 
cannula, respiratory inductance plethysmography belts 
(RIP) (schematic, Figure 7) and pulse oximetry. The 
prominence of cardiac problems in 22q11.2DS suggested 
Figure 7 Schematic of the thoracic and 
the abdominal RIP belts 
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that it was important to use electrocardiography (ECG) during the night to assess the heart 
rate of the participant. The respiratory and cardiac measures could be used to control for 
physiological changes in the EEG that could not be rationalised by changes in brain activity.  
The breathing and cardiac sensors were vulnerable to restlessness during the night and this 
could result in the wires detaching or loosening. The sensors were attached securely before 
the participant went to sleep.  
After consulting with different sleep clinicians and researchers whom had worked with this 
equipment, it was apparent that there would be difficulties regarding universal adherence to 
the respiratory measures. The pilot study was a particularly vital time to assess the tolerance 
of the breathing measures. 
See section 5.5.3 for the methods used to assess cardiac and respiratory measures in the pilot 
study.  
In addition to these measures, there were non-invasive measures that needed to be trialled; 
actigraphy watches, sleep diaries, and validated sleep-questionnaires.  
5.2.2.3 Actigraphy in the Pilot Study  
Currently, actigraphy remains unused in a 22q11.2DS population; there is evidence of the use 
of actigraphy in studies of genetic syndromes such as Angelman syndrome and in 
neurodevelopmental disorders (NDDs) such as ADHD (Fawkes et al., 2015) and autism 
spectrum disorders (ASD) (see Chapter 2, section 2.1.4) (Allen et al., 2013).  
The watch was strapped onto the non-dominant wrist of the participant and worn during the 
day and night for two-weeks. A sleep diary was completed during the same period. Acquiring 
two-weeks of data allowed a normative sleep-wake pattern and rhythm to be observed for 
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each individual. It is important to recognise the normal routines and activities of individuals 
as this helps to identify how a problematic night differs from a routine night’s sleep. A single 
night of EEG could show an abnormality however this could be an isolated event. Actigraphy 
could be used to confirm this based on abnormalities identified in the sleep-wake patterns 
and activities.  
Sleep parameters such as sleep onset, wake time, nocturnal activity and wake after sleep 
onset can help to deduce if there is a persistent problem. Actigraphy is used to complement 
the overnight assessment however the nature of actigraphy, as a non-invasive assessment, 
enabled individuals that might not want to or be able to complete the overnight assessment 
to participate.  
5.2.3 Parent and Self-Report Measures of Sleep  
In paediatric sleep studies, it is more common for subjective measures of sleep to be acquired 
and parental reports to comment on the sleep behaviours of their child. Sleep questionnaires 
can be easily completed yielding a large dataset. However, it is recognised in the sleep 
literature that differences between parental reports and subjective measurements such as 
actigraphy are present (Meltzer et al., 2012). In the study design, both the objective and 
subjective sleep measures are included to ensure acquisition of a comprehensive dataset that 
allows for comparisons between measures also.  
Actigraphy is the most common objective measure of sleep with minimal invasiveness and 
reduced costliness compared to clinical polysomnography. However, actigraphy requires a 
complementary sleep log or sleep diary to corroborate timings and parents can comment on 
the behaviours of their child on the sleep diary. Such additional information can help to create 
a comprehensive understanding of the sleep patterns and behaviours of young people.  
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5.2.3.1 Sleep Diaries 
The sleep diaries were developed based on examples from the National Centre for Mental 
Health (Lewis, Foster and Jones, 2016) and the University of Bristol (Hellmich et al., 2015). 
The sleep diaries that were originally trialled were based off the adult examples that were 
available and therefore, piloting these enabled development and changes to be made to the 
diaries to ensure appropriateness for the age and developmental level of the young people. 
The ease of use and adherence to the diary for the two-week period was important, and by 
assessing the completeness of the sleep diaries, it was apparent as to whether these would 
be appropriate for the future main study. It was important to note whether participants 
recorded when the actigraphy watch was removed.  
5.2.3.2 Sleep Questionnaires – Parental and Participants  
The sleep questionnaires were chosen based on the paediatric sleep literature and a sleep 
questionnaire reference book (Shahid et al., 2012). The sleep questionnaires were extensively 
researched and licences were gained for each sleep questionnaire. All questionnaires were 
validated for the sample age range (see section 5.4.4.1).  
5.2.4 Sharing the Data  
The pilot and main studies were a collaborative effort with a colleague who was investigating 
seizure-related activity in 22q11.2DS. The EEG method was shared and for adequate data to 
be acquired for the assessment of seizures, a continuous 24-hour period was needed to 
capture both daytime and night time activity. 
The pilot study showed how a young person could tolerate multiple wires and electrodes 
during a night’s sleep and for the continued day. Assessing the feasibility and tolerability of 
this was vital in making adaptations to the main study.  
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5.2.5 Feedback from the Pilot Study  
Feedback from the sleep aspects of the protocol helped to develop the delivery and 
application in the main study. Understanding how individuals without 22q112.DS react to the 
different sensors informed the approach in the main study.  
5.3 Aims and Objectives 
The assessment of the feasibility of the protocol and procedures were the main priorities. As 
a result, the following were the main aims of the pilot study: 
1) Assess feasibility of the 24-hour EEG acquisition setup as part of the wider protocol, 
and the tolerability of the different devices and sensors worn by the child;  
2) Monitor the level of disruption to the participants and family from the visit structure 
(visit in evening, morning and following evening); 
3) Deduce whether it was possible to acquire data of reasonable quality when undertaking 
ambulatory EEG in the participant’s home.  
To address the aims the following was undertaken: 
1) Comparisons between the two methods of EEG acquisition: The Geodesic high-density 
net and the traditional silver-chloride cup electrodes were made; 
2) A dialogue between the researcher and the parents and the young participants; 
feedback both written, in-person and over email was invited.  
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5.4 Methodology 
The protocol was developed collaboratively. Where there was exaggerated input from an 
individual, this is emphasised. 
5.4.1 Ethics 
The ethics were approved by the School of Medicine, Cardiff University. The School of 
Medicine Research Ethics Committee (SMREC) granted ethical approval for the study. 
Additionally, SMREC granted two amendments to the pilot study during its delivery. This 
ensured that the study could be conducted with the intended population and could maximise 
the measures trialled during the pilot.  
The data collected was stored centrally in securely password protected encrypted files, that 
were accessible by the immediate research team. All data was anonymised. No video or audio 
recordings during the night period were used during the pilot study despite their intended 
use in the main study; there was not sufficient time to develop the video recordings. 
5.4.2 Recruitment  
To recruit individuals for the pilot study, colleagues from across the Division of Psychological 
Medicine and neighbouring schools were asked if their children were able to partake. The 
yield of participants from this method was lower than expected and resultantly posters were 
produced and emails were sent to increase recruitment numbers. All participants had an 
affiliation with the University either directly or indirectly. 
5.4.2.1 Sample Size 
The sample consisted of n=12 participants ranging from 6-19 years old (x ̅= 12.6 years old, 
58.3% females). Geographical location was similar with 75% of the participants located in the 
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Vale of Glamorgan and the other 25% in Chepstow. The pilot study received ethics for three 
months and therefore was completed within this time. This resulted in a limited sample for 
the time period. As the pilot cohort was from the general population, the biological ages were 
considered to reflect the developmental age.  
5.4.3 Information from the Pilot 
As previously outlined, the primary aim of the Pilot Study was to assess the feasibility of the 
methodology and the protocol that had been developed prior to testing. Acquiring feedback 
from the participants and the primary carers would enable changes to be implemented prior 
to conducting the protocol in young people with 22q11.2DS (Table 10).  
Table 10 Information we wanted to acquire from the Pilot Study 
 
What is to be decided from the Pilot 
Study? 
How the information was 
acquired? 
What method of EEG acquisition is best 
with regards to data acquisition? 
To assess the density of information 
acquired: can the net provide more 
information than the traditional 
electrodes? 
What equipment is most comfortable 
for the participants? 
Discuss the comfort levels with the 
participants to gauge a perception of the 
comfort level 
Is the proposed protocol and the 
timings feasible? 
Discuss and note the perceptions of the 
primary carers and the participants with 
regards to time spent at house and 
participating in the study 
How did the set-up timings differ 
between the EEG methodologies? 
Note how long set-up was for the 
different methods of EEG acquisition and 
compare  
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5.4.4 Sleep Assessments  
5.4.4.1 Sleep Questionnaires 
Many sleep studies in the literature have a design built around the objective assessment of 
sleep problems resulting in polysomnography, or actigraphy often worn for a minimum of 
seven nights. Objective measures are often supported by subjective measures such as sleep 
questionnaires.  
Questionnaires can be used without restraints on cost as they can be widely distributed to 
families. Wearing an EEG net over a single night is an invasive process which some young 
people, especially those with neurodevelopmental disorders, might find uncomfortable. 
Having a non-invasive measure of the study that can still yield a large wealth of data allows 
those individuals to still participate and contribute to the understanding of sleep. It isn’t only 
that individuals with NDD might not be able to tolerate the study, the study is completely 
voluntary and as a result, some individuals might not want to participate in the overnight 
aspect but are receptive to completing questionnaires. Whether the questionnaires are used 
to support the sleep EEG and actigraphy data or stand alone to assess behaviours of sleep 
problems in young people, each component added a new dimension.  
I chose age-validated sleep questionnaires to cover the age span of the participants intended 
to be in the main study. These sleep questionnaires were trialled in the pilot study to see how 
easily they were to complete. The younger participants were not required to complete the 
sleep questionnaires whereas older participants completed a sleepiness questionnaire with 
the primary carers providing the remaining information.  
Logistically, the best time for the questionnaires to be completed by the parents and the 
participants was trialled in the protocol; sending the questionnaires prior to the study visit 
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and taking them along for completion during the study visit were both trialled. Remaining 
flexible with the times and providing pre-paid envelopes for returning the questionnaires, 
along with the sleep diaries and actigraphy watches, proved to be a reliable method of 
receiving the questionnaires back. The different sleep questionnaires are outlined.  
Cleveland Adolescent Sleep Questionnaire 
The Cleveland Adolescent Sleep Questionnaire (CASQ) (Spilsbury et al., 2007) is a validated 
sleep questionnaire for 11-17-year olds that includes sixteen questions aiming to identify 
daytime sleepiness in adolescents. The degree of sleepiness and of alertness in an individual 
is assessed on a 1-5 Likert-scale response. The CASQ is scored based on the higher the total 
score, the greater the implied sleepiness. There is no normalised scale. Some of the questions 
in the CASQ are reversed-coded (a smaller number on the Likert-scale equates to a ‘stronger’ 
response in some questions whereas in other, a higher number equates to a ‘stronger’ 
response) and care was taken when coding these questions. Where there were difficulties, 
primary carers could help the participant in the understanding of the reversed question. In 
the pilot study, the CASQ was completed by n=6 young people.  
Children’s Morningness-Eveningness Scale  
The Children’s Morningness-Eveningness Scale (CMES) is a validated questionnaire for 12-18-
year olds (Shahid et al., 2011) and was completed by the participant to obtain a subjective 
opinion regarding their morningness/eveningness (M/E). The CMES consists of ten multiple 
choice items based on a 1-5 Likert-scale including questions regarding perceived preferred 
time to complete exams, to do exercise and preferences regarding wake and bedtimes if they 
were able to choose these times themselves. The CMES was completed by n=6 young people.  
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Children’s Chronotype Questionnaire and the Munich Chronotype Questionnaire 
The Munich Chronotype Questionnaire (MCTQ) (Roenneberg and Merrow, 2016) is a self-
rated scale assessing individual phase of entrainment on scheduled days and free-days. It was 
designed to work in ages 6 to over 60 years old, but a younger version was adapted for the 
assessment of younger children to be completed by their primary carer called the Children’s 
Chronotype Questionnaire (CCTQ).  
The MCTQ estimates the chronotype (CT) on an individual. Chronotype or CT is the 
behavioural manifestation of underlying circadian rhythms and develops as an individual’s 
propensity to want to sleep at a particular time during a 24-hour period. The CT is derived 
using the midpoint between sleep onset and offset on work-free days, called the mid-sleep 
on free days (MSF) variable. The MSF quantifies the average mid-point of the sleep duration 
across free days. However, if a particular night were to be atypical, for example if an individual 
slept longer on the weekends to compensate for any ‘sleep debt’ they had accumulated 
during the scheduled days of the week, this would need to be accounted for. Therefore, the 
MSF can be corrected for the ‘excess’ sleep resulting in the MSFsc variable. MSFsc represents 
a measure of CT.  
Many variables can be derived from the MCTQ: sleep latency (how long is needed to fall 
asleep (mins)); time in bed (TIB, get-up time-bedtime); sleep onset (SO, sleep latency + lights-
off); sleep duration (SD, wake-up time - sleep onset (SDf (free) or SDw (work))); average 
weekly sleep duration ((SDweek, SDw x number of ‘work’ days + SDf x number of ‘free’ 
days/7)); sleep inertia (SI, time fully alert-wake-up time) and midsleep point defined as (MSF, 
sleep onset (SO) + sleep period)/2)).  
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The Children’s Chronotype Questionnaire (CCTQ) is an adaptation of the MCTQ. The CCTQ 
was devised for parents to answer open-ended questions regarding sleep/wake parameters 
for their child’s scheduled and free days. The parameters assessed and variables derived are 
like the MCTQ: bedtime, lights off time, sleep latency, wake-up time, get-up time and time 
taken to be fully alert. Including the scheduled and free day assessments shows whether 
sleep/wake patterns are directly influenced by activities such as school on scheduled days and 
on the free days these restrictions aren’t present and sleep/wake patterns could differ.  
There are three different parental report measures of children’s chronotype in the CCTQ: the 
midsleep point on free days (MSF), the Morningness/Eveningness (M/E) scale score and the 
Chronotype (CT). These measures are comparable to the MCTQ derived variables and 
chronotype measures. This allows for the entire sample to have a chronotype as the MCTQ 
and CCTQ together are inclusive of the age-range of the sample.  
There were n=6 young people who completed the MCTQ and n=6 who completed the CCTQ. 
These numbers of completion were based on the age distribution of the sample.  
Paediatric Sleep Questionnaire and Sleep-related Breathing Disorder Scale  
The Paediatric Sleep Questionnaire (PSQ) is an extensive questionnaire completed by primary 
carers of young people aged 2-18 years old. The PSQ includes general information including 
demographic information; night time parameters including snoring, breathing, restlessness, 
growing pains and number of nocturnal awakenings; daytime section regarding how 
refreshed the child is, complaints of sleepiness and sleep paralysis; health which includes 
growth rate, tonsillectomy and breathing conditions; stimulant use regarding caffeine and 
Ritalin; medical information about medication, psychiatric symptoms and sleep diagnoses, as 
well as clinic attendance and an ADHD behavioural section. Overall, these sections can be 
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divided into subscales which assess the total scores for behavioural problems, sleepiness, and 
a total score for snoring-related outcomes. In addition, there is a periodic limb movement 
index (PLMI).  
Within the PSQ there is an additional stand-alone scale called the Sleep-related Breathing 
Disorder Scale (SRBD) which is a 22-item scale including variables taken from the main PSQ 
questionnaire such as sleepiness, hard to wake, headaches and snoring frequency. The SRBD 
scale has a total sleep-breathing disorder score outcome that can be added to a five-point 
ADHD scale to get an overall SRBD score. The ADHD scale is a 5-point Likert scale regarding 
how well the outcomes match the participant: doesn’t listen, difficulty organising, easily 
distracted, fidgets, on the go and interrupts.  
There were n=12 parental completions of the PSQ and SRBD. An option of ‘don’t know’ was 
available to parents and this could be scored as such and included in calculating subscales. 
Sleep Disturbance Scale for Children  
The Sleep Disturbance Scale for Children (SDSC) is a 27-item questionnaire rated on a five-
point Likert-type scale based on how well the question describes the individual. The parents 
completed the questionnaire on behalf of their child. The instrument is used to categorise 
sleep disorders in children and gives an overall score for the instrument matched to a t-score. 
There are five subdomains: disorders of initiating and maintaining sleep (DIMS), sleep 
breathing disorder (SBD), disorders of arousal (DA), and sleep-wake transition disorder 
(SWTD), disorders of excessive somnolence (DOES) and sleep hyperhidrosis. The scale is 
validated for use on 2-18-year olds, with n=12 parental reports completed.  
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5.4.4.2 Actigraphy and Sleep Diaries 
The actigraphy watches were purchased from Philips Respironics (Philips, 2018) and 
calibration was completed by volunteers to ensure accurate data acquisition. The actigraphy 
protocol for the pilot study was developed in line with the standardised procedure of 
actigraphy acquisition outlined (Meltzer et al., 2012). Further information regarding the 
finalised actigraphy protocol is in the experimental section for the main sleep study (Chapter 
6). 
The watches were used in the pilot study to determine whether they were tolerable and 
whether the participants were likely to adhere to wearing the watches for the total two 
weeks’ period. The watches have been extensively used in published research both in younger 
populations and in adults suggesting that these watches were reliable in their data acquisition 
(see Chapter 6). 
The watches were designed to be used in research conditions which in the circumstance of 
this study, would eventually be in the homes of young people who experienced 
developmental and behavioural difficulties. The watches were chosen for the validity, 
robustness and water resistance to mitigate damage to the watches. Minimal damage was 
inevitable as these watches were intended to be used as part of the pilot study, main study 
and future studies.  
The type of actigraphy watch that was used was not the same for all ages. Phillips had a 
smaller, more appropriately sized watch for young children to wear which looked similar to a 
wristband. This was especially important in this study sample with younger children, both of 
physical age and of developmental age, so a larger watch with a digital watch face and date 
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on it might not be as appropriate. The pilot study assessed the effectiveness in measuring 
sleep/wake activity across two weeks across the two different types of watches.  
In conjunction with wearing the watch for two weeks, the participants were asked to 
complete a sleep diary for the same two-week period as wearing the actigraphy watch either 
on their own or with a primary carer ensuring accuracy. The primary carer completed the 
sleep diary if the child was considered not able to.  
The first sleep diary was a basic assessment of timings: time in bed, lights off time, sleep time, 
wake time and out of bed time in addition to sections for commenting on removal of the 
watch, whether medication had been taken and whether they had napped during the day. 
The sleep diary evolved over the pilot study and in the preliminary stages of the main sleep 
study (see section 5.5.4 and Chapter 6) generating a more comprehensive diary. 
5.4.4.3 Polysomnography 
Sleep EEG  
Dr Ullrich Bartsch, a Lilly sponsored Postdoctoral Fellow, supported all technical aspects of 
EEG acquisition during the study including sponsoring the acquisition setup.  
Training  
A three-day polysomnography course organised by the University of Edinburgh and Dr Lizzie 
Hill from NHS Lothian provided guidance and training on how to practically acquire EEG. This 
course included application of polysomnography sensors with sessions on breathing 
apparatus and the interpretation of breathing pressures and data from nasal cannula, RIP 
belts, pulse oximetry and thermistors. A small number (n=5) of sleep EEGs were available to 
practice on. A trained somnologist was available to assist in the interpretation and provide 
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help with scoring. Experience of sleep scoring was gained, however this was complemented 
with by continuing to practice scoring of EEG traces downloaded from open sourced 
databases online (Grandchamp, Braboszcz and Delorme, 2014). Additionally, an open-source 
EEG database from Boston, USA was made available from collaborators of Dr Ullrich Bartsch 
for practising sleep scoring. Ten sleep EEGs were available to practice scoring and to become 
accustomed to working with sleep EEGs.  
At the time of developing the in-home EEG setup, the University of Bristol Clinical Research 
Imaging Centre (CRIC) housed a longitudinal population-based sleep study (Hellmich et al., 
2015). This was based on a ‘recall-by-genotype’ study protocol of male participants aged 25 
who were members of the Avon Longitudinal Study of Parents and Children (ALSPAC) study. 
By volunteering to help run the study overnight, I was provided with an opportunity to 
develop a better understanding of EEG setup in addition to contributing to interpreting EEGs 
acquired in the study. There were ten sleep EEG traces that were available to practice scoring 
on. Once I had scored these EEGs, a post-doc re-assessed these EEG traces and then a trained 
somnologist re-scored a 10% sample of the EEGs to ensure concordance. The somnologist 
used an agreement of 80% (average) when scoring the EEGs.  
To increase exposure to EEG data, I attended six sessions with an electrophysiologist at the 
University Hospital Wales, Heath. I was able to ask questions regarding the 
electrophysiological traces. This did not include sleep EEG however it did provide an 
opportunity to learn how to interpret traces and to spot inconsistencies. Each week provided 
a new EEG sample that had been recorded as part of the epilepsy clinic.  
The pilot study compared two methods of EEG acquisition. For the traditional silver-chloride 
cup electrode setup, the amplifier used for the acquisition of the EEG signals could be used to 
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acquire the cardiorespiratory signals also. This was an Embla Titanium amplifier (Natus, 
2018b) resulting in the full PSG assessment to be acquired on one device. However, with 
regards to the high-density 60-channel Geodesic net from EGI (Philips Company, 2018), this 
method of EEG acquisition required an EBNeuro BE Plus LTM 64 amplifier and the Galileo 
acquisition software (EBNeuro, 2018). Therefore, this meant that two amplifiers were 
required for the full PSG assessment as there were no additional inputs in the EBNeuro 
amplifier. The signals were synchronised post-acquisition before analysis. 
Electrooculography (EOG) and Electromyography (EMG) 
When undertaking EEG setup, regardless of technique, the minimal PSG application is the 
electrooculography (EOG) and electromyography (EMG) electrodes to the face. These free 
adhesive electrodes are required for the interpretation of the sleep EEG.  
Eye movements were measured by one electrode positioned 1 cm lateral to the outer canthus 
of the left and right eyes and then 1 cm up from the right eye, and 1 cm down from the left 
eye. Eye movements such as saccades and rapid and slow eye movements could be detected 
dependent on the polarisation of the eye. This was especially important in determining sleep 
stages as eye movements in REM sleep are biological markers of the stage. The impedance of 
the EOG electrodes was under the 10kΩ for the best quality signal to be measured.  
In addition, free adhesive electrodes were placed under the chin to the left and right of the 
midline of the neck. These were used to assess muscle tone and atonia during REM sleep. The 
impedance levels of the EMG electrodes were under 10kΩ for the best quality signal to be 
measured. 
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Once the EOG and EMG electrodes were applied to the participants face, the EEG electrodes 
or the EEG net were glued to the scalp/placed over the head. 
10-20 International Electrode Placement System 
The head of the participant was measured before application: the circumference; left pre-
auricular to right pre-auricular distance and the nasion to inion measurements were 
recorded. Marks were made where 21 electrodes could be applied to the scalp using a 
porcelain pencil. This was easily removable by an antiseptic wipe.  
For the standard sleep study, there were 12 electrodes that were applied to the scalp: F3, F4, 
Fpz, Fz, C3, C4, Cz, Pz, O1, O2 and M1 and M2 (the left and right mastoid bones behind the 
ears) (see Figure 8). 
 
 
 
 
 
 
 
 
 
Figure 8 10-20 International electrode placement  
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The areas marked were swabbed with abrasive NuPrep gel (Nuprep Skin Prep Gel | For Use in 
Cardiac Rehabilitation Monitoring, 2018) which works to clean and moisten the skin, reducing 
the impedance so that a higher quality signal can be detected. Once the positions were dried, 
the silver-chloride cup electrodes were glued to the scalp with collodion glue, ensuring that 
any hair was separated to ensure best contact with the skin. Once dry, Signa gel (SignaGel 
Electrode Gel: Parker Laboratories, Inc., 2018) an electro-conductive gel, was injected into the 
small hold in the centre of the silver-chloride electrodes. The electro-conductive gel works to 
increase the signal quality detected globally across the cortex and conducted across the scalp 
which is detected by the 21 electrodes. 
Geodesic Net  
The primary difference of the two methods was that the net included 60 active recording 
electrodes which is like an EEG cap available from other manufacturers.  
The net application required the circumference, left pre-auricular to right pre-auricular, 
nasion to inion and the central position known as ‘Cz’ to be measured. The technique did not 
require collodion glue but NuPrep was used to clean the head and exfoliate the area removing 
with an alcohol wipe. A curved plastic syringe was filled with Signa gel and was used to move 
hair away from the area to expose a larger area of the scalp for the electrode to be in contact 
with. Each of the electrodes was housed in a plastic pedestal where the electro-conductive 
gel was injected into from the curved syringe. 
Electrode impedances were checked using the impedance check tool in Galileo. The tool displayed 
electrode locations and impedance values which can then be individually checked and improved. An 
impedance of 30KΩ was aimed for and once this was achieved across the net, the signal quality was 
tested and calibrated.  
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Bio-calibration  
Once the electrodes were prepared using either technique, the signals had to be calibrated 
to ensure detection of the correct physiology. The protocol included a bio-calibration of the 
electrodes that was the same for both techniques. 
 Different instructions were given to the participants such as ‘blink’, ‘eyes closed’, ‘eye open’ 
and ‘grind teeth.’ Once the participant had reacted to the command, a marker was added to 
the computer physiological trace displayed on the Galileo programme to mark where the 
activity had occurred. This was relevant for analysis when assessing the signal quality during 
different activities.  
Bio-calibration was also completed for the EOG and EMG on a separate programme, 
REMLogic (Natus, 2018a) which displayed the cardiorespiratory signals. Similarly, the 
commands were noted for future analyses when assessing changes in physiology based on 
different activities.  
The cardiorespiratory and EEG bio-calibrations remained separate during the acquisition but 
would be combined post-acquisition for analyses.  
Cardiorespiratory Polygraphy  
The cardiorespiratory polygraphy protocol was developed in collaboration with Dr Claire 
Durant from CRIC, University of Bristol and Dr Jose Thomas, Respiratory and Sleep Consultant, 
Nevill Hall Hospital, Abergavenny. Dr Jose Thomas was available to help with the Pilot Study, 
however did not continue to assist throughout the study nor the main study. 
Working closely with Nevill Hall Hospital ensured that the correct measures were included in 
the study ensuring that the cardiorespiratory events would be detected accurately through 
   
143 
 
the night and could be used in further analysis. The cardiorespiratory measures were also 
important to identify whether there were any undetected clinical sleep problems relating to 
breathing or changes in the heart rate. 
The pilot study incorporated the use the following respiratory measures: nasal cannula to 
measure the breathing pressures and derive the breathing rate; respiratory inductance 
plethysmography (RIP) belts, one around the thorax and one around the abdomen which 
expand and contract based on breathing and a pulse oximeter which measures the oxygen 
saturation of the haemoglobin in the blood worn on a finger of the non-dominant hand.  
The cardiac measures were the electrocardiography (ECG) which was assessed by two 
adhesive electrodes connected by ECG wires to the amplifier that in turn was connected to 
the EEG net. There were an additional two adhesive electrodes that were connected by ECG 
wires to the cardiorespiratory Embla titanium amplifier. Pairs of electrodes were placed under 
the participants left and right clavicle; two adhesive electrodes on each side. The impedances 
of the ECG electrodes were assessed to be under the 10kΩ and were checked on both the 
Galileo (EBNeuro, 2018) and REMLogic (Natus, 2018a) programmes to ensure the signal was 
detectable and interpretable.  
5.5 Outcomes and Discussion 
Outcomes from the pilot study included the optimal protocol and the appropriate method of 
EEG acquisition. There were no quantitative analyses undertaken. For instance, the sleep EEG 
was not analysed from the pilot study in a strategic and systematic manner: it was assessed 
for quality of the signal and the duration of continuous assessment as well as assessing the 
wireless technologies. There were however results from the sleep questionnaires that have 
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been included but the remainder of this section will refer to the results obtained from the 
pilot study generally regarding feasibility, tolerability and the development of the protocol.  
5.5.1 Recruitment 
Individuals in the pilot study were recruited through the Division of Psychological Medicine 
and Clinical Neurosciences (the university Division that the researchers belonged to) and 
Cardiff University. Colleagues were asked whether their children, if the correct age, could 
volunteer for the pilot study. As a result of the nature of how the participants were recruited, 
neurological, psychiatric and psychological conditions were not controlled for. The parents 
and/or participants were encouraged to disclose problems to the researchers if they wished 
to. There was no evidence to suggest that any of the individuals had a neurodevelopmental 
problem. However, we recognise that because the participants were the children of 
individuals working at Cardiff University, there could be resistance to disclose problems to 
our research team.  
5.5.2 Polysomnography - Sleep EEG, and Daytime Recording 
Coordinating an evening, night and following day for the acquisition of data proved to be 
difficult. The following protocol was trialled:  
- Visit in the evening to undertake EEG setup  
- Return the following morning to remove EEG/to re-gel to lower the impedances  
- If continuing with the daytime assessment, return in the evening.  
Therefore, the total visit could last for 24-hours including the night sleep. Otherwise, the 
evening protocol should have lasted around three hours, followed by the following morning 
taking up to two hours.  
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One night seemed to be acceptable by the parents, but there were limitations in the 
acquisition of daytime EEG. Some of the assessments however were conducted during the 
summer holidays which allowed for more flexibility in arrangements.  
There were only n=3 participants that wore the EEG net for one night and up to 12-hours of 
the following day. These individuals wore the net for an average of 20.7 hours. When 
recruiting the young people, confirmation was required as to whether they were free the 
following day. All individuals excluding one confirmed that they were free however the small 
number of individuals completing the entire study suggested that the participants no longer 
wanted to complete the study after sleeping in the equipment.  
As a result, during the EEG setup and throughout EEG acquisition in the main study a 
suggested incentive could be provided to encourage continuous wearing of the geodesic net 
for the 24-hour period. Communication to the parents and the participants was important 
ensuring that the most comprehensive set of data could be acquired. 
There were n=2 participant who did not complete the overnight sleep EEG. Reasons for this 
were that one participant did not want to wear the net after attempting, and the second 
participant was unable to complete the overnight aspect of the study on the arranged night 
however their sibling was able to. Both individuals did however complete the other 
parameters such as the actigraphy watch and the sleep diary and completed the sleep 
questionnaires. 
For those individuals who asked for the net to be removed after the night’s sleep, they were 
asked to hypothetically say whether they would have been able to continue wearing the EEG 
net for an extended period during the day.  
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Table 11 outlines the feedback received from the participants based on their experience. 
Table 12 shows the outcomes of what was intended to be learnt from the Pilot Study (outlined 
in Table 10, section 5.4.3).
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Table 11 Findings from the Pilot Study 
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PS-01 10.4 - 22 End of study Yes 6/10 comfort – 
okay to sleep in 
PS-02 8.18 - 0 Didn’t want to wear 
after trying net on 
- Did not wear EEG 
PS-03 6.16 - 15 Wanted to remove 
after 1 hour of 
daytime recording 
No Fine to sleep in. 
PS-04 11.0 - - - - Did not wear EEG 
PS-05 11.7 115 11 Had badminton 
practice at 9 am 
No (would wear 
if opportunity to) 
Net dug into the 
back of head 
during sleep 
PS-06 8.8 - 13 Didn’t want to wear 
during the day 
No Uncomfortable to 
wear 
PS-07 13.5 - 18 Wore for portion of 
daytime 
Yes Uncomfortable to 
wear 
PS-08 17.7 55 13 Didn’t want to wear 
during the day 
No Uncomfortable to 
wear 
PS-09 14.2 50 15 Didn’t want to wear 
during the day 
No Uncomfortable to 
wear 
PS-10* 17.2 173 15 Didn’t want to wear 
during the day 
No Good sleeping 
position; okay to 
wear 
PS-11* 15.4 125 20 Had to leave at 11:00 Yes Free electrodes 
were quite 
comfortable 
PS-12 17.8 95 20 Didn’t want to wear 
during the day 
No Net 
uncomfortable to 
sleep in 
Asterisks (*) refer to those individuals which wore the silver-chloride free electrodes over the Geodesic net 
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Table 12 Outcomes from the Pilot Study 
 
One particular outcome that was shared by participants was the mild discomfort of the EEG 
net during the night’s sleep. The free electrode method was shown to be more comfortable 
however, the preparation was substantially longer and involved the use of irritant chemicals 
that required safe storage and transportation. The sleep study was coupled with the seizure-
related study that required a high density of electrodes suggesting that the high-density EEG 
net was a more appropriate technique.  
The EEG net would yield a higher quality of data for the sleep EEG and covered a wider area 
of brain activity for assessment. However, the EEG net also introduced potential discomfort 
and an abnormal sleep night. The discomfort was something that would be particularly 
intrusive for the individuals sleep so efforts to minimise this, by suggesting the use of soft toys 
and blankets under the occipital electrodes at the back of the cranium, was important to 
include in the main sleep study protocol.  
What is to be decided from the Pilot 
Study? 
Outcome 
What method of EEG acquisition is best 
with regards to data acquisition? 
The Geodesic EEG net 
What equipment is most comfortable for 
the participants? 
The traditional electrodes  
Is the proposed protocol and are the 
timings feasible? 
Protocol fine and timings, when using 
the Geodesic EEG net, were fine for 
the evening.  
How did the set-up timings differ between 
the EEG methodologies? 
Time it took to apply the traditional 
electrodes in 10-10 placement was 
too long. 
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5.5.3 Polysomnography - Cardiorespiratory Polygraphy  
All participants wore the RIP belts during the night’s sleep who completed the overnight sleep 
EEG. There were n=10 individuals who wore the pulse oximeter and n=10 wore the ECG 
electrodes.  
The nasal cannula was problematic as it was the most invasive sensor that was inserted 
slightly in the nostrils of the participant to accurately measure breathing. Two of the pilot 
participants wore the nasal cannula; both reported discomforts.  
5.5.4 Actigraphy, Sleep Diaries and Sleep Questionnaires  
The subjective measures in the pilot study were easily adhered to with all the n=12 
participants wearing the watch for the two-week period other than when they were taking a 
bath, doing contact sport or swimming. There was one individual who worked as a lifeguard 
so had to remove the watch whilst on duty two times a week and another participant who 
went on a surfing holiday during the two-week period.  
All participants completed the sleep diary in conjunction with the actigraphy watch, and the 
necessary sleep questionnaires that were then sent back with the watch. 
5.6 Strengths and Limitations  
The pilot study aimed to assess the feasibility of the current protocol to allow for the 
development of an optimal setup for the EEG and for the overall sleep study protocol with 
young people with 22q11.2DS.  
It is important to note that there was a lack of reliability in the training that was provided 
regarding sleep EEG scoring. This was not utilised in the Pilot Study due to the inconsistency 
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of the software to acquire and store the data reliably. Once acquired, the data could not be 
exported and in some situations, data was lost. This was rectified before the main study. 
Nonetheless, the training provided for sleep scoring was insufficient to derive clinical 
conclusions from any further sleep EEG scoring that is commented on later in this thesis. I am 
not a qualified somnologist nor am I a certified sleep physiologist. The training I received was 
provided from such professionals however, the training was from numerous sources and from 
different individuals and therefore, introduces some unreliability in the reporting of the sleep 
EEG scoring. 
The feasibility of the intended measures was assessed resulting in mixed success. The small 
sample size suggested that results could not be extrapolated. However, they suggested the 
strengths of the protocol and areas that required modifying before the main EEG study.  
The recruitment will be easier in the main EEG study as the participants are current recruited 
members of the ECHO Study (see Chapter 3). Of the people which expressed interest in the 
pilot study n=3 withdrew their interest and n=2 didn’t partake in the EEG measure. There was 
a 66.6% success rate in the recruitment and execution of the sleep EEG.  
The pilot study helped to develop the protocol and helped to devise a step-by-step protocol 
for each of the experimenters working on the project as well as for the parents and 
participants so that they were able to know exactly what was going on and ask as many 
questions as possible. Making sure that the families were completely aware of what was 
happening and what the study was for needed to be reinforced so that the main study 
protocol involved the development of pre-study information packs, during the study 
information and post-study information and evaluation to ensure that all participants 
received the same information and guidance throughout.  
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The sleep measures showed some problems in the pilot study with regards to comfort and 
adherence. Having developed an EEG setup and for that to not be undertaken as intended, 
added to personal development of the researchers. Resilience and adaptability of the 
researchers ensured that each study was approached with openness for flexibility. 
Maintained communication with the participant and their family was vital to ensuring trust 
and participation in the study. If a participant was uncomfortable then in some instances, it 
would be deemed appropriate to conclude the study. Having the ability to objectively judge 
this ensured that the researchers, parents and participants remained comfortable and 
satisfied. Some measures were considered more invasive such as the nasal cannula. If the 
nasal cannula could not or would not be worn, this did not detract from the wealth of other 
monitoring systems and data analysis would be adapted accordingly. 
The pilot study was conducted with typical young people of which the majority were related 
to an academic at Cardiff University so biasing the sample slightly with regards to IQ and 
socioeconomic status. This homogenous sample might not be reflected in the main sleep 
study sample. It would be important to remember that each different family, each participant 
and different environment must be tailored to ensure that the family is as comfortable as 
possible and the participant at ease.  
The actigraphy watches were a proven success and were shown to be tolerated by a range of 
ages. The sleep diaries were also completed by all, but from the pilot feedback suggested that 
the lengthiness of the sleep diaries should be reduced and that sleep diaries for different ages 
should be developed. For example, adding an element of fun to the task for younger children, 
and in order to gain a direct response to a question (i.e. have you consumed caffeine today), 
include more closed questions. The sleep dairies were developed to be gender-neutral and 
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age-appropriate for example, including colouring for young children. There was an additional 
area for the participant to provide comments on how they felt after waking and how they 
perceived their quality of sleep. An example of the various sleep diaries that were included in 
the main sleep study can be found in Appendix 4, pages 334-344. 
The sleep questionnaires were answered and returned with the only complaint from parents 
of older children suggesting that they were unaware of their child’s sleeping behaviours and 
patterns because of their independence. As a result, these primary carers were unable to 
provide responses to some questions. Parents and carers of older children from the typically 
developing population anecdotally might not have as much involvement with the sleep 
behaviours and activities of their children compared to the parents and carers of young 
people with 22q11.2DS. This is anecdotal and based on evidence provided verbally from 
parents.  
The primary strength of the pilot study was that it could gather a comprehensive and broad 
picture of sleep behaviours and physiology from the participants. This was promising for the 
main sleep study in identifying sleep phenotypes of young people with 22q11.2DS. 
5.7 Future Work 
The future work was the main EEG sleep study which was developed from what was learnt 
from the pilot study. These findings were incorporated into an ethical application for the main 
sleep EEG study.  
Most importantly, the pilot study motivated the development of step-by-step protocol, a 
clinical research framework (CRF) for the experimenters and the parents for the main sleep 
study that would include a list of equipment to ensure that everything was packed and taken 
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with us on every study, tick boxes for different procedures from measuring the head to 
turning the EEG amplifier on and there were also sections for further comments relating to 
the participant. This would ensure that any individual with a working knowledge of the sleep 
EEG study would be able to follow the protocol step-by-step without trouble.  
Incorporating these measures, updating the sleep diaries and finalising the EEG net protocol 
was necessary for the ethics of the main sleep study and to ensure that the main sleep study 
was a great success.  
5.8 Summary  
The pilot study was pivotal in the development of the main sleep study and without it, a 
succinct and reliable protocol would not have been delivered during the main sleep study. 
The feasibility and the tolerability of the measures throughout the night was assessed and 
showed varying acceptance which potentially related to age whereby older young people 
tolerate more of the measures throughout the night. This is an important outcome that needs 
to be taken forward into the sleep study. The intricacies of the protocol were apparent during 
the pilot. As a result, a clinical research framework (CRF) was developed that could be used 
explaining step-by-step the protocol for the experimenters as well as the participants and 
parents.  
From the pilot, it was apparent that the high-density EEG net was a fast and efficient 
technique for acquiring high quality datasets and could be system could be set up with greater 
ease for use in young people. The pilot also suggested that further practice with the EEG net 
was required to shorten the duration of the protocol before the main sleep study, quickening 
the process and lessening the disruption to the families and their homes. The EEG net was 
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considered uncomfortable so maximising comfort during the night would be important to 
allow the participant to sleep as typically as possible. 
The actigraphy yielded high adherence with watches worn for the two weeks and only 
removed when suggested. The sleep diary was completed by all, yet the information provided 
was less comprehensive in some than others. Developing the sleep diaries to make them 
easier to complete and requiring fewer written comments would be vital in the main study.  
The main study could now incorporate these changes, improving efficiency and the quality of 
data obtained. The pilot study ensured development of a better organised and succinct 
protocol, yet further practice and protocol development would be required before the main 
study and in the earlier stages of the main study.
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Chapter 6 – Actigraphy, Sleep Diaries and Sleep Questionnaires in 
22q11.2 Deletion Syndrome 
6.1 Overview of Chapter 
Parent-reports have anecdotally suggested that sleep problems are preponderant in young 
people with 22q11.2DS. These subjective views of their children’s sleep can incorporate 
unintentional bias. Therefore, parent-reports should be followed-up and sleep problems in 
young people should be objectively assessed. Parental perspectives can contribute to the 
development of a comprehensive assessment of sleep including both subjective and objective 
assessments. 
Movement patterns can be monitored using accelerometers (Kavanagh and Menz, 2008) that 
can exist within wearable devices such as actigraphs. Actigraphy watches can be worn by an 
individual to assess their movement and provide an objective measure of activity during 
wakefulness but also during sleep. This equipment can measure nocturnal activity in young 
people and help to support the evidence of sleep problems from parents. Nonetheless, the 
perspective from the individual themselves is important in understanding the sleep 
behaviours including whether an individual prefers sleeping in later or waking earlier 
compared to others. These perspectives can be derived from the actigraphy measures but 
validation from self-reports can help to substantiate the evidence. Difficulties can occur 
where younger children are unable to verbalise their views on their sleep or where learning 
disability prevents a child from having the capacity to report. Parental-reports are important 
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for these individuals, acting as a replacement to self-report to compare with actigraphy 
measures. 
This chapter is divided into two sections. The first section will comment on the use of 
actigraphy in the main sleep study assessing the nocturnal activity of young people with 
22q11.2DS and unaffected sibling controls. The actigraphy-derived sleep parameters and 
sleep diary data are used to investigate differences between the individuals with 22q11.2DS 
and siblings, in addition to exploring the relationship between nocturnal activity in individuals 
with 22q11.2DS and the neurodevelopmental phenotype. 
The second section of this chapter will outline and describe the different sleep questionnaires 
that were used in the main sleep study. These validated sleep questionnaires are described 
and used to cross-validate the sleep problems section of the CAPA (Chapters 3 and 4). 
Validation of the sleep questionnaires, parent and self-report, alongside parental-report of 
sleep problems from the CAPA can help to identify the appropriateness of the CAPA in the 
assessment of sleep problems in young people with and without neurodevelopmental 
problems.  
6.2 An Introduction to Actigraphy 
6.2.1 What is Actigraphy? 
The practice of actigraphy was defined in 2007 by the American Academy of Sleep Medicine 
(AASM), the world authority in sleep medicine, as ‘…is indicated for delineating sleep patterns, 
and to document treatment responses in normal infants and children (in whom traditional 
sleep monitoring by polysomnography can be difficult to perform and/or interpret), and in 
special paediatric populations’ (Iber, 2007). 
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Actigraphy can provide an alternate assessment to polysomnography techniques which are 
clinically required for diagnosis of certain sleep disorders. Actigraphy records the frequency 
and degree of movement of an individual over time with an actigraphy watch worn on either 
the wrist or ankle, or as a band around the waist. The position of the watch on either the wrist 
or ankle allows for the recording of triaxial movements (in axes X, Y and Z) in space. Despite 
the increasing use of actigraphy, there is currently no single definitive and replicable protocol 
or method used to analyse the data. This results in inconsistencies in the protocols used and 
therefore, there are differences in the parameters assessed and algorithms used. There are a 
number of different watches that have undergone different validation processes resulting in 
added irregularities in the variables that can be derived from actigraphy assessments. One 
review of the literature showed that of the papers they systematically reviewed, 72 did not 
report the protocol for their actigraphy data scoring or interpretation resulting in 
nonreplicable results (Meltzer et al., 2012).  
Clinically, an actigraphy assessment can last between one and two weeks to acquire a 
normative profile of the sleep-wake patterns. This time period aims to include examples of 
weekend and weekday nights of sleep. This is important when analysing the data as there are 
often differences in sleep-wake patterns during weekdays, defined as ‘scheduled days’, and 
the weekends which tend to have fewer restrictions. It is widely acknowledged that a period 
of seven days (Ulate-Campos, Tsuboyama and Loddenkemper, 2017) including at least one 
weekend with the remaining five days as ‘scheduled’ days of work or study is adequate in the 
analysis of sleep-wake patterns and nocturnal activity.  
Actigraphy can generate estimates of similar sleep parameters to those derived from PSG. 
These include sleep onset latency (SOL), total sleep time (TST), time in bed (TIB), wake after 
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sleep onset (WASO) and sleep efficiency (SE). Actigraphy watches present an adequate 
alternative to acquire more objective measures of sleep activity but cannot replace the clinical 
gold-standard assessment of PSG which can obtain measures of neurophysiology and 
breathing. Actigraphy can be used across all demographics however should be supported by 
PSG to comprehensively assess sleep. 
6.2.2 Actigraphy in the Typical Paediatric Population 
There is a limited number of actigraphy studies in the typical paediatric population and the 
validity of actigraphy in young people is debated. Evidence from one study suggested that 
actigraphy underestimated TST and SE and did not accurately report SOL when compared to 
PSG assessment (Meltzer et al., 2012). Assessing young people’s nocturnal activity can be 
difficult as normative sleep patterns are not often acquired until later childhood with 
physiology changing until the age of 10 (Berry et al., 2012). 
Bedtime behaviours and nocturnal activity in very young infants can be assessed by different 
types of accelerometer: a baby-mat with an integrated accelerometer can detect movement 
of babies during the night period for example (Lambiase et al., 2014). These techniques could 
be used to map the development of nocturnal activity over different ages.  
In young children it can be difficult to undertake clinical studies, especially studies which 
require the participant to stay away from home for at least one night of sleep. Actigraphy can 
be a helpful tool by contributing to the understanding of a child’s problems, whilst causing 
minimal disruption.  
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6.2.3 Actigraphy and the Neurodevelopmental Phenotype  
6.2.3.1 Actigraphy in Neurodevelopmental Disorders  
In individuals with neurodevelopmental problems, objectively assessing sleep can be difficult 
as a result of behavioural, communicative or intellectual impairments (Thackeray and 
Richdale, 2002). Parental-reports of sleep problems are commonly used to assess sleep in 
these young people however this is a subjective measure contributing bias to the assessment. 
A combined assessment can yield the most data and help to identify inaccuracies. 
Attention-Deficit Hyperactivity Disorder  
Actigraphy watches in individuals with neurodevelopmental disorders can be used to assess 
motor or activity-related phenotypes such as hyperactivity in ADHD. Small studies of children 
with intellectual disability can provide objective insights into the sleep phenotype (Goldman, 
Richdale, et al., 2012). Actigraphy is more suitable for these children where invasive 
techniques could cause substantial distress; actigraphy is generally tolerated by young people 
with intellectual disability (ID) (Goldman, Richdale, et al., 2012; Ashworth et al., 2013). 
However, some individuals find it difficult to wear a band around the wrist or the ankle 
(Fawkes et al., 2015; Veatch et al., 2016).  
Actigraphy studies in young people with ADHD have shown higher levels of average activity 
during sleep, but a similar sleep duration and no substantiate alterations in the sleep-wake 
pattern compared to typical young people (De Crescenzo et al., 2014). Another study 
investigated the role of actigraphy in identifying ADHD subtypes however, this was not 
nocturnal activity and did not show any differences between the subtypes based on daytime 
activity either (Dane, Schachar and Tannock, 2000). The use of actigraphy in 
neurodevelopmental populations has helped to explore the validity of parental reports, 
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especially in young people who may have problems communicating. One study found that 
parents of children with ADHD reported a substantially higher number of sleep problems 
compared to the parents of typical children. This was confirmed by actigraphy assessments 
suggesting that the parents had reported these problems accurately apart from the longer 
sleep duration, which was not objectively identified, and bedtime resistance (Corkum et al., 
2001). 
Autism Spectrum Disorders 
The problem of bedtime resistance is a common complaint of parents of children with autism 
spectrum disorders (ASD). Objective measures including actigraphy have been used to 
confirm parent-reports of sleep problems (Wiggs and Stores, 2004; Goldman, Richdale, et al., 
2012; Malow et al., 2016) in studies of young people with ASD. However, there is contrasting 
evidence that suggests some parental responses to sleep questions that form part of 
behavioural assessments can overestimate problems in their children when compared to 
actigraphy (Humphreys et al., 2014).  
Elevated levels of sleep problems have been reported by parents across NDDs. Potentially 
there could be elevated reports through parents being hyper-aware of problems in young 
people with existing conditions including ASD and resultantly, this could influence the report 
of sleep problems in these individuals (Couturier et al., 2005). However, there is a larger 
literature which continues to report sleep problems in this cohort of young people. Therefore, 
the evidence suggests there is a high preponderance of sleep problems in young people with 
ASD. One study demonstrated that parents reported higher numbers of sleep problems in 
their child with ASD compared to a control cohort, but reported a comparable sleep duration 
(Schreck and Mulick, 2000). Behavioural interventions in young people with ASD have 
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changed parental perception of sleep problems suggesting improved sleep but actigraphy 
measures did not demonstrate the same marked differences (Johnson et al., 2013).  
Objective measures can be used to complement the subjective parent reports (Moore et al., 
2017). The best way to capture the sleep phenotype in young people with NDDs is a combined 
approach. This is particularly pertinent in these young people because of the complexity of 
their phenotype. Parent-reported sleep diaries can capture the behaviour of children and 
comment on the impact of the child’s poor sleep quality on the rest of the family. Actigraphy 
can provide a more objective measure of the actual changes in the child’s sleep itself. 
Actigraphy detects movement and activity and therefore, can provide information regarding 
restfulness and fragmentation across a night. In many cases, it would be difficult for parents 
to report such activities during the night (Moore et al., 2017). 
6.2.3.2 Actigraphy in Psychiatric Disorders 
In young people with psychiatric disorders, actigraphy allows the individual to remain in their 
own environment, reducing disruption. It allows for the objective assessment of sleep-wake 
patterns that have been reported in the sleep literature (Pritchett et al., 2012) without 
requiring the individual to stay overnight in a sleep clinic. There is a limited literature 
regarding actigraphy assessments in young people with anxiety disorders and schizophrenia 
with most studies focussing on adult samples, especially in schizophrenia. 
Anxiety Disorders 
Young people have been assessed with actigraphy in combination with parent-report sleep 
questionnaires to measure sleep in anxiety disorders. The objective measure showed in one 
study that anxiety was not associated with average sleep variables including sleep onset 
latency, sleep duration and daytime sleepiness however an association between elevated 
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anxiety and night-to-night variability of the sleep-wake patterns was shown (Fletcher et al., 
2018).  
Schizophrenia  
Actigraphy has been used to assess individuals with SCZ as it provides an objective, non-
invasive technique, minimising the disruption to the individual. Prolonged latency to sleep 
onset, delayed awakening times and increased nocturnal awakenings across six-weeks of 
actigraphy have been illustrated by one study (Wulff et al., 2012). Reduced daytime activity 
relative to nocturnal is shown in SCZ with frequent reports of daytime naps supporting a 
dysfunctional 24-hour sleep-wake cycle (Wichniak et al., 2011).  
6.2.4 Actigraphy in Copy Number Variant Research 
Young people with CNVs often have many comorbidities which complicate the assessment of 
physiology, especially where young people have an intellectual disability. Comprehensively 
examining the sleep phenotype can be completed by a combination of different assessments. 
An individual might not be able to undertake one aspect of a study such as a PSG, but other 
methods used might be more appropriate for them, such as wearing an actigraphy watch. 
This flexible approach ensures the maximal yield of data. 
6.2.4.1 Angelman Syndrome 
Individuals with Angelman Syndrome (AS) show elevated rates of ID with delayed 
development, severe speech impairment and problems with motor movements. These 
problems could be detrimental in assessing sleep problems subjectively from the participant 
so the use of objective measures can play a significant role in understanding the sleep 
phenotype of these individuals. One study used actigraphy in combination with PSG and sleep 
questionnaires to assess sleep parameters in young people with AS showing major problems 
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such as delayed sleep onset latency, fragmented sleep and a shorted sleep duration compared 
to typical controls (Goldman, Bichell, et al., 2012).  
6.2.4.2 Prader-Willi Syndrome 
Individuals with Prader-Willi Syndrome (PWS) have been reported to have more WASO but 
shorter SOL. This demonstrates that young people with PWS take a shorter time to fall asleep 
but spend more of the night in wake periods compared to typical populations (Gibbs, 
Wiltshire and Elder, 2013). Young people with PWS have a high incidence of hyperphagia in 
which obesity is a main component of the phenotype (Heymsfield et al., 2014). This puts these 
young people at a higher risk for the development of sleep-related breathing disorders such 
as OSA which can lead to fragmented and disrupted sleep, adding to the sleep phenotype in 
PWS. 
6.2.4.3 Williams Syndrome  
Sleep problems have been reported in up to 63% of young people with Williams Syndrome, 
suggesting that the sleep phenotype plays a significant role in the prognosis of the syndrome. 
Actigraphy has shown extended SOL and work in adolescents and young adults has replicated 
these extended SOL coupled with poorer sleep efficiency, more fragmented sleep and 
increased nocturnal activity (Goldman et al., 2009). Intellectual disability is common and 
similarly to 22q11.2DS, there can be craniofacial dysmorphisms and cardiac problems, as well 
as reports of ADHD in around half of individuals (Mason et al., 2011).  
6.3 Rationale  
There are no studies that have explored sleep in 22q11.2DS and to date, the study in Chapter 
4 is the first study of its kind to outline the prevalence, nature and associations of sleep 
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problems in 22q11.2DS. This study formed the foundations of investigating sleep in 
22q11.2DS using actigraphy, sleep diaries and sleep questionnaires. The physiology of sleep 
has yet to be defined in 22q11.2DS. This chapter provides the first evidence of objective study 
of sleep problems in 22q11.2DS. Chapter 4 outlined that young people with 22q11.2DS had 
higher parent-reported sleep problems compared to parent-reports of their unaffected 
siblings. In the young people with 22q11.2DS, two distinct patterns of sleep problems were 
identified: tiredness-related sleep and insomnia-related sleep. These patterns of sleep 
problems were associated with the neurodevelopmental phenotype suggesting impairment 
was associated with experiencing more sleep problems. Additionally, there were individuals 
with 22q11.2DS using melatonin at the time of interview for their sleep problems. Evidence 
suggested that most of these young people continued to report sleep problems whilst on the 
melatonin. From these initial findings, further investigation into the nature and the aetiology 
of sleep problems in young people with 22q11.2DS is required.  
In the sleep literature, there are a large number of studies where subjective questionnaires 
have been used to assess sleep problems. It is recognised however that to be able to assess 
sleep problems comprehensively, a combined approach of using subjective and objective 
measure of sleep is required. Questionnaire data can provide an essential foundation for the 
evidence of sleep problems. Building on these findings with objective sleep studies of 
actigraphy or PSG (Markovich, Gendron and Corkum, 2014) can help to validate the findings 
and develop the understanding of the overall picture of sleep problems. Actigraphy watches 
and sleep diaries are non-invasive objective assessments of sleep in young children that are 
important to use in young children who experience problems that could affect whether they 
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could undertake an overnight sleep EEG assessment. The actigraphy watches provide a simple 
method of acquiring a large dataset of nocturnal activity.  
The evidence from the NDD, psychiatric and paediatric literature suggests that actigraphy is 
an effective tool in monitoring nocturnal activity in young people. Incorporating actigraphy 
watches positions this study at the forefront of understanding the sleep phenotype better in 
22q11.2DS. 
6.3.1 Aims of the Actigraphy Study and Sleep Diaries  
The primary aims of the actigraphy and sleep diaries were: 
1. to acquire a large dataset of objective activity in young people with 22q11.2DS 
compared to their siblings; 
2. to assess whether there are differences in sleep parameters and nocturnal activity of 
young people with 22q11.2DS compared to their siblings; 
3. to determine whether the sleep parameters and nocturnal activity in young people 
with 22q11.2DS are associated with the psychopathology and cognitive outcomes that 
were identified previously in Chapter 4 i.e. the outcomes that were associated with 
the patterns of sleep problems.  
To address aim 1, a relatively large dataset of individuals with 22q11.2DS and siblings were 
collected.  
Aim 2 was addressed by extracting sleep parameters from the actigraphy using the automatic 
sleep scoring algorithm. Unpaired two-tailed t-tests were used to explore the differences 
between the young people with 22q11.2DS and the sibling control group (see Tables 14 and 
15). Paired t-tests were used to explore the differences between the 22q11.2DS and their 
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paired, related sibling in further analyses. Findings were corrected for multiple testing and 
the initial analyses did not account for covariates however in section 6.5.3, pages 178-180, 
covariation using age, gender and highest maternal education level is explored.  
Aim 3, which involved exploring the relation between the actigraphy-derived sleep 
parameters and the neurodevelopmental phenotype in 22q11.2DS, was investigated through 
hierarchal linear regressions. Covariates such as age, gender and highest maternal education 
level were included. There were only a few families that completed psychopathology and 
cognitive assessments on the same day as the sleep study. Therefore, when exploring these 
associations, the age difference between the date of assessments and date of actigraphy was 
accounted for as a covariate. Melatonin was also investigated as a covariate of the regression 
analyses.  
6.4 Methodology 
In Chapter 5, the pilot study protocol outlines the difference aspects of the sleep study. This 
includes the use of actigraphy and the sleep diaries. The actigraphy protocol was developed 
during and after the pilot study to develop its consistency and replicability within research 
groups in the MRC Centre at Cardiff University.  
6.4.1 Recruitment, Sample and Demography 
Participants were part of the ongoing Experiences of CHildren with cOpy number variants 
(ECHO) study (Niarchou et al., 2014; Chawner et al., 2017; Cunningham et al., 2017). 
Recruitment for the ECHO Study can be found in Chapters 3 and 4 and in Appendices 1 and 
2.  
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During recruitment, the aim was to invite the families to complete the entire sleep study 
including PSG, actigraphy and the sleep diary, and sleep questionnaires. As previously 
mentioned, the sleep study was combined with a seizure-related study and therefore when 
families were recruited, they were asked if they would be happy for their child/children to 
wear the EEG net for a 24-hour period inclusive of a single night’s sleep. The extent of the 
study proved to dissuade some families from taking part therefore as recruitment progressed, 
the study was broken down into sections and the families were able to consent into the 
different aspects of the study resulting in different overall sample sizes of the different 
aspects. See Appendix 2 for the different sample sizes. 
The actigraphy watches were worn by a larger sample than those who completed the PSG. 
The study asked that the watch was worn for a two-week period, however during those two 
weeks whenever the watch was removed, it was noted in the sleep diary. There were n=22 
young people with 22q11.2DS and n=10 sibling controls who did not wear the watch for all 14 
nights. There is evidence in the literature that n=7 nights of complete actigraph is sufficient 
for interpretation (Allik, Larsson and Smedje, 2006; Goldman et al., 2009) if the period 
includes weekdays and weekends. This parameter resulted in n=1 young person with 
22q11.2DS and n=1 sibling control excluded from the interpretation of the actigraphy. 
In addition to the actigraphy watch, the protocol included a sleep diary. Some of the 
participants however did not return their sleep diaries, or they were returned incomplete. In 
these cases, where there were no or insufficient sleep timings on the sleep diary, sleep timings 
that had been automatically determined by the actigraphy analysis could not be compared to 
the sleep diary sleep timings. In n=3 young people with 22q11.2DS and n=2 sibling controls, 
there was enough automatically scored actigraphy data that could be analysed, however 
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there were no subjective sleep diary timings to compare the timings to. There were n=22 
young people with 22q11.2DS and n=7 sibling controls that had at least one night of sleep 
timings incomplete in the sleep diary over the two-week period. Despite the absence of a 
complete sleep diary, if the actigraphy data was sufficient (>7 nights including a weekend) 
and the quality of the data was good, these findings were still included in analyses. 
After processing and quality control of the actigraphy data, the sample size of analysable data 
included n=49 young people with 22q11.2DS (x ̅age=14.5, range = 6 years, ~8 months – 19 
years, ~8 months, s.d.=3.45, 52% females) (98% of the original sample) and n=27 unaffected 
sibling controls (x ̅age=13.2, range=7 years, ~6 months – 19 years, ~1 month, s.d.=3.55, 52% 
females) (97% of the original sample). Not all individuals wore the actigraphy watch for the 
total 14 nights. The sleep diaries were not returned by all individuals. For some individuals 
however, the sleep diaries were completed more frequently than the watch was worn, 
resulting in n=44 sleep diaries returned for the young people with 22q11.2DS (x ̅ age=14.6, 
range=7 years, ~9 months – 19 years, ~7 months, s.d.=3.47, 61% females), but n=28 sleep 
diaries for the unaffected sibling controls (x ̅age=13.2, range=7 years, ~6 months – 19 years, 
~1 month, s.d.=3.40, 46% females). Therefore, there was n=1 more sleep diary completed 
than the analysable actigraphy data for the siblings. The demography of the final sample of 
22q11.2DS and sibling controls is outlined in Table 13.
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Table 13 Demographics of the sleep actigraphy and sleep diary sample 
   % 
Family ethnic background   
 Mixed   4.26 
 British  89.4 
 Other  6.39 
Highest maternal education qualification  
 No qualifications  2.13 
 Low: O-levels or GCSEs 2.13 
 Middle: A-levels/Highers or vocational training 29.8 
 High: University degree and/or other higher 
postgraduate qualification 
38.3 
 Other 27.7 
 Unknown  0.00 
Family annual income (£)  
 £≤19,999 14.0 
 £20,000-39,000 32.0 
 £40,000-59,000 24.0 
 £≥60,000 30.0 
 Unknown 0.00 
Age, years: mean (s.d.)   
Probands 14.5 (3.45) Siblings 13.2 (3.55) 
Gender, n (%)   
Probands 26 F (52) Siblings 15 F (51.7) 
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In the 22q11.2DS cohort, 30/49 (61.2%) of young people were on medication and n=8/30 
(26.7%) of these young people were taking melatonin. There were n=3 sibling controls who 
were on medication; one sibling took clonal modulate, salbutamol and multivitamin, for 
asthma and general health; one sibling took Pizotifen for migraines and another took codeine 
phosphate for surgery-related limb pain.  
Prior to recruitment, primary carers consented for all participants to partake in the main 
ECHO Study and consented to further contact regarding other studies. Additional consent was 
obtained. For further information regarding consent in the ECHO Study, refer to Appendices 
1 and 2. 
6.4.2 Assessments – Actigraphy and Sleep Diaries  
Actigraphy data was scored using Actiware software version 6.0.9 (Respironics, 2018). The 
medium threshold sensitivity value (TSV) (40 counts per epoch) is the default setting for this 
program and therefore was used as the primary threshold in these analyses (Meltzer et al., 
2012).  
The sleep diaries were created for the pilot study and modified so that they could be 
understood better and for ease of use in the main study. Three versions of the sleep diaries 
were developed: parent, adolescent and child that could be distributed to the families 
appropriately. Examples of the sleep diaries can be found in Appendix 4, pages 334-344.  
6.4.2.1 Actigraphy Protocol 
The actigraphy was measured by either of two watches: The Actiwatch 2 and Actiwatch 
Spectrum Plus (Mini Mitter Division of Philips Respironics Ltd.). The Actiwatch 2 is a light-
weight strap weighing 16 grams and 43mm x 23mm x 10mm in size. Where available, this 
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watch was given to younger participants or where the participant had a strong preference for 
it. The Actiwatch 2 had a typical battery life of 30 days and included solid state piezo-electric 
accelerometer with a 32Hz sampling rate. The light sensor had a wavelength range of 400-
900nm and was waterproof at 1m for 30 mins. The Actiwatch Spectrum Plus was a heavier 
watch with a full digital display. It weighed 31 grams and is 48mm x 37mm x 15mm and was 
often given to older participants or those who preferred replacing a watch display that they 
removed during the study. This watch had a standard battery life of 60 days and included a 
microelectromechanical system (MEMS) type of accelerometer that works on change in 
capacitance, but with the same 32Hz sampling rate. The light sensor wavelength range is 
slightly shorter in the longer wavelengths, 400-700nm, but was also waterproof.  
 Actiwatch data was scored using Actiware software version 6.0.9 (Respironics, 2018) using 
the automatic scoring algorithm that has been validated on numerous populations including 
young people (Meltzer et al., 2012). The activity across the two-week period was measured 
in 30-second epochs with each epoch of activity determined based on comparison to the 
other epoch counts. For example, the activity in the epochs immediately before and after the 
said epoch under analysis were considered and each epoch was weighted dependent on the 
standardised threshold sensitivity value (TSV or activity count). Any activity above 40 TSV 
would be regarded as wake and below would be sleep.  
Actiware software produced preprogramed outcome measures including bedtime, get up 
time, time in bed (TIB), total sleep time (TST), sleep onset latency (SOL) (how long it takes to 
get to sleep), sleep efficiency (SE) (TST/TIB*100), wake after sleep onset (WASO) (the 
accumulated time spent awake during the night after sleep onset) and number of awakenings 
during the night based on the 40 TSV. It is important to note that for the sleep onset latency, 
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the Actiware software calculates a proxy onset latency based on the estimated time (in 
minutes) that a subject takes to fall asleep. This is based on automated calculations calculated 
from parameters of ‘rest’ and ‘sleep’ periods. As an example, the Actiware software takes the 
start time of the ‘Rest’ interval and the ‘Sleep’ interval start time to then calculate the onset. 
This is what was used in this study however it is recognised that sleep latency calculations 
require information regarding ‘bedtime’. This is often derived from the sleep diaries as that 
can help to distinguish the differences between immobile wakefulness or ‘rest’ as the 
actigraphy is measuring movements. An example where sleep diaries have been used to 
correct for the sleep latency timings can be found in a 2012 paper by Gringras et al (Gringras 
et al., 2012).  
Further to these variables the exported raw data made more variables available: sleep 
duration (SD), total activity during sleep, average activity during sleep, average activity for 
each epoch, standardised activity during sleep and maximum activity during sleep. Each of 
the outcomes were measured in minutes.  
Actiwatches were either sent out to participants who did not complete the overnight sleep-
EEG aspect of the study or they were handed out on the night of the sleep-EEG. The 
participants wore the watches on their non-dominant wrist and were asked to keep this on 
for a continuous two-week period other than bathing or playing high impact, contact sports 
such as rugby. A sleep diary was provided alongside this. 
6.4.2.2 Sleep Diaries 
Sleep diaries were provided to each participant to complete in conjunction with wearing their 
actigraphy watch for two weeks. A primary carer copy of the sleep diary was produced and 
given to them if their children were under the age of 12 or if the child was considered to not 
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have capacity to complete the diary themselves. All children over the age of 12 were offered 
the opportunity to complete their own sleep diary with or without the assistance of the 
primary carer. A simplified version was offered to younger children where they were able to 
colour areas of a table showing how long they had slept for each night.  
The sleep diaries included open ended questions such as what time did you get into bed, what 
time did you turn the lights off, what time did you fall asleep, what time did you wake and 
what up time did you get out of bed. In addition to these questions, the participants were 
asked to note whether they had napped during the day, exercised, drunk caffeine-containing 
drinks or alcohol and what medication they had taken that day. The sleep diary data was 
entered into a datasheet and was used to create the custom intervals on the actigraphs as 
mentioned previously.  
Examples of the different sleep diaries which were used in the main sleep study are available 
in Appendix 4. It is important to note that the sleep diaries have not been used in the results 
section of this chapter. The sleep diaries cannot be analysed as a result of the lack of validation 
and reliability data across the different types of sleep diaries. For example, some of the sleep 
diaries were completed by parents and others by the participants. Unfortunately, there is not 
a consistent report regarding who completed the sleep diaries across the two weeks and 
therefore by combining all of the sleep diaries, findings would be unreliable. Future use of 
sleep diaries in this manner will require a consistent approach to recording who completed 
the sleep diary each night and therefore, reliability and validation data would also need to be 
calculated. The sleep diaries did form part of the protocol and have therefore been included 
in the methodology. However, there will be no further reference to the sleep diaries in the 
results.  
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6.4.3 Statistical Analysis  
The actigraphy data was analysed in the Philips Respironics Actiware Version 6.0.9 
(Respironics, 2018). Individuals that completed seven or more nights of total actigraphy are 
included in the analyses: the other individuals did not have sufficient data to compare with 
the larger dataset.  
Statistical analysis was carried out using Microsoft Excel Microsoft Office Professional Plus 
(2016), STATA (version 13.1) (https://www.stata.com/stata-news/news28-4/stata13.1) and R 
(version 3.5.0) (R: The R Project for Statistical Computing, 2018).  
Unpaired two-tailed t-tests were used to explore the differences in the sleep parameters 
between the young people with 22q11.2DS and siblings. Paired t-tests were used to explore 
the differences between the 22q11.2DS and their paired, related sibling in further analyses. 
The initial analyses did not account for covariates however in section 6.5.3, pages 178-180, 
covariation using age, gender and highest maternal education level is explored.  
Hierarchal linear regressions were used to explore the relationship between the actigraphy-
derived sleep parameters and the neurodevelopmental phenotype in 22q11.2DS. Covariates 
such as age, gender and highest maternal education level were included. There were only a 
few families that completed psychopathology and cognitive assessments on the same day as 
the sleep study. Therefore, when exploring these associations, the age difference between 
the date of assessments and date of actigraphy was accounted for as a covariate. Melatonin 
was also investigated as a covariate of the regression analyses.  
To correct the analyses for multiple comparisons, we used a Benjamini–Hochberg false 
discovery rate (FDR) rate of 5% (Benjamini and Hochberg, 1995). The Benjamini-Hochberg 
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method ranks the individual p-values from smallest to largest, with the smallest p-value 
ranking as 1. By comparing each individual p-value to the Benjamini-Hochberg critical value 
((rank/total number of tests) * FDR (i.e., 5%)), if the largest p-value in our analyses before 
correction is smaller than its critical value, it is considered significant. Any p-values smaller 
than the largest p-value are also interpreted to be significant.  
6.5 Results  
The sleep parameters were derived from the Actiware software. The nocturnal activity and 
sleep parameters were generated using the standardised algorithm in the software. All of the 
parameters are averages taken across the total time the actigraphy was recorded for (average 
nights = 13.1 nights for the siblings and n = 12.7 nights for the 22q11.2DS) and the activity 
during sleep is measured in units relating to the threshold sensitivity value (TSV) based on the 
standardised algorithm: 40 units and above are considered wake, and below 40 considered 
immobile restfulness or sleep. 
6.5.1 22q11.2DS young people compared to sibling control group: objective 
assessment 
Tables 14 and 15 show comparisons between young people with 22q11.2DS and siblings not 
controlling for covariates. This table shows comparisons between the two groups only using 
two-tailed unpaired t-test. The tables illustrate that young people with 22q11.2DS had longer 
time in bed, total sleep time and a higher sleep efficiency than the sibling group. However, no 
notable differences in the nocturnal activity across the actigraphy period were identified 
between the young people with 22q11.2DS and the sibling group not controlling for 
covariates. The absence of group differences in activity was not hypothesised.  
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6.5.2 Relatedness between 22q11.2DS young people and their sibling control 
groups 
There were sibling pairs in the sleep study and this needed to be explored to ensure that 
relatedness did not affect the findings. Therefore, Tables 16 and 17 show direct paired t-test 
comparisons between the related couples (not controlling for covariates). The findings reflect 
the same findings from the overall group analyses: there was a longer time in bed, total sleep 
time and higher sleep efficiency for the young people with 22q11.2DS compared to the 
siblings. There were no differences identified between the young people with 22q11.2DS and 
their siblings with regards to their nocturnal activity. This also agrees with the findings from 
the larger cohort analysis.  
In these analyses, where there were two siblings available for analyses, which occurred in two 
instances, the sibling closest in age was paired with the young person with 22q11.2DS for the 
analyses.
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Table 14 Comparing the automatic, objective, actigraphy-measured sleep parameters between groups 
 
 22q11.2DS Siblings     
Automatic 
Actigraphy 
Scoring 
Average, (s.d.) Average, (s.d.) t p 
95%CI 
(combined) 
n 
Sleep Onset 
(hours) 
22:24:16 
(±01:12:23) 
22:49:27 
(±01:17:57) 
1.40 0.166 .928-.951 76 
Get Up Time 
(hours) 
08:29:00 
(±01:21:56) 
08:20:42 
(±01:11:27) 
-0.473 0.638 .339-.364 76 
Time in Bed 
(hours) 
10:05:26 
(±00:54:04) 
09:31:15 
(±00:51:55) 
-2.65 0.001* .403-.421 76 
Total Sleep 
Time (hours) 
09:07:53 
(±00:51:10) 
08:02:25 
(±00:48:33) 
-6.28 <0.0001* .360-.380 76 
Sleep Onset 
Latency 
(hours) 
00:28:19 
(±00:24:29) 
00:22:52 
(±00:16:28) 
-1.02 0.312 .0149-.0219 76 
Sleep 
Efficiency (%) 
92.4% 
(±4.92%) 
84.48% 
(±4.09%) 
-7.03 <0.0001* 88.3-91.0 76 
Wake After 
Sleep Onset 
(hours) 
00:48:05 
(±00:13:08) 
00:44:27 
(±00:12:27) 
-1.15 0.252 .0305-0.346 76 
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Table 15 Comparing the automatic, objective, actigraphy-measured nocturnal activity between groups 
 
22q11.2DS Siblings     
Activity measures 
(nocturnal average) 
Average, 
(s.d.) 
Average, 
(s.d.) 
t p 
95%CI 
(combined) 
n 
Total Activity  6768.7 
(±2443.0) 
5970.1 
(±1808.1) 
-1.47 0.146 5977.7-7013.3 76 
Average activity per 
epoch  
5.93 
(±1.78) 
5.75 
(±1.86) 
-0.412 0.682 5.46-6.28 76 
Average activity per 
minute  
11.9 
(±3.56) 
11.5 
(±3.73) 
-0.412 0.682 10.9-12.6 76 
Standard activity  28.2 
(±6.80) 
27.1 
(±6.37) 
-0.68 0.500 26.3-29.3 76 
Maximum activity 386.1 
(±99.1) 
362.9 
(±76.3) 
-1.04 0.301 357.1-399.2 76 
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Table 16 Paired comparison between the young people with 22q11.2DS and their siblings for the 
automatic, objective, actigraphy-measured sleep parameters between groups 
 
 
 
Paired sibling 
analysis 
22q11.2DS Siblings 
    
Automatic 
Actigraphy 
Scoring (paired) 
Average, 
(s.d.) 
Average, 
(s.d.) 
t p 
95%CI 
(combined) 
n 
Sleep Onset 
(hours) 
22:18:41 
(±01:16:03) 
22:51:23 
(±01:13:16) 
-2.05 0.05 -.0458-.000362 44 
Get Up Time 
(hours) 
08:28:02 
(±01:29:11) 
08:15:45 
(±01:05:02) 
0.936 0.360 -.0104-.0275 44 
Time in Bed 
(hours) 
10:09:20 
(00:59:33) 
09:24:21 
(00:52:04) 
2.57 0.0177* .00599-.0565 44 
Total Sleep Time 
(hours) 
09:23:43 
(±00:46:56) 
07:59:09 
(±00:59:33) 
5.88 <0.0001* .0379-.0795 44 
Sleep Onset 
Latency (hours) 
00:29:07 
(±00:27:35) 
00:20:26 
(±00:15:10) 
1.23 0.231 -.00414-.0162 44 
Sleep Efficiency 
(%) 
92.71% 
(±4.99%) 
84.92% 
(±3.64%) 
5.96 <0.0001* .0508-.105 44 
Wake After Sleep 
Onset (hours) 
00:46:03 
(±00:14:48) 
00:43:41 
(±00:12:50) 
0.83 0.416 -.00278-.00576 44 
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Table 17 Paired comparison between the young people with 22q11.2DS and their siblings for the 
automatic objectively actigraphy-measured nocturnal activity between groups 
 
6.5.3 Investigating covariation  
Covariates were not accounted for in section 6.5.1 and 6.5.2 as the associations between 
groups was explored first. However, it is important to account for covariation to better 
understand the relationships between the young people with 22q11.2DS and the siblings in 
relation to the sleep parameters.  
Before controlling for covariation, it was important to explore the total cohort and examine 
whether covariates of age, gender and highest maternal education were more generally 
associated with the sleep parameters. This meant that the covariates were explored using 
linear regression analyses without including the group status and therefore not distinguishing 
Paired sibling 
analysis 
22q11.2DS Siblings     
Activity measures 
(nocturnal 
average) 
Average, 
(s.d.) 
Average, 
(s.d.) 
t p 
95%CI 
(combined) 
n 
Total Activity 6426.9 
(±2442.3) 
5903.5 
(±1900.8) 
1.13 0.271 -438.7-1485 44 
Average activity 
per epoch  5.55 (±1.69) 5.65 (±1.91) -0.273 0.788 -.855-.657 44 
Average activity 
per minute  11.1 (±3.37) 11.3 (±3.81) -0.271 0.789 -1.71-1.32 44 
Standard activity  27.3 (±5.65) 26.9 (±6.63) 0.287 0.777 -2.20-2.91 44 
Maximum activity 386.2 (±93.2) 264.7 (±80.4) 0.990 0.334 -23.7-66.7 44 
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between the young people with 22q11.2DS and the siblings. The following relationships were 
identified. In relation to the sleep parameters derived from the objective automatic 
actigraphy sleep scoring, later sleep onset was identified in older individuals (B=.00938, 
p<0.0001), later get up time was identified in older individuals (B=.00931, p<0.0001), sleep 
onset latency was shown to be longer in older individuals (B=.00246, p<0.0001) and sleep 
efficiency was shown to be lower in older individuals (B=-.000139, p<0.0001). It is important 
to note that the effect sizes are relatively small and therefore associations would need to be 
explored further and corrected for multiple comparisons.  
When investigating the objective actigraphy nocturnal activity measures, only the maximum 
nocturnal activity count was associated with age showing a reduced maximum activity count 
in older individuals (B= -6.58, p=0.031).  
However, there were differences in nocturnal activity derived from the objective actigraphy 
data when controlling for gender. The average nocturnal activity count was higher in male 
individuals (B= -.867, p=0.035) compared to female. Similarly, the average nocturnal activity 
measure per minute was higher in male individuals (B= -1.73, p=0.035) compared to females 
also.  
Highest maternal education was added as a covariate to determine whether the sleep 
parameters were associated with the covariate that was associated with the pattern of 
tiredness-related problems in Chapter 4. No associations were found other than with the 
sleep efficiency measured by the actigraphy in the young people with 22q11.2DS showing an 
increase in sleep efficiency with better maternal educational attainment (B=.0250, p=0.003). 
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These findings helped to identify where particular associations could exist. It was important 
to explore the covariates in linear regression models taking into account group status. This 
would then allow for better interpretation of the findings between the young people with 
22q11.2DS and siblings, and explore whether the presence of age, gender and highest 
maternal education could account for the differences. Therefore, only the associations which 
showed significant differences after correcting for multiple testing were further explored for 
covariation. It is important to note that when adding the covariates, the sample size of the 
model reduces resulting in small cohorts being explored. This needs to be considered when 
reviewing the findings and basing decisions off this work. Exploring covariation is important 
however it would need to be repeated and replicated in a larger cohort sample to better 
understand robust associations.  
Covariates age, gender and highest maternal education were added to the associations noted 
by an asterisk in Tables 14-17. Changes to the associations between the young people with 
22q11.2DS and siblings are commented on. The difference in the time in bed derived from 
the actigraphy data between the young people with 22q11.2DS and siblings was attenuated 
when adding highest maternal education as a covariate (differences between the groups was 
accounted for B=0.0220, p=0.052, by adding highest maternal education.) It is important to 
note that the cohort size was reduced to n=47. The effect and relationship between the paired 
22q11.2DS young people and their siblings in the time in bed derived from the actigraphy data 
(reflecting the prior results) was attenuated when highest maternal education was added as 
a covariate (B=0.0186, p=0.153). All other associations that had been corrected for multiple 
testing and highlighted in Tables 14-17 remained when controlling for age, gender and 
highest maternal education.  
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6.5.4 Actigraphy and the Neurodevelopmental Phenotype  
The next step in the analysis was to examine whether there were differences in the actigraphy 
sleep parameters based on the symptomology of psychiatric problems and cognitive 
impairment in the 22q11.2DS young people only. Symptom scores for the sibling group were 
not sufficiently high to explore further.  
These analyses were based on the significant findings in Chapter 4 analyses that explored the 
patterns of sleep problems and comorbidities in 22q11.2DS. The patterns of sleep problems 
however could not accurately be applied to these current analyses as they were derived from 
a single time-point. The actigraphy could be compared to the psychopathology and cognitive 
data that was closest in time to the sleep data acquisition: some participants completed the 
sleep study on the same day as psychopathology and cognitive tests for wave 1 of the ECHO 
Study for example whereas others completed wave 2 of the ECHO Study three months prior 
to the sleep study acquisition.  
The time difference between the psychopathology and cognitive assessments and the 
actigraphy assessment was accounted for when investigating the associations including the 
differences in ages as a covariate in the analyses (mean time difference = ~10 months, s.d. = 
±13 months). Associations identified were tested with covariates to determine whether the 
relationship was robust or could be explained by another predictor. 
There were no associations between the more objective-actigraphy derived sleep parameters 
and the neurodevelopmental phenotype in young people with 22q11.2DS. There were no 
associations found for the nocturnal activity in young people with 22q11.2DS compared to 
the neurodevelopmental phenotype and this finding was particularly surprising.  
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6.6 Discussion  
This is the first study to explore sleep in young people with 22q11.2DS and in addition, to 
include a comparison sibling group in these sleep analyses. This study included the use of an 
objective assessment of sleep using actigraphy watches. Several different variables were 
derived and investigated in the young people with 22q11.2DS and their siblings. Surprisingly, 
there were no differences in the nocturnal activity between the 22q11.2DS and siblings 
however differences in the sleep parameters derived from the objective actigraphy data were 
found between the groups. 
6.6.1 Differences in sleep parameters between groups in actigraphy-derived 
sleep parameters  
From the actigraphy-derived sleep parameters, differences between the 22q11.2DS young 
people and their siblings were identified in total time in bed, total sleep time and sleep 
efficiency. The young people with 22q11.2DS slept for longer, remained in bed for longer and 
had a higher sleep efficiency than the sibling control group.  
There is conflicting evidence in the literature with one study suggesting that young people 
with neurodevelopmental disorders such as ADHD, when compared to typically developing 
controls, on average spend longer time in bed and have a longer total sleep time during 
weekdays and at the weekends across a seven night assessment (Corkum et al., 2001). 
However, it is widely reported than young people with ADHD and ASD have shorter sleep 
times when compared to typically developing controls and longer sleep onset latencies (van 
der Heijden et al., 2018) in other studies. The differences between young people with ADHD 
and ASD have been shown to be negligible. More severe ADHD symptoms have been shown 
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to be associated with shorter sleep duration when compared to young people with milder 
ADHD symptoms. However, ADHD symptoms in general have been repeatedly reported to 
associate with shorter sleep duration (Hysing et al., 2016). There is consistent report of sleep 
variability among young people with NDDs notably variability in sleep timings suggesting 
poorer sleep quality and quantity with common reports of insomnia and bedtime resistance 
(Hodge et al., 2014). 
The young people with 22q11.2DS despite having an elevated preponderance of 
neurodevelopmental problems compared to their siblings have demonstrated contrasting 
findings to the majority of the literature regarding NDDs and sleep. This work needs to be 
replicated with a larger sample of young people with 22q11.2DS in addition to using a 
different control sample such as an ADHD cohort that has been genotyped to exclude the 
presence of 22q11.2DS. Having a comparative NDD control group could help to identify the 
differences between the young people with 22q11.2DS and the non-22q11.2DS NDD 
populations if these differences are robust.  
Young people with 22q11.2DS do present with a number of problems which include physical 
problems. There are potential reasons for why an individual with 22q11.2DS might 
demonstrate differences in their sleep to other NDDs. Speculation could suggest that young 
people with 22q11.2DS might be confined to bed once in it as a result of their physical 
problems such as musculoskeletal problems which might require wearing a back brace at 
night. The comorbidities, especially affective disorders in 22q11.2DS, could also play a bigger 
role in influencing the sleep phenotype in 22q11.2DS than the NDDs. This is highly speculative 
but something which should be explored in the future. 
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6.6.1.1 Paired sibling analyses showed similar findings  
It was important to identify individuals who were related in these analyses. Therefore, 
undertaking paired analyses showed differences in the same parameters in the unpaired 
analyses between the 22q11.2DS and their paired sibling.  
Controlling for highest maternal educational attainment did explain the difference in the time 
in bed derived from the actigraphy data between the paired siblings, attenuating the finding. 
However, no other findings were account for in the paired analyses when adding covariates. 
In the literature however age has been shown to account for variation in sleep timings with 
younger individuals showing longer total sleep times (Hirshkowitz et al., 2015) and 
adolescents having a preference for later sleep onset times than younger children, with a later 
chronotype marking adolescence (Roenneberg et al., 2004). However, age did not account for 
differences in these analyses. Behaviours at bedtime can influence sleep onset (Jones and 
Ball, 2014) and potential daytime tiredness resilience a contributing factor. Sleep restriction 
studies in young typically developing children compared to individuals with 
neurodevelopmental disorders have shown evidence of daytime tiredness and impaired 
attention and poorer attainment of cognitive tasks, however the typically developing children 
showed more resilience and fewer general errors, with no individuals reaching a clinical 
inattention threshold (Gruber et al., 2011). 
These analyses do not account for a number of different parameters however including 
preferences and chronotype. Potentially, differences in the propensity for the young people 
to want to sleep at different times could influence findings. Twin-studies which have explored 
chronotype and diurnal preference have shown a stronger genetic link between monozygotic 
twins regarding their preferences than dizygotic twins. Nonetheless, there was evidence of 
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heritability but does suggest some convergence in siblings (Watson, Buchwald and Harden, 
2013). Therefore, these findings are interesting, however should be considered with caution 
as currently it is not known what factors are driving these sibling differences. 
6.6.2 No associations between actigraphy-derived sleep measures and 
psychopathology 
The parent-reported psychopathology did not show an association with any of the objective 
actigraphy-derived sleep parameters. This was surprising as it doesn’t agree with the 
literature surrounding psychopathology and objectively measured sleep problems. This was 
particularly interesting when taking into consideration the findings from Chapter 4 which 
showed the prevalence of sleep problems and associated neurodevelopmental phenotype. 
Sleep patterns and bedtime variability have been shown to be relevant to anxiety symptoms 
in early adolescence (McMakin and Alfano, 2015) however the absence of findings from the 
actigraphy suggest that it is not objectively supported. Understanding more about the 
bedtime behaviours and sleep patterns could help to better understand this finding. 
6.7 Strengths and Limitations  
Strengths include the use of the verified standard actigraphy analysis protocol that was 
conducted on this data. This algorithm and software have been used in many papers within 
the sleep medicine literature with verification on samples of young people. Furthermore, the 
combined use of the objective and subjective assessments of sleep allows more a 
comprehensive understanding of the sleep problems in 22q11.2DS and begins to explore the 
most appropriate method of sleep assessment in these young people.  
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The actigraphy watches were worn for two weeks however the watches could be worn for 
longer to provide further data for verification of sleep patterns. Furthermore, the most 
appropriate time for the participants to undertake the study was at the weekends and during 
the summer holidays. Therefore, it is important to note that the sleep timings would have 
fluctuated depending on whether they were assessed on free days or the school/work days. 
Unfortunately, it was not feasible to undertake the sleep study in the same period of the year 
among individuals. For example, some young people would have been at school for the two 
weeks whereas others were on summer holidays.  
The sleep diaries were not used in the analyses for this thesis. This was not the original 
intention however on reviewing the data that was acquired, it wasn’t possible to provide 
reliable and valid comparisons with the objectively measured actigraphy data. This was as a 
result of not having a consistent record of who was completing the sleep diary across the two-
week period. This was a mistake in the design of the protocol and in the future, this needs to 
be rigorously recorded especially where there are differences in the average IQ of individuals 
such as young people with 22q11.2DS compared to their siblings.  
There could also be an issue of reporter error as there has to be an assumption that the sleep 
diaries were reported accurately however some may have been completed retrospectively 
and therefore could introduce some errors into the outcomes. As a result, these findings need 
to be considered with caution before further objective sleep assessments are conducted.  
6.8 Introduction to Sleep Questionnaires  
Sleep questionnaires are widely used in the paediatric literature to obtain a parental report 
of child sleep behaviours. Having a questionnaire response from a parent can provide 
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information regarding the perceived phenotype of the individual. However, it cannot be used 
as the only assessment of sleep, especially when addressing sleep behaviours of adolescents. 
Sleep questionnaires are a subjective measure which take a snapshot of sleep-related 
behaviours of an individual. It is important to verify these measures with more objective 
measures. Nonetheless, validated sleep questionnaires have been used extensively in the 
paediatric literature to acquire a large yield of information about sleep in young people. 
Sometimes sleep questionnaires are the only measures that can be conducted reliably in 
children of a very young age or in a population with a high prevalence of learning disability.  
The second part of this chapter aims to outline why sleep questionnaires were used in the 
study and how they can be used to validate and support other measures to create a 
comprehensive assessment of sleep in 22q11.2DS. 
6.8.1 Sleep Questionnaires in the Paediatric Literature  
There are an extensive number of published and unpublished sleep questionnaires that are 
used in the paediatric sleep literature. Sleep problems should be assessed by validated sleep 
questionnaires that have been tested in the target population however there are a number 
of instruments that remain non-standardised (Spruyt and Gozal, 2011a).  
Sleep questionnaires are used initially to obtain a general assessment of the sleep problems, 
behaviours and potential phenotype. They are used to provide a screen of the individuals 
sleep and therefore inform further study and potentially intervention. Sleep questionnaires 
should not be used clinically as the only assessment tool (Spruyt and Gozal, 2011b). However, 
the validated questionnaires provide a reliable tool that can be distributed easily and at a 
reduced cost with the benefit of acquiring a large yield of data.  
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Validation of sleep questionnaires should be conducted against more objective measures of 
sleep such as polysomnography (PSG). However, undertaking a PSG in young people can be 
difficult and therefore, could contribute to a reason why there is limited validation. For 
example, the Children’s Sleep Habits Questionnaire is one of the most commonly used 
children sleep questionnaires that assessed sleep quality and quantity. Validation of the 
questionnaire was conducted in 2014 and the study demonstrated incongruence between 
the questionnaire and the PSG and actigraphy-derived sleep measures (Markovich, Gendron 
and Corkum, 2014). This study demonstrated that sleep questionnaires in the paediatric 
literature should be interpreted cautiously and that further verification of sleep problems in 
young people should be conducted. 
6.8.2 Sleep Questionnaires in Neurodevelopmental Populations  
Sleep questionnaires are predominantly validated in typical control samples of young people. 
Therefore, it can be difficult to obtain a sleep questionnaire that is appropriate for use in 
young people at elevated risk for learning disability. Parental-reports are used as a 
replacement for these young people as they are considered to provide a more reliable 
assessment of their child’s sleep behaviours. However, more objective measures have shown 
discrepancies in parent reports (Esbensen et al., 2018). Therefore, in young people with 
capacity, self-reports of sleep problems can provide a reliable and representative perspective 
of sleep habits (Richdale and Baglin, 2013). 
There are sleep questionnaires that were developed based on a typical population that have 
been adapted and validated for the assessment of sleep in young people with NDDs. The 
Paediatric Sleep Questionnaire (Chervin et al., 2000) is a 22-item symptom assessment of 
sleep problems in young people. However, it includes an assessment of behaviour and 
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specifically includes a 6-item scale that assesses attention and hyperactivity in reference to 
ADHD symptoms (Chervin et al., 2002). This questionnaire can be used in NDDs and can help 
to identify whether sleep problems and symptoms of NDD are overlapping and comorbid.  
Problems were using subjective sleep questionnaires include validation in the appropriate 
populations but using sleep questionnaires in large datasets can yield vast amounts of data 
as demonstrated by the assessment of sleep in the UK Biobank where in one sample sleep 
problems provided as a self-report were assessed in nearly 500,000 participants (Boakye et 
al., 2018).  
6.9 Rationale  
This thesis started with assessing sleep subjectively by the Child and Adolescent Psychiatric 
Assessment. The gold standard psychiatric assessment includes the sleep problems section 
which was used to explore the prevalence and nature of sleep problems in 22q11.2DS and 
siblings in Chapter 4. This assessment however was a semi-structured interview with the 
primary carer but did not account for the perspective of the individual. This analysis helped 
to form the basic questions that led to the further development of the sleep study.  
The sleep questionnaires outlined in Chapter 5 have been used to collect data from the largest 
subset of individuals. The questionnaires were short for the young people and often included 
closed responses on Likert-scales which involved little writing so that they were appropriate 
for most developmental ages. The questionnaires did not involve the participant having to 
wear any equipment or for the study team to visit the home of the family as the 
questionnaires were sent out before any of the home visits for all individuals. The parents 
also received sleep questionnaires which has added to the wealth of data now available for 
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the assessment of parental reports compared to the individuals report of sleep problems, 
allowing for further investigation of the state of sleep problems in 22q11.2DS and also in the 
typical young person population which can be acquired from the sibling data.  
The sleep questionnaires importantly have allowed validation of the CAPA sleep problems 
section showing that the evidence from the CAPA is validated by tested sleep questionnaires 
used in the target paediatric population.  
6.9.1 Aims of the Sleep Questionnaires  
The aims of the sleep questionnaires were: 
1. to acquire a large dataset of information from the primary carers and the individuals 
themselves (young people with 22q11.2DS and siblings); 
2. to validate the sleep section of the Child and Adolescent Psychiatric Assessment 
(CAPA) with the sleep questionnaires to determine the reliability of sleep problems 
(see Chapters 3 and 4);  
3. to begin to compare the subjective measures to the objective measures of sleep in the 
22q11.2DS and siblings. 
6.10 Methods  
Participants were part of the ongoing Experiences of CHildren with cOpy number variants 
(ECHO) study (Niarchou et al., 2014; Chawner et al., 2017; Cunningham et al., 2017). 
Recruitment for the ECHO Study can be found in Chapter 3 and information regarding the 
recruitment process for the sleep study can be found in section 6.4.1.  
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6.10.1 Assessments – Sleep Questionnaires  
The sleep questionnaires outlined in Chapter 5, as part of the Pilot Study, were used in the 
main study. It was confirmed that these questionnaires could accurately provide information 
regarding sleep behaviours and patterns in the young person population. However, there was 
a small gap in the information acquired. In individuals under the age of 11, there was no 
assessment of the daytime sleepiness as the Cleveland Adolescent Sleepiness Questionnaire 
(CASQ) could not be used in these younger children as it had not been validated. This resulted 
in the main study including a Teacher’s Daytime Sleepiness Questionnaire (TDSQ) to capture 
the daytime sleepiness activities of the younger children. By asking the teachers who spend 
school days with the child to assess their daytime sleep activity, sleepiness throughout a 
school day was assessed. 
6.10.1.1 Teacher’s Daytime Sleepiness Questionnaire (TDSQ) 
The remaining participants that were younger than 11 years old did not report their 
sleepiness. Primary carers provided consent regarding contact with their child/ren’s teacher. 
If the primary carer consented, an address was provided and subsequently the Teacher’s 
Daytime Sleepiness Questionnaire (TDSQ) was sent out with a pre-paid envelope for the 
teacher to complete and return. The TDSQ asks teachers about their perceived sleepiness of 
the young person in their class considering physiological responses such as yawning and 
behavioural responses such as does the young person complain about sleepiness/being tired, 
the child’s discipline and their hyperactivity. The TDSQ includes 10-items measured on a 1-3 
Likert-scale response. There were n=18 teachers who successfully completed and returned 
the TDSQ. There were n=3 teachers who did not return the TDSQ.  
   
194 
 
6.10.2 Statistical Analyses  
Pairwise correlations were conducted to explore the relationship between the CAPA-derived 
sleep problems and the total scores derived from the sleep questionnaires. Linear regression 
analyses were conducted to determine the relationships between correlating continuous 
scores and ordinal logistic regressions were used to investigate categorical scores. Statistical 
analysis was carried out using STATA (version 13.1) (https://www.stata.com/stata-
news/news28-4/stata13.1) and R (version 3.5.0) (R: The R Project for Statistical Computing, 
2018). 
6.11 Results 
The questionnaires were completed by different samples sizes. Some of the questionnaires 
were not returned by the families. The numbers completed are outlined in Table 18. 
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 Table 18 Number of sleep questionnaires completed and returned in the sleep study  
 
Sleep questionnaire  Sent to  
Returned 
incomplete  
Returned 
completed 
Cleveland Adolescent Sleep Questionnaire 
(CASQ) completed by 12-year olds 
69 0 69 
Children’s Morningness-Eveningness Scale 
(CMES) completed by 12-year olds 
59 2 54 
Children’s Chronotype Questionnaire 
(CCTQ) completed by primary carer of child 
11 years old 
28 1 27 
Munich Chronotype Questionnaire (MCTQ) 
completed by 12-year olds 
58 7 49 
Paediatric Sleep Questionnaire (PSQ) 
completed by primary carer 
89 4 84 
Sleep-related Breathing Disorder Scale 
(SBDS) completed by primary carer 
89 4 84 
SDSC completed by primary carer 89 2 86 
TDSQ completed by teacher 22 1 18 
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6.11.1 Cross-validation 
The total scores were derived from each of the sleep questionnaires and where appropriate 
the scores were correlated with the parent-reported sleep problems from the CAPA to 
demonstrate cross-validation of the CAPA as a sensitive tool for sleep problems (see Chapters 
3 and 4).  
The CASQ did not correlate with any of the other subjective measures and showed poor effect 
sizes. There was no association between the CASQ total and the CAPA sleep problems 
(p=0.893). The CAPA sleep problems did show an association with the other parental reports 
focussing on disorders of initiating and maintaining sleep (DIMS) (p≤0.001), sleep-wake 
transition disorders (SWTD) (p=0.001), disorders of arousal (DA) (p=0.0088) and disorders of 
excessive sleepiness (DOES) (p=0.0007) (see Table 19). After controlling for multiple testing, 
all associations remained. The disorders of initiating and maintaining sleep can be defined as 
insomnia-related which is pertinent for the two patterns of sleep problems derived from the 
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CAPA sleep problems: tiredness-related and insomnia-related. The CASQ was a participant 
report showing that parent-report did not correlate with the young person report. 
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Table 19 Pairwise correlations between the CASQ participant-completed questionnaire and the parent reports of sleepiness 
QA total score 
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Cleveland Adolescent Sleep Questionnaire (CASQ) completed 
by 12-year olds 
1       
Paediatric Sleep Questionnaire (PSQ) Sleepiness scale 
completed by primary carer 
0.171 1      
Sleep Disturbance Scale for Children, Disorders of Initiating 
and Maintaining Sleep subscale completed by primary carer 
0.0336 0.417 1     
Sleep Disturbance Scale for Children, Disorders of Arousal 
subscale completed by primary carer  
0.127 0.0898 0.181 1    
Sleep Disturbance Scale for Children, Sleep-Wake Transition 
Disorders Subscale completed by primary carer 
0.140 0.235 0.487 0.372 1   
 Sleep Disturbance Scale for Children, Disorders of Excessive 
Sleepiness completed by primary carer 
0.163 0.738 0.542 0.149 0.425 1  
Child and Adolescent Psychiatric Assessment Sleep Problems  0.0165 0.257 0.578 0.278 0.341 0.353 1 
Significant associations are highlighted in bold
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The CMES score is categorical and therefore an ordinal logistic regression showed associations 
with the SDSC DIMS (OR=0.844, p=0.028) and the DOES scores (OR=0.786, p=0.032) (see 
Figure 9). Controlling for multiple testing, the association between the CMES score and SDSC 
DIMS remained. These results show that an elevated score for DIMS and DOES is associated 
with a reduced risk for morningness chronotype preference. This indicates that individuals 
that have an eveningness preference associate with worse scores for DIMS and DOES. 
The TDSQ did correlate with parental measures of sleepiness including the CAPA sleep 
problems in the total group (p=0.018) however this was driven by siblings as no association 
was seen for individuals with 22q11.2DS (p=0.195).  
Figure 9 Lower scores for SDSC were shown to associate with the morningness preference in young 
people with 22q11.2DS on the CMES 
Preference for Sleep Timings 
(Chronotype indication)  
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6.11.2 Comparing Actigraphy measures with Self-Report 
The subjective, participant-reported measures derived from the sleep questionnaires were 
compared to the objective actigraphy measures. Elevated scores on the CASQ, indicative of 
more sleepiness, were associated with shorter total sleep time in young people with 
22q11.2DS (B=-0.393, p=0.0133). Lower scores on the CMES, suggestive of a preference for 
an ‘eveningness’ chronotype, showed associations with later get up time (B=-0.501, 
p=0.0035) (see Figure 10) and later sleep onset time (B=-0.369, p=0.0377 in young people 
with 22q11.2DS. Controlling for multiple testing resulted in only the association between the 
lower CMES total score and later get up time surviving. For the siblings, similarly an 
association between lower total CMES score and later get up time was seen (B=-0.585, 
p=0.0172) however this association did not survive correction for multiple testing.  
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Figure 10 Correlation between the objective actigraphy Get Up Timings, and the subjective 22q11.2DS 
young person, participant-reported CMES total score: the only associations to survive correction for 
multiple comparisons  
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6.12 Discussion  
This the first time, at time of writing, that validated sleep questionnaires have been used in a 
young person population with 22q11.2DS. The sleep questionnaires were used to assess the 
validity of the CAPA sleep problems and the parent reports generally. In addition, a brief 
description relating sleep problems identified by the sleep questionnaires is included, 
however further analysis is required. 
The Paediatric Sleep Questionnaire (PSQ) and the Sleep Disturbance Scale for Children (SDSC) 
subscale scores of parental-reports of sleep problems showed strong, positive correlations. 
However, the CASQ participant self-report sleep questionnaire did not show concordance 
with the CAPA sleep problems or any of the parent-reported sleep problems. Furthermore, 
for the younger participants, a sleep questionnaire was completed by their teachers. The 
outcome score from the Teacher Daytime Sleepiness Questionnaire (TDSQ) did not show 
concordance with the parental report sleep problems for the young people with 22q11.2DS, 
but it did show correlation with the parent report of the unaffected siblings’ sleep problems.  
The SDSC Disorders of Initiating and Maintaining Sleep (DIMS) and Disorders of Excessive 
Sleepiness (DOES) subscale scores showed an association with more problems and reduced 
risk for a morningness chronotype preference. This suggested that parent-reports of DIMS 
and DOES were associated with individuals reporting that they had a preference for an 
‘eveningness’ chronotype or ‘an owl’ chronotype.  
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6.12.1 Cross-validity of the CAPA Sleep Problems Section with Parent-reports 
but Discordance between Self-report and Parental-reports 
The parent-reported PSQ and SDSC validated the parent-reported CAPA sleep problems, 
showing a correlation between the two reports for the young people with 22q11.2DS and 
their unaffected siblings. This suggests that the CAPA Sleep Problems section could reliably 
identify similar sleep problems to validated sleep questionnaires used in the paediatric sleep 
literature. However, the CASQ showed a lack of concurrence with the CAPA sleep problems, 
suggesting that parent-reports and self-reports generated diverging scores. This potentially 
indicates that the parent reports are not the most reliable assessments of young people’s 
sleep problems. The CASQ was completed by young people over the age of 12 and therefore 
suggests that the older children and adolescents report differently to their parents. The 
findings support one study examining parent and adolescent reports of sleep problems in a 
population sample (not in 22q11.2DS). Parental reports accurately identified a third of the 
sleep problems that adolescents reported (Fatima et al., 2016). Moreover, another study 
assessing parent-reported sleep problems in their children compared to the adolescent 
reports showed that the parents were more sensitive to reporting sleep problems in their 
child who had a physical problem compared to the parents of the adolescents that did not 
have a physical problems (Pirinen et al., 2010). These parent-reports did not reflect the 
adolescent reports which showed that sleep problems did not vary dependent on a physical 
problem.  
Furthermore, the findings showed that the teachers of the younger children did not identify 
similar sleep problems to the parents in those young people with 22q11.2DS however they 
did accurately report siblings’ sleep problems. This potentially suggests that the parents are 
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more aware of potential sleep problems in their child with 22q11.2DS and therefore, they 
could over-report sleep problems. The teachers however anecdotally, have a class of young 
people that they can compare and are of potentially varying developmental ability. This could 
allow for teachers to forge reliably informed judgements of sleep problems.  
6.12.2 Preference for Heightened Evening Activity in Self-reports relates to 
Parent-reports of Sleep Problems 
The Children’s Morningness Eveningness Scale (CMES) was completed by young people over 
the age of 11 to acquire an understanding of their preference for their most active time of 
the day: would the young person prefer to be awake later into the night, or wake early in the 
morning for example. The self-reported preferences were shown to associate with elevated 
parent-reported problems in initiating and maintaining sleep and with parent-perceived 
excessive tiredness. The findings that adolescents and older children preferred going to bed 
later, and felt personally more active into the evening, was potentially misinterpreted by the 
parent as a problem relating to their sleep. For example, that their child had prolonged onset 
of sleep and difficulties with initiating sleep. This potential finding could support the absence 
of correlation between the parent and self-reported outcomes discussed in section 6.11.1 
also. A study including sleep questionnaires completed by parents and adolescents, in 
addition to actigraphy in the adolescents demonstrated that parent’s had an idealised 
perspective of their child’s sleep with inconsistencies in bedtimes on weekdays and weekends 
suggesting that they were earlier than the adolescent report and also the parent suggested 
later wake times on weekends compared to the adolescents (Short et al., 2013). Actigraphy 
parameters suggested that parents reported longer total sleep times than the more objective 
measures and the adolescent reports.  
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6.12.3 Uniting the Objective and Subjective Assessments of Sleep 
Comparing the participant-reported sleep problems and the objective actigraphy worn by the 
participants themselves showed interesting findings. After surviving multiple testing, lower 
CMES total scores were shown to associate with later get up times. The CMES assesses the 
preferences of a young person (over the age of 12) regarding sleep timings. The participants 
can comment on the preferred timing for sleep onset, and get up times and times of the day 
that they consider themselves to be most active. The fact that the objective measure in the 
adolescents corroborated the subjective report of their preference getting out of bed later, 
shows that the two methods of assessment can complement each other. In these analyses 
however, this was the only finding that survived multiple comparisons in young people with 
22q11.2DS and there were no findings relating the participant-reported sleep problems and 
the objective actigraphy measures in the siblings. There is mixed success in actigraphy 
corroboration of subjective reports of sleep problems however , with one study showing one 
significant associations between reported night time awakenings with actigraphy (Markovich, 
Gendron and Corkum, 2014).  
Therefore, this could suggest that it is important that objective actigraphy and subjective 
sleep questionnaires are used in a complementary manner to assess the sleep phenotype as 
sleep diaries can provide a cost-effective assessment of sleep times with actigraphy providing 
added information regarding nocturnal events (Werner et al., 2008). For the younger 
individuals, parent reports can provide an accurate and sensitive representation of the sleep 
problems in certain cases, especially in young children with NDDs (Wiggs and Stores, 2004). 
However, how the objective actigraphy measures relate to the parent-reported sleep 
problems in older children and adolescents suggests that parent-report=ed sleep problems 
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might not be representative of adolescent reports of sleep problems. The findings relating the 
objective actigraphy measures and the participant-reported subjective sleep problems, 
suggests that older individuals can provide reliable and replicable information about their 
sleep in some instances particular sleep parameters relating sleeping and waking preferences.  
The sleep questionnaire outcomes are more robust when the more objective actigraphy data 
can support outcomes. Nonetheless, together and in addition to the data outlined in Chapter 
4 and the next chapter, Chapter 7, these measures contribute to a comprehensive assessment 
of sleep in a young person population that has yet to be investigated. 
6.13 Strengths and Limitations 
This is the only study to have used actigraphy in young people with 22q11.2DS and the sample 
size is relatively large for a high-risk young person population. This is a novel assessment in 
these young people and the invaluable sibling control group allows for comparisons to 
typically developing children. 
The actigraphy and sleep questionnaire allowed young people who were not interested in 
completing an overnight assessment to contribute to the data acquisition in a non-invasive 
way. The participants were able to remove their actigraphy watch, complete their sleep 
diaries (yet this was not rigorously recorded and should have been) and sleep questionnaires 
with freedom and an understanding between the parent, child and researcher increasing the 
yield of data, with most young people keeping the watch on over the period of two weeks.  
A limitation to the actigraphy was that watches had to be sent out to participants and this 
relied on the families to return the watches in good time for the data to be removed from the 
watches. Unfortunately, there were instances where the watches were not returned and 
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therefore data was lost. If actigraphy was to be used in the future, devising a better way of 
returning the watches would be advisable.  
The actigraphy watches were placed on the non-dominant wrists of the young people. Studies 
have used actigraphy watches on the dominant wrist, ankles and have used bed mats 
containing accelerometers to assess night time activity. For the younger individuals, another 
device such as a mat might be more appropriate and cause less discomfort as the watches 
were sometimes bulky and larger than the wrists of the smaller children. Furthermore, new 
and innovative technologies that can measure multiple different physiological measures are 
not readily available. The assessment only focussed on the acquisition of movement however 
future work could consider a technology with several different physiological measures of the 
young people.  
The neurodevelopmental phenotype was assessed on a different day to the actigraphy 
assessments in many of the individuals. The age differences were accounted for however it 
would be interesting to conduct cognitive and psychiatric assessments throughout a period 
of actigraphy or in relation to an objective-measure of sleep.  
Actigraphy has been shown to accurately estimate TST in the literature however the 
sensitivity of actigraphy to detect immobile wakefulness, such as lying in bed awake has been 
questioned. This is important to the findings as the sample included young people and 
adolescents that biologically would have a predisposition to ‘lying-in’ during the weekends or 
during a free day (Sadeh and Acebo, 2002; Sadeh, 2011). This could cause some inaccuracies 
in the TST and therefore the SE. This is one of the reasons the sleep diary is completed in 
concordance with the actigraphy to attempt to remove inconsistencies between the two 
measures.  
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Statistical comparisons were corrected for multiple comparisons and therefore, the findings 
can provide the foundations to build upon to investigate sleep problems further in young 
people with 22q11.2DS. 
6.14 Clinical Implications  
These findings have suggested that parent-reports might not potentially be the most reliable 
assessment of sleep in young people with 22q11.2DS. This indicates that the perspective of 
the individual, particularly in adolescents, should be obtained with regards to their sleep. 
Having a parent-report, self-report and a more objective measure such as actigraphy, will 
allow for a more reliable assessment of the sleep phenotype in 22q11.2DS. This can help to 
examine whether there are underlying sleep problems or if there are potential genetic and 
individual variations in sleep parameters such as bedtimes which might present as sleep 
problems to a parent. This information can help to develop better sleep interventions 
including sleep hygiene and sleep education which can involve the individual, teachers and 
the family.  
6.15 Future Work  
The sleep questionnaires should be used to validate the more objective measures of sleep in 
young people in 22q11.2DS. This would be the first validation of sleep questionnaires in this 
population and would unite the different sleep assessment measures to create a 
comprehensive, valid sleep assessment that can be replicated in other groups with 
22q11.2DS. 
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 There are many physiological changes during sleep and nocturnal activity is only one 
assessment. Heart rate, oxygen saturation and hormone levels vary over the night time period 
and sophisticated innovative technologies have been developed which could give an insight 
into other physiological measures. This could be conducted through smart technologies to 
identify stress or skin conductance through the night. Furthermore, stress hormones fluctuate 
overnight and circadian profiles of cortisol and melatonin are inherent to sleep-wake cycles. 
Therefore, melatonin and cortisol samples could be acquired through the night and daytime 
to determine circadian profiles in 22q11.2DS. 
6.16 Summary  
This chapter has shown that there are actigraphy-derived differences in sleep parameters 
between young people with 22q11.2DS and their unaffected sibling controls. There are 
potential relationships between the sleep problems and the neurodevelopmental phenotype 
in the young people with 22q11.2DS also. This chapter has also helped to identify the validity 
of the CAPA sleep section supported by parental-reports of sleep problems, but it has further 
indicated that parent reports might not be the most reliable perceptions of sleep problems in 
older adolescents whether young people with 22q11.2DS or siblings. Associations with the 
neurodevelopmental phenotype suggest that more work is required to determine whether 
actigraphy can be used to identify particularly symptoms in young people with 22q11.2DS 
from monitoring their sleep. 
 
 
 
   
209 
 
Chapter 7 – Polysomnography in 22q11.2 Deletion Syndrome 
7.1 Overview of the Chapter  
Sleep problems in 22q11.2DS have been reported anecdotally by parents who suggest that 
sleep problems are disruptive to the young person and their family. To be able to investigate 
sleep problems clinically and comprehensively explore the sleep phenotype in the young 
people with 22q11.2DS, a gold-standard sleep study is defined as a ‘polysomnography’ (PSG). 
A PSG is conducted after a referral from a general practitioner to assess sleep architecture 
and physiology in an individual suspected to have sleep problems such as sleep breathing 
disorders (SBD) or parasomnias. There are several measurements conducted in a PSG: sleep 
EEG, EOG, EMG, ECG and respiratory measures. The equipment and measures used in this 
study are outlined in Chapter 5.  
The pilot study showed that PSG could be used in the homes of young people to assess their 
sleep. The high-density Geodesic net was adopted as the best technique for acquiring 
neurophysiology data in addition to assessing cardiorespiratory measures. These methods of 
assessment provide a comprehensive measurement of the different physiological changes 
throughout the sleep period. This maximises the possibility for interpretation of sleep 
physiology in young people with 22q11.2DS and the sibling control group.  
7.1.1 Recognising Waveforms of Sleep  
To characterise the neurophysiology of sleep in young people with 22q11.2DS and compare 
this to unaffected sibling controls, normative brain physiology during sleep needs to be 
understood. Typical sleep physiology is outlined in Chapter 2 and studies including the 
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acquisition of sleep EEG, in the typically developing population and within the 
neurodevelopmental phenotype, are reviewed. However, to be able to assess and analyse the 
data acquired from a sleep EEG, markers need to be identified in the EEG trace. This allows 
for staging of sleep and further analysis. The different types of waveforms and architecture 
of sleep is discussed in Chapter 2. The AASM guidelines (Berry et al., 2016) used to score sleep 
EEG are dependent on these waveforms.  
The physiology of the brain changes throughout the night with stages of sleep transitioning 
in a 90-minute cycle. Changes in neurophysiology and categorisation of sleep stages was 
initially developed by Allan Rechtshaffen and Anthony Kales (Rechtschaffen and Kales, 1968) 
who produced the first staging criteria in 1968. Scoring criteria for sleep physiology have been 
developed into a systematic assessment that is re-evaluated each year to ensure consensus 
within the sleep research community. As a result, guidelines are uniformly adopted by sleep 
researchers to score and assess PSG physiology. The American Academy of Sleep Medicine 
(AASM) unified these guidelines and it is important to note that ‘The AASM Manual for the 
Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, 
Version 2.3’ (Berry et al., 2016) was used to acquire and interpret the data (see section 7.3.2) 
and analyse data outputs outlined in section 7.3.3.  
Across a lifetime, sleep neurophysiology changes with neonates often spending around 50% 
of their time in NREM and 50% in REM sleep, with 50-minute sleep cycles (see section 2.3). 
Physiology stabilises in the first year of life showing increasing similarities in activity and cycle-
length with adolescents and adults. In adults, on average 18-25% of a night’ sleep is spent in 
REM with a full cycle around 90-minutes.  
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The following section will briefly highlight the fundamental aspects of each sleep stage that 
are needed for the interpretation of the results in this chapter. It is important to note in this 
thesis that the physiological markers in the EEG are not analysed. Instead, the sleep 
physiology is assessed more generally and can provide the foundations to further exploring 
sleep physiology in the future.  
7.1.1.1 Wake 
Figure 11 shows a characteristic wake EEG signal: the wake brain exhibits fast and low 
desynchronised voltage activity. There is characteristic alpha activity (8-14Hz) that localises 
to the occipital cortex and is present in quietened and relaxed wakefulness (Blume, 2006). 
When eyes are shut, alpha dominates and can continue accompanied by slow eye movements 
when transitioning into sleep and stage 1.  
Figure 11 A 30-second epoch illustrating wakefulness. The red box shows alpha activity whereas the 
orange box shows slow eye movements. These are 30-second epochs from my own acquired data. 
   
212 
 
Identifying wake is important in an EEG trace as nocturnal awakenings can occur through the 
night. Periods of wakefulness can be scored if there is 10 seconds of normal EEG followed by 
an arousal into 15 seconds of continuous alpha activity. An arousal is an abrupt shift in the 
EEG frequency in sleep stages NREM Stage 1, 2 or 3 or REM sleep. The frequency change must 
be greater than 16 Hz and includes alpha and theta (4-8 Hz) frequencies but not sleep 
spindles. The shift must last for a minimum of three seconds and 10 seconds of stable sleep 
frequencies must precede the shift. In REM specifically, an arousal can only be scored if there 
is a concurrent change in the EMG showing that the muscle tone has increased for a minimum 
of 1 second (Berry et al., 2012).  
Brain activity is variable amongst individuals, but most brain activity will present like a 
standardised model of each stage of sleep. However, there are some individuals (around 10% 
of people) who do not generate alpha rhythm and as a result it is much harder to identify the 
restful wakefulness and transition into stage 1. As a result, other waveforms and 
characteristics need to be identified to recognise stage 1 such as theta activity, vertex sharp 
waves and slow eye movements (Berry et al., 2016).  
7.1.1.2 NREM - Stage 1  
NREM Stage 1 is scored by observing low voltage activity, with dominant low-amplitude mixed 
frequency (LAMF) waveforms (highlighted by the orange box in Figure 12) some slow eye 
movements and a transition from alpha activity into theta frequencies (4-8 Hz) (Biswal et al., 
2010).  
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7.1.1.3 NREM - Stage 2 
Stage 2 of NREM sleep can be characterised by the dominance of theta waveforms (4-8 Hz) 
and cortical signatures of patterned network activity called ‘K-complexes’ and ‘sleep spindles’ 
(see Chapter 2 for definitions). Figure 13 demonstrates the architecture that needs to be 
detected to score a 30-second epoch of sleep as stage 2: the star denotes the peak of a K-
complex (contributing to the frequency band ranges 0.5-0.9 Hz and 1-4 Hz) and arrows show 
sleep spindles (11-16 Hz, most commonly 12-14 Hz) in stage 2 of the sleep EEG.  
 
 
 
 
Figure 12 A 30-second epoch showing stage 1 sleep. There is evidence of low-amplitude mixed 
frequency waveforms throughout. These are 30-second epochs from my own acquired data. 
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K-complexes that are connected to an arousal effects the interpretation of the sleep stage. If 
an arousal is scored in the first 15 seconds of stage 2, and no other arousal occurs during the 
next 30 seconds, the next epoch will be scored as stage 1. The occurrence of the next K-
complex that is not associated with an arousal allows for NREM Stage 2 to be scored again. K-
complexes and sleep spindles are important physiological features which have been and 
continue to be explored in conjunction with psychiatric disorders (see section 2.4 and 2.5). 
7.1.1.4 NREM - Stage 3 
Stage 3 is characterised by slow-wave activity (SWA) which is inclusive of slow-waves (0.5-2 
Hz) and delta activity (1-4 Hz). Evidence of K-complexes in NREM Stage 3 has suggested that 
a K-complex could be an isolated slow-wave or down-state (Cash et al., 2009). This is due to 
their frequency band range contributing to both slow-wave and delta frequencies. The 
Figure 13 A 30-second epoch showing stage 2 sleep EEG. The orange arrows show examples of 
polyphasic spindling (sleep spindles) and the red stars show examples of K-complexes which are shown 
here to be coupled with the spindles. These are 30-second epochs from my own acquired data. 
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presence of K-complexes is considered an indicator of a cortico-thalamic processing mode 
(Cash et al., 2009).  
In NREM Stage 3, the general physiological activity observed can be defined as slow-wave 
activity (SWA) which encapsulates the 0.5-4 Hz frequency band (outlined by the orange box 
in Figure 14) SWA can be measured locally at the frontal regions of the brain by EEG and is 
generally modulated in the neocortex (Achermann et al., 1993). Slow-wave oscillations derive 
primarily from the cortex however delta waveforms are generated deeper in the mid-brain 
from the thalamus, showing that SWA does not originate from one isolated brain region 
(Esser, Hill and Tononi, 2007).  
To score a 30-second epoch of sleep EEG as NREM Stage 3, brain activity must show 20% or 
more SWA in those 30 seconds. A healthy individual will spend around 10-25% of their total 
sleep time in slow wave sleep (SWS) (Ohayon et al., 2010). SWA is dominant in stage 3 and 
Figure 14 A 30-second epoch of NREM Stage 3 sleep. The orange box illustrates SWA. These are 30-
second epochs from my own acquired data. 
   
216 
 
used to characterise this stage, however SWA is detectable through NREM and the ‘deepness’ 
of sleep can be characterised by the density of SWA: the deeper the NREM sleep, the more 
SWA is present and the fewer spindles present in the trace (Dijk and Archer, 2009). 
Throughout the 90-minute sleep cycle, the frequencies of waveforms present can reflect the 
deepness of sleep: the deepest sleep is NREM Stage 3 showing the lowest frequency band 
range of waveforms and the highest frequency, other than wakefulness, is identifiable in stage 
1 and REM sleep. 
7.1.1.5 REM sleep  
REM sleep is characterised by rapid eye movements (outlined by the orange box in Figure 15) 
and saw-tooth waves (outlined by the red box in Figure 15). They present as sharply 
contoured trains of waves which often look serrated and occur at a frequency band range of 
2-6 Hz. Rapid eye movements can be derived from electrooculography (EOG) in which eye 
movements are bi-laterally measured by electrodes positioned close to the eyes (Berry et al., 
2016). 
During REM sleep muscle atonia happens (loss of muscle tone) which is often likened to 
paralysis. This lack of muscle movement is required to confirm the presence of an epoch of 
REM sleep. Low muscle tone is assessed using electromyography (EMG) where either two or 
three electrodes are placed under the chin.  
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7.2 Rationale 
There are currently no studies that have comprehensively described subjective or objective 
features of sleep in 22q11.2DS. There is scant literature that refers to the rates of sleep-
related breathing disorders (SRBD) especially obstructive sleep apnoea (OSA) in 22q11.2DS 
(Heike et al., 2007). These studies, which are predominantly based on clinical samples, have 
identified around 10% of individuals with 22q11.2DS have OSA, showing a higher 
preponderance than the typical young person population (O’Brien et al., 2004).  
However, there is evidence to suggest that there is a prevalence of up to 5% (on average) of 
young people in the age range investigated, with reported OSA or sleep-related breathing 
Figure 15 30-second epoch showing an example of rapid eye movement (REM) sleep. The orange box 
shows rapid eye movements and muscle atonia, and the red box illustrates saw-tooth waves. These are 
30-second epochs from my own acquired data. 
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problems (Capdevila et al., 2008). This suggests that despite there being a higher prevalence 
in the 22q11.2DS young people, evidence of OSA across the study sample might not be 
completely unusual. Nonetheless, there have been no research studies that include subjective 
or objective measures of sleep in 22q11.2DS outside of case studies or clinical populations. 
However, there have been clinical cases of OSA or SRBD in individuals with 22q11.2DS which 
results into poorer sleep quality, reduced quantity, disruption to the sleep architecture and 
impairment of daytime cognition (Certal et al., 2012). In the young people with 22q11.2DS, 
cognitive impairment especially is reported in the literature and supported by the findings in 
Chapter 4. Therefore, in the investigation outlined in this chapter, it is important to include 
objective assessment of sleep-breathing in addition to the electrophysiology to try and 
capture all potentially sleep-related effects in young people with 22q11.2DS.  
Chapter 4 outlines these subjective parent-reported sleep problems showing that there is a 
higher prevalence of sleep problems in young people with 22q11.2DS compared to the 
typically developing sibling group. Furthermore, Chapter 6 demonstrates differences in the 
objective actigraphy-derived sleep parameters showing that young people with 22q11.2DS 
spend longer in bed, a longer time asleep and have a higher sleep efficiency than the control 
sibling group. These current findings suggest differences in the sleep patterns and behaviours 
of young people with 22q11.2DS compared to typically developing young people. 
The literature outlined in Chapter 2 shows abnormal sleep physiology in individuals with NDDs 
and psychiatric outcomes that commonly present in 22q11.2DS. Individuals with 22q11.2DS 
are at a high biological risk for the development of SCZ and have elevated prevalence of 
ADHD, ASD and anxiety symptoms in addition to cognitive impairment within the 
neurodevelopmental phenotype. As a result, it was hypothesised that there could be 
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evidence of spindle and slow wave abnormalities during sleep. Evidence in the literature 
suggests that spindles might be an endophenotype of SCZ (Manoach et al., 2016) and 
therefore, studying sleep physiology in a genetically high-risk population can add to the 
understanding of aberrant sleep physiology and the neurodevelopmental phenotype (see 
Chapters 1 and 2). Abnormalities in sleep physiology in NDDs also contribute to the rationale 
behind exploring sleep in 22q11.2DS (see Chapters 1 and 2). The unaffected siblings were a 
control sample that could be used to compare brain neurophysiology directly.  
 The overnight sleep EEG study was developed to identify the baseline sleep neurophysiology 
and from here, investigate subjective measures of sleep in young people with 22q11.2DS.  
7.2.1 Aims of the EEG study  
In Chapter 2, the third aim described exploring the sleep phenotype further in 22q11.2DS by 
conducting a sleep study in comparison to their unaffected sibling controls. The sleep study 
adopted the following three aims to address the main thesis aims: 
1. to score the stages of sleep from the sleep EEGs and remove the artefacts from the 
sleep EEGs in young people with 22q11.2DS compared to their unaffected sibling 
controls; 
2. to compare the objective PSG-derived sleep architecture between young people with 
22q11.2DS and their unaffected control siblings; 
3. to investigate the objective PSG-derived sleep architecture in relation to the 
neurodevelopmental phenotype in young people with 22q11.2DS  
To achieve this, the full PSG with high density EEG 64-channel net was conducted in 
collaboration with another PhD student. The additional measures were used to gain a 
comprehensive understanding of the sleep phenotype including actigraphy watches with a 
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complementing sleep diary. My work aimed to derive objective assessments of sleep from 
these measures.  
The sleep EEG assessments was based on the following hypotheses: 
1. it was hypothesised that sleep problems would have an underlying physiological basis 
in 22q11.2DS; 
2. it was hypothesised that individuals with 22q11.2DS will show more disturbed sleep 
compared to their siblings, shown by the objective sleep architecture such as reduced 
total sleep time; 
3. objective measures of sleep in individuals with 22q11.2DS will show associations with 
the neurodevelopmental phenotype, but to what extent is unknown. 
The scant literature regarding sleep in 22q11.2DS centres on SRBD and OSA. As part of the 
overnight sleep study, sleep-related breathing problems were measured however not 
analysed. Having a physiological signal could mean that potential sleep-related breathing 
problems could be accounted for to prevent confounding of results. Initially, a respiratory 
clinician was available to interpret any respiratory problems identified. However, 
unfortunately the clinician did not continue involvement in the study. The breathing traces 
were not analysed themselves. Instead they were used as a reference trace when analysing 
the EEG. Therefore, there is not adequate evidence to state that there was no evidence of 
OSA or SRBD in this sample of young people. Future investigation requires the assessment of 
the cardiorespiratory signals. 
7.3 Methodology 
The methods used in the main study were developed from the pilot study. Chapter 5 outlines 
the basic EEG protocol. In this section, the protocol for acquisition of the data is outlined in 
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more detail identifying how the protocol evolved from the pilot study. Additionally, pre-
processing of the EEG data will be addressed with reference to the pipeline used and the 
protocol for sleep EEG scoring and staging of sleep as well as the technique used to identify 
and remove the artefacts from the processed data. The cardiorespiratory data acquisition is 
outlined in this section. This was not analysed independently but used for interpretation of 
the EEG. This has been mentioned in the prior section.  
7.3.1 Sample and Demography  
Participants were part of the ongoing Experiences of CHildren with cOpy number variants 
(ECHO) study (see Chapter 3, section 3.1, and Appendices 1 and 2) (Niarchou et al., 2014; 
Chawner et al., 2017; Cunningham et al., 2017). Recruitment for the ECHO Study can be found 
in Chapter 4 and the recruitment process for the sleep study can be found in section 6.4, 
Chapter 6.  
After pre-processing of the sleep EEG data and quality control (see section 7.3.3), the sample 
size reduced to n=28 young people with 22q11.2DS (x ̅age=14.6, range = 6 years, ~8 months–
20 years, ~5 months, s.d.=3.44, 50% females) (59.6% of the original sample) and n=17 age-
matched unaffected sibling controls (x ̅ age=13.7, range=7 years, ~9 months–18 years, ~11 
months, s.d.=3.36, 58.8% females) (77.3% of the original sample). This was due to the age of 
participants and the availability of overnight assessments with young people. For example, 
weekends and school holidays were the only available times. Family income information and 
highest parental education was obtained from primary carer questionnaires and can be found 
together with information of the age and gender of the participants in Table 20.
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Table 20 Demographics of sleep EEG cohort 
   % 
Family ethnic background   
 Mixed   3.57 
 British  92.9 
 Other  3.57 
Highest maternal education qualification  
 No qualifications  6.90 
 Low: O-levels or GCSEs 24.1 
 Middle: A-levels/Highers or vocational training 31.0 
 
High: University degree and/or other higher 
postgraduate qualification 
34.5 
 Other 3.45 
 Unknown  0.00 
Family income per annum (£)  
 £≤19,999 3.45 
 £20,000-39,000 31.0 
 £40,000-59,000 31.0 
 £≥60,000 27.5 
 Unknown 6.90 
Age, years: mean (s.d.)   
Probands 14.6 (3.44) Siblings 13.7 (3.36) 
Gender, n (%)   
Probands 14 F (50) Siblings 10 F (58.8) 
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In the 22q11.2DS cohort, n=12 (42.9%) of young people were on medication and n=4 of these 
young people were taking melatonin (14.3%) (see Table 21). There were n=3 sibling controls 
that were on medication. Table 21 shows the number of individuals that were on medication 
at the time of assessment.  
Table 21 Current medication taken by the individuals  
Current medication for 
treatment of: 
Number of young people 
with 22q11.2DS 
Number of 
siblings  
Hypothyroidism 2 1 
Sleep problems 4 0 
Gastrointestinal  4 1 
Asthma 4 1 
Supplements 1 1 
ADHD 1 0 
Cardiac problems 1 0 
Migraine 0 1 
Hormonal 1 0 
Antibiotics 2 0 
Hypocalcaemia 1 0 
Mood 1 0 
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7.3.1.1 Study Logistics and Preparation  
The study often required travel to the participant’s 
home, which could be anywhere in the UK. Figure 
16 shows a map of the UK with markers denoting 
the locations of the sleep studies. Figure 16 
demonstrates the vast distances travelled across 
the UK to acquire the data for the sleep study.  
The evening visit consisted of explaining the study 
and different pieces of equipment to the 
participant/s and primary carer such as the 
actigraphy watch (see Chapter 6), sleep diary (see 
Chapter 6) and the EEG net. Note, the sleep 
questionnaires had been sent to the family prior to the visit (see Chapter 6).  
The methods used in the main study were outlined in a Case Report Form (CRF) for each 
participant. This document was produced for each study visit for each participant and a CRF 
for the primary carer was also produced. The CRF was divided into four sections: Visit Part A, 
evening activities; Visit Part B, morning activities; Visit Part C, midday battery change; Visit 
Part D, evening activities and Cardiff Activities.  
The main CRF included a checklist of the equipment that was packed for every visit before 
leaving Cardiff. The Visit Part A section included a pre-set-up checklist and steps to ensure 
that all the pre-sleep activities had been completed accurately such as tick-boxes for each 
sensor that was applied and the equipment required for the bedroom setup.  
Figure 16 Map of the UK with pins of study 
locations. 
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Part B of the CRF included a section where events during the night could be recorded and 
ensured that any abnormalities during the night were recorded such as loose electrodes.  
Parts C and the first section of Part D referred to part of the study that is not presented by my 
work but instead by Chris Eaton who was a PhD student on the project exploring seizure-
related activity in 22q11.2DS. We both completed data acquisition for the full study protocol. 
Visit D included post-visit evaluations, a clean-up checklist, consumables re-stocking and the 
checklist of equipment to minimise loss of equipment in family’s homes.  
This document was developed during the pilot study and was modified throughout the pilot. 
This meant that by the end of the pilot, we had a comprehensive CRF with all the required 
information for the main study. Including sections for comments and notes was something 
we developed during the main study to ensure that all information regarding the participant 
and the family could be recorded during the study. It was a comprehensive document which 
ensures that the same protocol was conducted during each visit.  
7.3.2 Polysomnography Assessments 
The PSG includes the preparation of electrooculography (EOG), electromyography (EMG), 
electrocardiography (ECG), sleep EEG, pulse oximetry, respiratory inductance belts (RIP) and 
a nasal cannula. The EOG, EMG, pulse oximetry, RIP belts and nasal cannula were connected 
to an Embla Titanium, PSG ambulatory amplifier (Natus Neurology Supplies, Oxford, UK). The 
sleep EEG was acquired by a 64-channel high-density Geodesic net that was connected to an 
EGI EEG amplifier (Philips Company, 2018). The ECG was recorded by both amplifiers: one pair 
of electrodes was plugged into each amplifier. The ECG recordings were used to synchronise 
the two amplifiers and their outputs to allow interpretation of all measures together.  
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7.3.2.1 Electrooculography (EOG) and Chin Electromyography (EMG)  
Surface electrodes were used to measure eye and muscle movements (see Chapter 5 for 
explanation) (Ambu® Neuroline 720, 2018). These electrodes contain conductive gel and self-
adhesive allowing for them to be easily applied directly to the skin and are relatively 
comfortable. The conductive gel enables low impedances and optimal signal quality. The 
connector at the terminus of the electrode was compatible with the inputs on the Embla 
titanium.  
A preset setting was created for the Embla titanium that assigned inputs for the EMG and 
EOG to ensure consistency of measurements. The EOG was measured at a 128 Hz sampling 
rate with a low-frequency filter of 0.3 Hz and a high-frequency filter of 35 Hz; same as the 
EEG. The EMG was measured at a low-frequency filter of 10 Hz and a high-frequency filter of 
100 Hz.  
As outlined in Chapter 5, two EMG electrodes were positioned under the mandible lateral to 
the midpoint of the chin and two EOG electrodes were used, one positioned by the left eye 
and one by the right eye. These measures are essential in overnight sleep studies to allow 
accurate scoring of sleep stages throughout the night (see section 7.3.3.1).  
7.3.2.2 Breathing and Cardiac measures  
The measures used in the pilot study were continued in the main study (see Chapter 5). The 
pulse oximeter was used to measure the oxygen saturation of the haemoglobin in the blood. 
The pulse oximeter in the study was placed on a finger on the participant’s non-dominant 
hand. A beam of infrared light passes through the finger and the blood, detecting the oxygen 
saturation. This measured by detecting the changes of light absorption in oxygenated blood. 
The pulse oximeter also provided the heart rate of the individual. This is required to measure 
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oxygen deprivation due to apnoeas or hypopneas occurring through the night. In a clinical 
setting, this would allow for the scoring of these events throughout the night also. 
Electrocardiography (ECG) 
The participants wore two pairs of ECG electrodes to monitor their heart rates. We know that 
individuals with 22q11.2DS have a higher risk for cardiac abnormalities (McDonald-McGinn et 
al., 1999) that could result in abnormalities detectable on ECG. Where this was the case, the 
primary carer informed us and it was noted.  
 The ECG was used to be able to decipher between cardiac events and neurophysiological 
events and proved to be essential in the matching of the different datasets. One pair of ECG 
electrodes was inserted into the EGI amplifier whereas the other was attached to the Embla 
titanium amplifier.  
The participants wore four single-use ECG electrode pads (Ambu, 2018) that had a stud 
connection for easy application of the ECG snap electrodes) which were attached to the pads. 
The pads were pre-gelled like the EOG and EMG electrodes and could be directly applied to 
the skin. Two pads were applied to the participant’s skin under their left clavicle, and the 
other pair applied underneath their right clavicle in proximity to the anterior auxiliary line so 
that ECG was detectable from the auxiliary artery. The ECG was measured at a sampling rate 
of 128 Hz with a low-frequency filter of 0.3 Hz and a high frequency filter of 70 Hz.  
Respiratory Sensors Application  
The nasal cannula was used to measure the pressure of inspiration and expiration, with an 
output showing the respiratory rate and transference of air. The nasal cannula was the most 
invasive and uncomfortable piece of equipment from the feedback of the pilot study. As a 
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result, there were individuals that wore the nasal cannula throughout the night; there were 
some who wore it initially however removed it during the night and others that did not wear 
the cannula. Therefore, there was a varied amount of data acquired from the nasal cannula. 
This itself must be acknowledged as contributing to potential underestimation of significant 
sleep-related breathing problems: without the nasal cannula measure, there would be 
insufficient data acquired to recognise changes in the respiratory pressure and airflow. The 
other respiratory measures, the pulse oximetry and RIP belts were tolerated better and could 
provide limited information regarding respiratory events during the night’s sleep.  
The RIP belts measure the expansion and deflation of the thoracic cavity and the abdomen 
during the process of breathing: expansion of the thoracic cavity and narrowing of the 
abdomen during inhalation and deflation of the thorax and extension of the abdomen during 
exhalation. The movement of the thorax and abdomen is measured by the physical expansion 
of copper wire that is contained within elasticated belts that sit under the participant’s 
armpits and above their navel (see Chapter 5 for an example). The RIP belt signals were 
recorded at a 0.1 Hz low-frequency filter and a 15 Hz high-frequency filter.  
The respiratory measures require clinical input for the analysis of SRBD and potential 
incidences of OSA. The protocol used in the sleep study with the young people with 
22q11.2DS and the sibling control group does not adequately record the breathing 
parameters required to state the prevalence of OSA or SRBD in this sample. It is important to 
identify the rates of OSA in these young people but it is also important to recognise that to 
do so, further input is required from external clinical experts and this will be required before 
further investigation of the sleep physiology can take place in the future.  
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Bio-calibrations 
All signals were acquired and analysed initially by Embla REMLogic software (Natus Neurology 
Supplies, Oxford, UK). Embla REMLogic software is a sleep acquisition and diagnostic software 
which was also used to review the EOG, EMG, ECG and respiratory measures. It was used 
during setup, bio-calibrations and subsequent ambulatory acquisition.  
Standard bio-calibrations were used to ensure that the equipment was accurately detecting 
the correct signal. It was important to identify that the EOG was detecting eye movements by 
testing movements and assessing the output on the EOG trace. This was conducted for the 
EMG and airflow also. To bio-calibrate the ECG, a heart rate signal is assessed on the trace 
and compared to a baseline ECG.  
The geodesic net was not compatible with the Embla Titanium; the EGI amplifier which used 
the Galileo software to acquire and review the EEG signals was compatible with the net.  
7.3.2.3 Sleep Electroencephalography (EEG)  
The sleep EEG was acquired using a 64-channel, high-density geodesic net (Electrical 
Geodesics, Inc. Eugene, Oregon, USA). This 64-channel net was a relatively new piece of 
equipment which was designed for ease of use for EEG application and detection of brain 
activity derived across the cortex. EGI provided the equipment along with the EEG interface 
programme Galileo Suite (EBNeuro S.p.A, Florence, Italy) used to acquire the data and for 
monitoring and calibration of the data.  
EEG Net Application 
The application of the net was outlined in Chapter 5 with images, showing the matrix of 
electrodes. The net was used in the acquisition of data from all participants apart from one 
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individual. This individual wore a continuous positive airway pressure (CPAP) mask during the 
night as a result of previous obstructive sleep apnoea having been identified. This meant that 
the net could not be used in this case as both the mask and net could not sit comfortably on 
the individual’s head. The free silver-chloride electrodes were used for this individual with 22 
electrodes measuring the brain activity of this one individual overnight. The EEG net however 
was used during the day for the daytime assessment. The protocol used is outlined in Chapter 
5 for the free electrodes.  
The first step in the application of the net was to measure the participants head. The 
circumference was recorded as was the distance between the nasion (bridge of the nose) and 
the inion (the raised, curved part at the posterior of the cranium), with a midline on the scalp 
and the distance from left to right preauricular with midline on the scalp which should overlap 
to create a cross at the central point of the scalp. The cross demonstrates the overlap of the 
midline and the interaural line and where the Cz electrode on the net is aligned to. 
Once these positions were measured, the appropriate net was chosen: we had three 
differently sized nets. A particular technique was used for applying the net: the matrix of 
pedestals had to be expanded using both hands to ensure the net could fit over the 
participant’s head and sit snuggly on their scalp. The Cz central electrode was positioned in 
alignment with the central cross that was marked on the participant’s head. The pedestals 
were spread across the head to ensure best fit. Straps were tightened under the chin, 
positioning the net correctly and keeping it in place during sleep.  
Once the net was positioned, the pedestals could be filled with electro-conductive gel to 
decrease the impedance between the electrode and the scalp to ensure best detection of 
brain activity across the cortex.  
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There were 60 pedestals that we needed to gel. The pedestals were numbered and we used 
a PDF map of the net to match the number of the pedestal with the anatomical position such 
as pedestal 1 was FCz. Once we had matched each pedestal with the anatomical location, we 
could use the surface map of electrode locations to monitor the recorded signal. This map 
showed the impedances for each electrode whilst gelling so we could ensure that we had the 
best signal (impedance below 30 kΩ). We performed a separate bio-calibration for the EEG 
signals using the Galileo software. Bio-calibrations were marked in the software for later 
inspection.  
Acquisition of Data  
The Galileo Suite was used to acquire the data but the traces were transferred to REMLogic 
for convenience of interpretation.  
The design of the equipment also meant that the EGI amplifier had to be plugged in overnight 
as the battery pack only lasted for eight hours of constant data acquisition. This meant that 
we depended on the primary carer, and/or participant to remember to plug the equipment 
in before they went to bed and when they were inactive such as sitting in the living room or 
in bed watching a film. Figure 17 
shows an example of the image that 
was attached to the front of the 
amplifier and included an instruction 
booklet to ensure that the amplifier 
was plugged in overnight. This was 
included in the methods of data Figure 17 An example of the image stuck to the front of the 
EGI EEG amplifier to ensure the charging cable was inserted 
correctly before lights out. 
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acquisition as we learnt from the pilot study and early studies in the main study that the 
charging wire could be easily forgotten.  
7.3.3 Data Analyses  
7.3.3.1 Sleep EEG Interpretation 
The two amplifiers (Embla titanium and EGI) were combined to generate a reduced EEG 
dataset from 60-channels on the EEG net. There were four channels that did not detect a 
physiological signal. This new reduced EEG dataset was merged with the cardiorespiratory 
signals measured by the Embla Titanium amplifier to generate a complete PSG dataset. 
However, because the EEG signals were acquired using a different amplifier, the two groups 
of signals had to be merged. During the setup, there were two lots of ECG: one connected to 
the EGI amplifier and one connected to the Embla titanium. This meant that the participants 
wore four individual ECG electrodes but each pair led to one of the amplifiers. When 
combining the signals, the ECG could be used to align the signal traces as the ECG signature 
would be identical. This meant that all the signals could be combined into one data file and 
analysed together.  
Once the files were combined using MATLAB R2017a (MathWorks, 2017), EEGLAB V14.1.2 
(Delorme and Makeig, 2004) toolbox was used to generate the '.edf files' that allowed for the 
data to be transferred and imported into any software for further analysis.  
The EEG data file required pre-processing before analyses could be conducted to ensure that 
the signal to noise ratio was minimised and the signals across the channels were clean. From 
the 60-channels that were acquired, there were six channels in the scoring set and used for 
sleep analyses: frontal (F3 and F4), central (C3 and C4) and occipital (O1 and O2). The odd 
number refers to the left hemisphere and the even, the right hemisphere of the brain. 
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Electroencephalography (EEG) Pre-processing PREP pipeline and Sleep Montages  
For the pre-processing, MATLAB R2017a (MathWorks, 2017) was used. The raw EEG data was 
pre-processed by Dr Nick Donnelly at the University of Bristol using a standardised early-stage 
EEG processing pipeline (PREP) which is freely available from a MATLAB library on a software 
development platform, ‘GitHub’. The plug-in for the PREP pipeline was downloaded and could 
be used in the eeglab toolbox (Delorme et al., 2011). The fundamental reasons for the pre-
processing were to reduce the signal-to-noise ratio and removal of unwanted artefacts in the 
EEG data. The PREP pipeline worked to robustly re-reference the signals to allow for the data 
to be standardised, retaining the cleaned data.  
To summarise the PREP pipeline (quoted verbatim from (Bigdely-Shamlo et al., 2015)), the 
pipeline aims to: 
1. “Remove line-noise without committing to a filtering strategy. 
2. Robustly reference the signal relative to an estimate of the ‘true’ average reference. 
3. Detect and interpolate bad channels relative to this reference. 
4. Retain sufficient information to allow users to re-reference using another method of 
to undo interpolation of a particular channel.” 
All the sleep EEGs were pre-processed meaning that there were n=47 22q11.2DS and n=22 
sibling controls. During the pre-processing phase, it could be determined whether the sleep 
EEGs were of sufficient quality to pass quality control and therefore be analysed further. This 
resulted in the total output of n=28 22q11.2DS and n=17 sibling control sleep EEGs that were 
of sufficient signal-to-noise quality and could be robustly referenced and interpolated. 
Montages of the sleep EEGs were produced using markers of the ‘lights off’ and ‘lights on’ 
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conditions that were marked post-acquisition on each of the participants sleep EEG using the 
Galileo programme.  
Sleep EEG Scoring – Staging Sleep  
For sleep staging, Windows Python Programming Language (version 3.6.5 release) 
(https://docs.python.org/3.6/reference/) was used. The processed EEG data files were scored 
before PSG sleep parameters could be derived and analysed.  
The n=45 sleep EEGs were recorded and analysed in accordance with the American Academy 
of Sleep Medicine (AASM) Manual for the Scoring of Sleep Events and Associated Events 
Version 2.3 (Berry et al., 2016) using an open-source module ‘Sleep’ from an open-source 
Python software package, ‘Visbrain’ (Combrisson et al., 2017) downloaded from GitHub. 
Windows Python Programming Language (version 3.6.5 release) (https://docs.python.org/ 
3.6/reference/) was used to open the Sleep package and analyse the data.  
The sleep EEGs were manually scored based on my experience gathered prior and throughout 
the study. Previously mentioned in Chapter 5, I undertook a polysomnography three-day 
course, assisted with the sleep staging of 10 sleep nights as part of the University of Bristol 
ZNF804a study in addition to practicing scoring of EEG with an electrophysiologist at the 
University Hospital Wales at the Heath. In addition to this, open source EEG data was available 
and I practiced my scoring using this data which was then reviewed by an experienced 
polysomnographer at the University of Bristol. Nonetheless, I recognise that I am not certified 
nor have expertise in the staging of sleep physiology. The staging that I completed was 
secondly staged by an automated sleep staging module in addition to 10% of these being 
scored by a colleague at the University of Bristol who had experience of conducting a clinical 
sleep study using two-night EEG measurements. Nonetheless, before further exploration of 
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the sleep physiology in the young people with 22q11.2DS, we intend to have 10% of the 
staged sleep EEGs to also be staged by a registered sleep physiologist.  
It is important to note that there is observer variation in sleep staging: this occurs amongst 
different individuals with the most experienced polysomnographers aiming for 80% 
agreement in their sleep staging in most sleep laboratories (Schaltenbrand et al., 1996). The 
80% agreement was applied to the comparisons between my staging and the automated 
scoring script. This will also be adhered too when the registered sleep physiologist analyses a 
10% selection of the EEGs before future work.  
The EEG channels were measured at 254 Hz but when undergoing pre-processing were 
reduced to a sampling rate of 128 Hz. This is enough for measurement of the sleep channels. 
During acquisition of the EEG and EOG, the frequency filters were 0.3 Hz low-frequency and 
35 Hz high-frequency. On analysing the sleep EEG channels, an amplitude of 150 μV was used 
for visualisation and 200 μV for the EOG channels. The EMG was acquired using a low-
frequency filter of 10 Hz and a high-frequency of 100 Hz with a 200 μV amplitude applied to 
the channel during analysis. The ECG was acquired using 0.3 Hz as the low-frequency filter 
and 70 Hz as the high-frequency filter. An amplitude of 700 μV was used for visualisation of 
the ECG channel during analyses. The Respiratory Inductance Belts were measured at a 0.1 
Hz low-frequency filter and a 15 Hz high-frequency filter. On using these channels during 
analyses to ensure that artefacts in the EEG weren’t a consequence of respiratory changes, 
an amplitude of 250 μV was used for visualisation. The nasal pressure, if measured, was 
acquired with a low-frequency filter of 0.03 Hz and high-frequency filter of 100 Hz. These filter 
frequency bounds were recommended by the AASM guidelines and were changed before the 
acquisition of the data. The stages of sleep were scored based on the assessment of a 30-
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second epoch of sleep EEG that was either deemed to be stage 1,2,3 of NREM, REM, wake or 
an artefact usually as a result of movement or a consequence of an underlying 
cardiorespiratory problem. The sleep EEGs were double scored. See section 7.1.1 for figures 
demonstrating characteristic EEG signatures for the stages of sleep and for wake. Figure 18 
demonstrates a 30-second epoch captured from the analysis. 
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Once the sleep EEGs were scored and all stages allocated, the data was cleaned once more to 
ensure that all areas of artefact, wake and arousals were removed before the sleep 
architecture parameters were derived ready for analysis.  
Artefact and Wake Epoch Removal  
Once the sleep EEG data files had been scored and each 30-second epoch had an allocated 
stage, the data was reviewed for artefact removal. The PREP pipeline removed significant 
artefacts that would make the EEG uninterpretable, but during the sleep scoring process, 
stages were identified as an artefact where there were movements shown by complete noise 
across the signals as well as the disruption to respiratory signals and the EMG.  
The sleep EEG data files were converted into a ‘.set’ and ‘.fdt’ data type by co-investigator Dr 
Ullrich Bartsch, from the University of Bristol so that they could be opened in MATLAB R2017a 
(MathWorks, 2017) and analysed using the EEGLAB V14.1.2 (Delorme and Makeig, 2004) 
toolbox. I cleaned the scored sleep EEG montages using the ‘eeglab’ command to load the ‘. 
set’ data files as existing datasets into the package. Using the ‘plot’ option, the six sleep 
electrodes (F3, F4, C3, C4, O1, O2) separated into 30-second epochs were scrolled through at 
a sampling rate of 128 Hz. The amplitude of the typical six sleep channels was set at 150 μV.  
Each of the 30-second epochs were assessed as to whether there were any artefacts present. 
Take Figure 19, there is an evident noisy signal across all six channels suggesting that there is 
an artefact. However, looking at the stage of ‘sleep’, it is obvious that all the epochs shown in 
the figure are wake. Therefore, all five of these 30-second epochs would be highlighted and 
‘rejected’, removing the wake periods and artefacts from the overall EEG signal. 
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7.3.4 Statistical Analyses  
The first aim of the PSG was addressed in the data analysis as this did not require statistics. 
To address the second and third aims multiple linear regression analyses were used to 
examine the differences in the PSG-derived sleep architecture between groups including 
covariates, and to investigate the relationship between the neurodevelopmental phenotype 
and the PSG-derived sleep architecture. Box-plots were generated to demonstrate 
differences in PSG-derived sleep parameters. 
All regressions were controlled for age, gender, highest maternal education and family 
income which highlighted no differences between the groups.  
Figure 19 An example of wake EEG epochs that would be rejected from the EEG dataset before 
waveform analyses. The 30-second epoch highlighted in yellow shows noise across all channels 
showing an artefact. This is a 30-second epoch of my acquired data. 
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The psychiatric and the cognitive assessments that were used to derive the symptom scores 
and the cognitive outcomes are outlined in Chapter 3, sections 3.5-3.9. These outcomes were 
used to explore the relationships between the PSG-derived sleep architecture after the pre-
processing, scoring and cleaning of the sleep EEG data. 
All statistical analyses were completed using STATA (version 13.1) 
(https://www.stata.com/stata-news/news28-4/stata13.1) and R (version 3.5.0) (R: The R 
Project for Statistical Computing, 2018). To correct the analyses for multiple comparisons, we 
used a Benjamini–Hochberg false discovery rate (FDR) rate of 5% (Benjamini and Hochberg, 
1995). The Benjamini-Hochberg method ranks the individual p-values from smallest to largest, 
with the smallest p-value ranking as 1. By comparing each individual p-value to the Benjamini-
Hochberg critical value ((rank/total number of tests) * FDR (i.e., 5%)), if the largest p-value in 
our analyses before correction is smaller than its critical value, it is considered significant. Any 
p-values smaller than the largest p-value are also interpreted to be significant.  
7.4 Results  
Results were derived from the sleep EEGs sampled from n=28 individuals with 22q11.2DS and 
n=17 sibling controls. The following section includes comparisons between 22q11.2DS and 
sibling controls and explores psychopathology in relation to 22q11.2DS sleep EEG measures.  
7.4.1 Sleep Architecture – 22q11.2DS vs. Siblings 
From the scored sleep EEG, there were several PSG-derived sleep architecture parameters for 
all individuals: total sleep time; time in bed; wakes after sleep onset; sleep efficiency; 
percentage of time spent in NREM Stage 1, 2 and 3 and percentage of time spent in REM 
sleep. Sleep architecture was recorded over a single night. This must be considered when 
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exploring the differences seen between the 22q11.2DS young people and siblings: findings 
are to be considered loosely and preliminary with a further, more robust study needed to be 
conducted. 
It was important to recognise that the individuals in the study only undertook a single night 
of sleep EEG. As a result, there was no way of accounting for the ‘first-night effect’ of wearing 
the EEG equipment and various sensors (Agnew, Webb and Williams, 1966). These young 
people, especially the young people with 22q11.2DS, are regarded at elevated risk for anxiety 
and therefore, it would be important to realise that these young people would sleep 
differently during the night when their sleep was being assessed. Additionally, night to night 
variability is common and therefore multiple nights would be important to assess to control 
for this in addition to the ‘first-night effects.’ However, the current study could not logistically 
be conducted across multiple nights and there were additional confinements to the reason 
why two-nights could not be assessed (controlling for the ‘first-night effects’). There is further 
information in the Strengths and Limitations on pages 248-250.  
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7.4.1.1 Hypnograms – Stages of Sleep  
Hypnograms were derived showing the composition of the night’s sleep for all participants: 
the stages of sleep and the percentage of time spent in each stage could be derived (Figures 
20 and 21). 
7.4.1.2 Percentage of time spent in NREM and REM sleep stages 
Comparisons between the percentage of time spent in the stages by individuals with 
22q11.2DS and siblings excluded the n=4 individuals with shortened sleep EEGs. 
Figure 21 Hypnogram showing the stages of sleep and transitions in an unaffected sibling control 
Figure 20 Hypnogram showing the stages of sleep and transitions in a young person with 22q11.2DS 
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Differences in the percentage of time spent in NREM Stage 1 (B=-3.23, p=0.04) and REM sleep 
(B =-3.33, p=0.04) were found in individuals with 22q11.2DS compared to the sibling controls. 
The differences in the percentage of time spent in NREM Stage 1 and REM sleep remained 
even when accounting for covariates: age (B=0.219, p=0.364); gender (B=-0.771, p=0.627), 
and highest maternal education level (B=-0.878, p=0.260). Age showed an association with 
the percentage of time spent in REM (B=0.514, p=0.039) in the total cohort however was lost 
when accounting for group status (22q11.2DS or sibling control).  
There was a non-significant trend in the time spent in NREM Stage 3 sleep (B=4.12, p=0.055) 
however showing young people with 22q11.2DS spent a longer percentage of time in NREM 
Stage 3 but there was no difference in the percentage of time spent in NREM Stage 2 sleep 
(B=-0.659, p=0.784) (see Figures 22-25).  
 
 
 
 
 
 
 
 
Figure 22 Boxplots of percentage of time spent in Stage 1 NREM sleep in 22q11.2DS compared to 
siblings 
   
244 
 
 
 
 
 
 
 
 
 
Figure 23 Boxplots of the percentage of time spent in Stage 2 NREM sleep in 22q11.2DS compared to 
siblings 
 
 
 
 
 
 
 
 
 
Figure 24 Boxplots of the percentage of time spent in Stage 3 NREM sleep in 22q11.2DS compared to 
siblings 
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7.4.1.3 Other PSG-derived Sleep Architecture  
The additional PSG-derived sleep architecture was compared between 22q11.2DS and 
siblings, showing no differences (see Table 22).  
 Table 22 No associations were found between 22q11.2DS and unaffected sibling controls 
Outcome 
variable 
22q11.2DS 
(mean) 
Siblings 
(mean) 
B SE p 95%CI 
Total Sleep Time 
(TST) (hours) 
08:12 ±01:28 08:07 ±01:20 7.31 26.7 0.785 -46.6-61.3 
Time in Bed (TIB) 
(hours) 
9:26 ±01.17 9:27 ±01:22 24.0 25.1 0.345 -26.7-74.7 
Wake After 
Sleep Onset 
(WASO) (mins) 
00:41 ±00:04 00:42 ±00:04 5.49 14.4 0.706 -23.7-34.7 
Sleep Efficiency 
(%) 
87.1 88.9 -1.75 2.76 0.530 -7.34-3.83 
Figure 25 Boxplots of the percentage of time spent in REM sleep in 22q11.2DS compared to 
siblings 
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There were n=4 individuals with 22q11.2DS taking melatonin for their sleep problems. No 
differences between TST (p=0.188), TIB (p=0.930), WASO (p=0.097) or SE (p=0.06) in those on 
melatonin compared to individuals not on melatonin were found. Melatonin was therefore 
not incorporated as a covariate into further analyses exploring the PSG-derived sleep 
architecture.  
7.4.1.4 Sleep Architecture in 22q11.2DS – How Does this relate to the Neurodevelopmental 
Phenotype? 
An assessment of the sleep study cohort of individuals with 22q11.2DS showed that it was 
not representative of the overall ECHO study cohort outlined in Chapter 4. Table 23 shows 
the differences in diagnoses based on published work from the ECHO study (Niarchou et al., 
2014; Cunningham et al., 2017). 
Table 23 Sleep study cohort vs published proportions of psychopathology in ECHO Study cohorts 
 
 Sleep Study 
cohort 
Niarchou, M. 
et al. (2014) 
Cunningham, 
A.C. et al. (2017) 
Chapter 4 
Sleep problems 
47.6% / / 60% 
ADHD 
4.76% 40.5% / 38.7% 
Putative ASD 
11.1% 26.0% / 36% 
Anxiety 
14.3% 26.3% / 25% 
Indicative DCD 
47.1% / 80% 81.4% 
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Presence of diagnoses did not necessarily reflect symptomology and therefore it was 
important to explore whether there were any associations between the sleep architecture 
and the neurodevelopmental phenotype in these young people with 22q11.2DS. 
Similarly, to the analyses conducted in Chapter 6, it was important not to over-interpret the 
findings and therefore the sleep architecture was investigated in relation to the statistically 
significant findings in Chapter 4, reflecting analyses undertaken in Chapter 6. In this chapter, 
it was important to explore whether there were associations in the psychopathology and the 
cognitive outcomes only in the differences seen between the young people with 22q11.2DS  
 and the sibling control group. This further reflected the analyses conducted in Chapter 6 and 
helped to limit the over-interpretation. The findings were corrected for multiple testing.  
 The CAPA and cognitive assessments were, on average, conducted ~9.6 months from the EEG 
assessment. As a result, the time difference needed to be controlled for.  
Where associations were found between the neurodevelopmental phenotype and the stage 
of sleep, the age difference was added as a covariate to test the robustness of association. 
There were no associations between the percentage of time spent in Stage 1 NREM sleep for 
the young people with 22q11.2DS (Table 24). 
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Table 24 Percentage time spent in Stage 1 NREM in relation to psychopathology and cognition in 
22q11.2DS 
 
 Table 25 Percentage time spent in REM in relation to psychopathology and cognition in 22q11.2DS 
 
% time spent in Stage 1 NREM B SE p 95%CI 
ADHD symptoms (n=24) 0.068 0.182 0.711 -0.309-0.446 
Any anxiety symptoms (n=24) 0.189 0.124 0.143 -0.069-0.447 
Indicative DCD symptoms (n=22) 0.040 0.086 0.646 -0.139-0.219 
CD symptoms (n=24) 1.21 0.898 0.191 0.652-3.07 
Set shifting ability (n=22) -0.024 0.0484 0.623 -0.125-0.077 
% time spent in REM B SE p 95%CI 
ADHD symptoms (n=24) -0.127 0.163 0.445 -0.465-0.211 
Any anxiety symptoms (n=24) 0.006 0.118 0.963 -0.240-0.251 
Indicative DCD symptoms (n=22) 0.043 0.078 0.585 -0.189-0.205 
CD symptoms (n=24) 0.942 0.821 0.263 -0.760-2.65 
Set shifting ability (n=22) 0.086 0.040 0.045 0.002-0.173 
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A better performance on the set shifting on the WCST was shown to associate with a higher 
percentage of the night spent in REM sleep (B=0.086, p=0.045) (see Table 25). This association 
remained when correcting for the age difference in the participant between the cognitive 
assessment and the sleep EEG (B=0.106, p=0.031), however it did not remain when correcting 
for multiple testing.  
7.5 Discussion  
This is the first EEG study to assess the neurophysiology of young people with 22q11.2DS 
during sleep. The percentage of time spent in the different stages of sleep showed that young 
people with 22q11.2DS spend a longer percentage of their night’s sleep in NREM Stage 1 and 
a shorter percentage of the night in REM sleep compared to their siblings.  
7.5.1 Differences in percentage time spent in stages of sleep between young 
people with 22q11.2DS and siblings 
There were differences in the time spent in the NREM Stage 1 and REM in the young people 
with 22q11.2DS and the sibling control group. The boxplots show differences however there 
are large overlapping confidence intervals which is related to the small sample sizes of the 
groups. Therefore, as a result there is large variability in the findings and it suggests that the 
differences seen do not map onto clinically relevant differences in the sleep stages. It is 
important to understand that individual sleep fluctuations and night-to-night changes 
themselves could contribute to these differences rather than clinical implications (Juda, 
Vetter and Roenneberg, 2013). Despite the statistically significant findings, the current data 
that has been collected cannot provide information that can be interpreted as clinically 
significant. It is important to recognise that these findings are taken from a single night of 
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assessment. They provide a snap-shot of the sleep architecture of the individuals and 
exploring this further would be over-interpreting the findings. There is evidence in the 
literature to suggest that a single night of PSG cannot provide an accurate projection of what 
the sleep architecture of an individual looks like (Verhulst et al., 2006). It is important to 
account for variability in a night’s sleep and as a result, the single night that is measured in 
this study is insufficient to draw conclusions about the differences in the percentage of the 
night’s sleep spent in particular stages between the young people with 22q11.2DS and the 
sibling control group.  
Furthermore, it is important to recognise that these single nights of sleep were scored by an 
inexperienced individual and there is need for confirmation from a well-trained and qualified 
polysomnographer. This will ensure that any further findings from the data are not over-
interpreted or misconstrued. Work to explore sleep physiology and architecture further can 
be developed from this initial work.  
7.5.2 Association with better set-shifting performance on the WCST 
Correcting for multiple testing accounted for the association between spending longer time 
in REM sleep and better performance on set-shifting on the WCST, and therefore was not 
maintained. This is important to recognise as by not controlling for the multiple testing could 
lead to over-interpretation of the cognitive findings. Additionally, there is a problem with 
selection of positive associations. For example, the better performance on the WCST was 
associated with higher percentage of the night spent in REM sleep. This in itself is problematic 
as the sleep architecture was derived from the single night of sleep and is subject to variability 
as a result of the night-to-night variability and the ‘first-night effects’. Additionally, the 
particular outcome which showed an association was a cognitive-related variable: cognition 
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varies daily and performance on cognitive tests is subject to great variability (Van Herwegen 
et al., 2011). Therefore, this could form the reason for the seen associations: that variability 
in both the measures map onto each other when only accounting for a snap-shot of the sleep 
architecture and the cognitive ability of the young people with 22q11.2DS.  
7.6 Strengths and Limitations 
Current literature shows that this is the only study to have assessed sleep in young people 
with 22q11.2DS. The sample in this study is modest in size however it remains the only study 
to have acquired sleep EEG in 22q11.2DS. It is therefore novel in its nature and includes a 
valuable sibling control group that allows for comparisons to typically developing children to 
be made.  
This study was conducted in the homes of the young people and their families. This was done 
to try and reduce the amount of stress experienced by the family. It allowed the participant 
to be comfortable in their own environment although this resulted in difficulties regarding 
protocol consistency, ensuring that the equipment was operating and ensuring availability of 
researchers to attend domiciles across the UK. Working in a sleep clinic would have ensured 
that the environment was consistent, but the young people would have had to travel to stay 
overnight in a clinic, away from their family and their environment.  
Gold-standard sleep measures and protocols were used to acquire an objective assessment 
of sleep in these young people. The cardiorespiratory measures in this study also ensured that 
confounding problems regarding breathing and cardiac problems could be accounted for 
when analysing the sleep EEG. However, this study does not include an objective analysis of 
the cardiorespiratory measures as there was no clinician available to assist in the 
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interpretation of the respiratory oscillations. The cardiorespiratory measures however did 
pose an issue: the sensors did not connect to the amplifier that was used for the EEG net. This 
resulted in the need for two different amplifiers for data acquisition.  
It is important to recognise that the sleep EEG analyses were undertaken by an individual 
without a specific qualification or expertise in the area. I was personally responsible for 
undertaking the sleep staging and analyses and as a result, there is a need for confirming the 
scoring before definitive results can be concluded and before future investigations into sleep 
problems in young people with 22q11.2DS can be conducted. Despite attending training 
courses and undertaking hours of practice scoring, it cannot go unnoticed that a qualified 
somnologist must confirm these findings to inform further investigation into the physiology 
of sleep in young people with 22q11.2DS. 
The sleep EEG was acquired in conjunction with the other measures as part of the wider sleep 
study that included the actigraphy and the sleep questionnaires. Nonetheless, this study 
despite including a multidimensional approach to assessing the sleep phenotype in young 
people with 22q11.2DS was cross-sectional so it remains difficult to comment on the aetiology 
of the sleep problems and whether sleep problems emerged before the associated 
neurodevelopmental phenotype.  
The number of sensors used for the assessment of the cardiorespiratory measures should be 
addressed in further studies as the use of the nasal cannula caused issues with tolerability for 
some of the young people. The number of different tasks that the young people were asked 
to complete and the management of the family’s expectations should be reassessed in future 
studies to avoid any misunderstanding or questions from parents regarding the nature of the 
assessment.  
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Statistical comparisons were corrected for multiple comparisons and as a result, the 
significant findings did not remain.  
Additionally, a limitation to the study and findings is that there was only one night of sleep 
EEG acquired. This means that the participants did not have time to become accustomed to 
wearing the equipment and there was no baseline night to make comparisons to. As a result, 
the findings need to be interpreted with caution as the single night could have impacted on 
the night’s sleep that the individual experienced and resultantly, affected the derived 
objective measures of sleep. During analyses, wake periods and artefacts were removed and 
percentages were used over raw data to account for this, however in the literature the norm 
is for a baseline night to be completed.  
7.7 Clinical Implications 
This objective assessment of sleep in young people with 22q11.2DS has contributed to the 
understanding of sleep problems in this population adding to the cross-sectional assessment 
of sleep problems from interview data, objective actigraphy measurements and assessment 
of subjective sleep measures from sleep questionnaires. However, these findings are 
insufficient to suggest any features of clinical importance. The normal distribution of sleep 
problems and fluctuation between nights is most probably of relevance to these current 
findings rather than clinical problems in young people with 22q11.2DS.  
To be able to draw clinical findings, further work must robustly explore sleep physiology in 
young people with 22q11.2DS as replicable and reliable outcomes could potentially act as 
biomarkers in relation to sleep problems and the neurodevelopmental phenotype. 
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7.8 Future Work  
Qualified somnologists, sleep physiologists and respiratory clinicians should be involved in the 
development of further work regarding sleep in young people with 22q11.2DS. It is important 
to investigate the prevalence of SRBD in these young people and in order to achieve this, 
clinicians are required to be involved in the study from the onset, to its completion.  
A larger sample of individuals should be assessed to test how robust the results are. If there 
are potential physiological sleep differences in young people with 22q11.2DS compared to 
typically developing children after corrections, this would be a significant finding which could 
have an impact on intervention development.  
Further analyses regarding waveform characteristics including the frequency, amplitude, 
density and length need to be undertaken to investigate whether differences in specific 
features of the waveforms differ between the groups. These analyses take the form of linear 
mixed models and are in the preliminary stages. With additional time, the models can be 
completed to supplement the current findings. 
Future investigation would need to be conducted with a much larger sample of individuals 
and they would need to be followed-up longitudinally to determine whether sleep 
electrophysiology could be used to assess the prognosis of the neurodevelopmental 
phenotype of 22q11.2DS. Investigating objective sleep measures in younger individuals with 
22q11.2DS such as toddlers could help to identify whether there is a physiological 
underpinning to the sleep problems. Additionally, adult individuals with 22q11.2DS could help 
to identify whether there is persistence of such problems identified using PSG. 
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For future PSG assessment, including a baseline night for the sleep EEG to allow the 
participants to be accustomed to the wires and the equipment they wear is essential, to 
remove first-night effects that can confound the findings from the PSG. The first night wearing 
the equipment often provides an alternative sleep architecture to a second night (Agnew, 
Webb and Williams, 1966). In young people susceptible to neurodevelopmental and anxiety 
problems (Saletu et al., 1996), this could further impact their participation in the study and 
their sleep that is measured. The second night of assessment would provide a more realistic 
picture of the sleep architecture and physiology of the young person. Ideally, there would be 
multiple nights of assessment that would also demonstrate the natural night-to-night 
variability. This would benefit analysis as recognition of the baseline changes in the sleep 
night-to-night could be accounted for when exploring the sleep architecture and physiology 
of the individual.  
Furthermore, sleep problems are not isolated to 22q11.2DS. In the IMAGINE-ID Study (see 
Chapter 3) there are several different CNV genetic syndromes that are characterised by 
intellectual disability. Sleep problems are commonly reported in these individuals therefore, 
the sleep EEG study could be extended to include other CNV genetic syndromes to compare 
outcomes and develop further understanding of the sleep phenotype in these rare genetic 
syndromes.  
7.9 Summary  
This results chapter has shown that there are potential differences in PSG-derived sleep 
parameters in young people with 22q11.2DS compared to their unaffected sibling controls. 
This study is novel in assessing sleep architecture of these young people and has worked to 
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contribute to the understanding of sleep problems in 22q11.2DS. However, it is important to 
note that this work should not be over-interpreted: it is important to further explore the 
physiology of sleep in the young people with 22q11.2DS and the siblings. Findings also did not 
survive correction for multiple comparisons either. Understanding normative and typical 
findings of their sleep physiology, potentially by assessing more than one night, can help to 
provide the foundations to build upon when making conclusions about the differences in 
sleep problems between young people with 22q11.2DS and unaffected siblings.  
The electrophysiology of sleep in young people with 22q11.2DS requires further investigation 
to begin to better understand how the sleep phenotype could relate to the 
neurodevelopmental phenotype.  
These findings have begun to explore the architecture of sleep in young people with 
22q11.2DS but are heavily reliant on further investigation with more rigour and involvement 
of sleep experts and clinicians.  
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Chapter 8 – General Discussion  
8.1 Overview 
This thesis aimed to examine sleep problems in young people with 22q11.2DS by using 
subjective and objective measures of assessment to comprehensively assess sleep in these 
young people. Sleep problems can significantly impact day-to-day life and in individuals at 
elevated risk of neurodevelopmental disorders, how sleep affects their prognosis is of great 
importance. In 22q11.2DS, investigation into sleep problems is scant and the aetiology of 
sleep problems in this high-risk population remains to be elucidated. In neurodevelopmental 
disorders such as ADHD and ASD, sleep problems are regularly accounted for in treatments 
and the behavioural phenotype. However, focus on sleep in 22q11.2DS is lacking; masked by 
other aspects of the syndrome.  
8.2 Collating Findings  
In the first experimental chapter (Chapter 4), sleep problems were preponderant in 
22q11.2DS compared to their siblings, with parent-reports suggesting around 60% of young 
people experienced sleep problems compared to 23% of their unaffected sibling controls 
(p<0.001). Moreover, it was determined that there were specific patterns of sleep problems 
in young people with 22q11.2DS: tiredness-related sleep and insomnia-related sleep. 
Abnormalities in these patterns were seen in 22q11.2DS with 44.7% of young people 
endorsing a tiredness-related sleep pattern, and 21.1% an insomnia-related pattern. 
Furthermore, there were a number (n=17) of young people with 22q11.2DS who were taking 
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melatonin for treatment of their sleep problems. However, 16 of the 17 individuals taking 
melatonin still reported sleep problems.  
The patterns of sleep problems showed associations with the neurodevelopmental 
phenotype of 22q11.2DS: tiredness-related sleep was associated with symptoms of ADHD, 
indicative DCD, anxiety disorders and impaired executive functioning (explored as set shifting 
ability). Furthermore, an association was seen between insomnia-related problems and 
symptoms of anxiety disorder, indicative DCD and conduct disorder. These findings suggested 
that sleep problems in 22q11.2DS are associated with concurrent psychiatric symptomology 
and cognitive impairment. These findings survived multiple testing corrections. 
A small sample of young people with 22q11.2DS (n=87) and unaffected sibling controls (n=39) 
that were assessed at wave 1 and wave 2 of the ECHO Study were investigated to look at the 
persistence of sleep problems over time. A comparative prevalence of sleep problems of sleep 
problems in young people with 22q11.2DS reached 57.5% and in siblings, 20.5% respectively 
(p=0.001) at wave 2. There was no overall change across the two waves in the prevalence of 
sleep problems shown in the young people with 22q11.2DS (p=0.835) or the unaffected 
sibling controls (p=0.739). The small group of toddlers with 22q11.2DS (n=10) and unaffected 
sibling controls (n=3) showed that 60% of the toddlers with 22q11.2DS had parent-reported 
subjective sleep problems compared to 33.3% of the unaffected sibling controls (p=0.559). 
This mirrored the preponderance in the larger, better powered cohort of young people with 
22q11.2DS investigated earlier in Chapter 4. Furthermore, the small subsample of 22q11.2DS 
adults (n=23) who reported sleep problems objectively, excluding a small few individuals that 
required an advocate to respond on their behalf, reported sleep problems at a prevalence of 
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56.5%. These findings suggested potential persistence of sleep problems throughout the life 
course of individuals with 22q11.2DS.  
Chapter 5 outlined the pilot study that was completed with typical young people from the 
general population (n=12) to assess the feasibility of the sleep study protocol that had been 
designed for use with the young people with 22q11.2DS. The aim of the pilot study was to 
assess the feasibility of the study including the tolerability of the equipment and methods 
that were used to assess sleep. The n=12 young people had varying experiences of the 
protocol but ultimately, there was a preference for the Geodesic EGI net. This resulted from 
the reduced time taken to setup the equipment compared to the traditional electrodes, the 
ease of application and subsequent removal, convenience and the lack of need for solvents 
to be transported around the UK. 
The protocol had to be refined before implementation in the main sleep study, to ensure that 
the highest yield of data could be acquired but not to the detriment of the comfort and 
understanding of the families involved.  
The protocol and the main sleep study were developed successfully resulting in n=50 young 
people with 22q11.2DS and n=29 unaffected sibling controls completing the actigraphy 
protocol, sleep diaries and sleep questionnaires. While this smaller that was included in the 
sleep study is likely underpowered, this sample was the first individuals with 22q11.2DS to 
complete objective and subjective assessments of sleep as part of a research study. 
Therefore, any findings were considered novel and could be built upon with further work.  
After controlling for multiple comparisons, the actigraphy data demonstrated that young 
people with 22q11.2DS spent longer time in bed than their siblings (p=0.001) and slept for 
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longer also (p<0.0001). Young people with 22q11.2DS also had better sleep efficiency than 
their siblings as measured objectively by the actigraphy watches (p<0.0001). There were no 
differences however in the nocturnal activity measures between groups.  
No associations were found between the objective actigraphy and the neurodevelopmental 
phenotype.  
In the final experimental chapter (Chapter 7), PSG was obtained and was preliminarily 
analysed for n=28 young people with 22q11.2DS and n=17 unaffected sibling controls. There 
were several limitations with regards to these analyses. Namely, the PSG was obtained over 
a single night and ‘first-night effects’ were not adequately controlled for. Additionally, the 
young people with 22q11.2DS were not accustomed to the equipment and therefore, further 
disruption was introduced. Furthermore, the cardiorespiratory measures were not 
adequately interpreted and therefore, no conclusions referencing SRBD could be made from 
this work. However, what could be shown was the baseline percentages of time spent in 
different stages of sleep in 22q11.2DS young people and their siblings. Nonetheless, it was 
important to recognise that individual variability and night-to-night fluctuation could also 
provide reasons for the minimal differences observed between the young people with 
22q11.2DS and their siblings.  
Differences in the percentage of the night that young people with 22q11.2DS spent in NREM 
Stage 1 (p=0.04) and REM sleep (p=0.04) were seen compared to their unaffected siblings 
however, nothing could be definitively derived from this as first-night effects and general 
night-to-night variability in individuals was not accounted for. The overlapping nature of the 
95% confidence intervals in the analyses also suggested a wide range of percentages of sleep 
stage. Therefore, despite the difference, it would be difficult to derive clinical meaning from 
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these analyses. Despite conditions for the acquisition of data using different objective and 
subjective sleep methods not being optimal, this thesis describes a unique and novel study; 
the first to explore sleep problems in young people with 22q11.2DS. It is the first to explore 
how sleep problems relate to the neurodevelopmental phenotype in these young people and 
can potentially provide foundations for further work into sleep problems in individuals with 
22q11.2DS in the future. This is a novel, unique study that is the first of its kind, and therefore 
has contributed to an understanding of sleep in individuals with 22q11.2DS that can be built 
upon and developed further.  
8.3 Implications for Research  
Young people with 22q11.2DS have a higher prevalence of sleep problems than their 
unaffected siblings, and these sleep problems show some associations with psychopathology 
and cognition. Nonetheless, when exploring the sleep phenotype further using validated 
sleep assessment methodology including subjective and objective measures, these 
associations were not replicated. Mentioned previously, there were a few problems with the 
objective PSG data acquisition and subsequently the analyses that could be undertaken. 
Furthermore, the sample sizes were not comparable with the subjective parent-reported 
sleep problems outlined in Chapter 4. Nonetheless, it was interesting to observe concordance 
between the subjective parent-reported sleep problems both on the CAPA and the sleep 
questionnaires. However, the suggestion that parent-reports do not accurately define older 
adolescents’ sleep is of interest for further research and has a wider sleep medicine 
implication. Furthermore, individuals with more severe psychopathology were unable to 
complete the PSG therefore, a representative sample was not assessed objectively.  
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Currently, there is no other research into sleep in 22q11.2DS. Sleep problems in NDDs such 
as ASD have been shown to have a biological aetiology but not in all individuals (Veatch et al., 
2015). The underlying mechanisms that could relate to the manifestation of sleep problems 
in 22q11.2DS require further investigation. In individuals with numerous problems, including 
both physical and neurodevelopmental, it is important to not underestimate the importance 
of gene-environment interactions and how environment can impact upon sleep (Barclay et 
al., 2012) as well as the contributions that familial or social influences can have (Poisson et 
al., 2015). In this thesis, the investigations have included family income and highest maternal 
education to test for confounding. This provides a basis to build from with regards to exploring 
socioeconomics and the influence of sleep-related behaviours (Grandner et al., 2010). Further 
research should be carried out to better understand these relationships for individuals with 
22q11.2DS but also for the wider paediatric population.  
8.4 Limitations and Experiences 
The ECHO Study aims to recruit a representative sample from the UK through NHS Genetics 
Clinics and charities: there is no exclusion criteria. However, the study does depend on 
families having free-time to complete the assessments. This has resulted in the slight skew of 
the sample towards including families from an above average socioeconomic background. 
Parents and primary carers with access to supportive medical professionals and who are 
motivated to engage with the study are more likely to volunteer. This interaction with medical 
professionals could derive from their child/ren having a more severe phenotype and 
therefore they want answers regarding this for example.  
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Families where a parent has a CNV also could have limited ability to undertake assessments 
or find it difficult to do so. This should be accounted for when interpreting results. There could 
also be an ascertainment in recruitment through NHS Genetics Clinics as these individuals 
present with an impairment such as an NDD which would result in their referral to the 
genetics clinic. Therefore, the ECHO Study might not be a representative sample of the 
22q11.2DS population but regardless, it does provide the best sample that can be acquired 
for examining the relationship between sleep problems and the neurodevelopmental 
phenotype.  
With regards to the sleep study, the sample was not representative of the general ECHO 
Study. Young people with fewer severe problems completed the full sleep study. In those 
young people with psychotic-like symptoms, parents reported that they would be unable to 
undertake the study. Drawing conclusions from this work was therefore difficult and it 
remains important that over-interpretation is not conducted.  
The ambulatory study allowed for us to reach families across the UK however it resulted in a 
small number of incomplete studies because of technical problems or equipment failure. 
There are smaller technologies that can acquire EEG data and if more PSG studies were 
conducted, considering less invasive techniques which could increase tolerability could be an 
option. However, travelling to the young people’s homes and engaging with the families in 
their comfortable environment was a strength of the study. The concerns of the parents and 
families were prioritised.  
There is the issue of power also for the sleep study. The larger sample completed the 
actigraphy and sleep diaries however there was a smaller subsample of EEGs that survived 
quality control. This was due to poor signal-to-noise ratios in the EEG data. This occurs from 
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interference in the room which occurs at similar frequencies to the acquisition frequency 
however this was limited by the software which applied a filter when acquiring the data. 
Additionally, artefacts include movement of the person and the equipment itself. This is 
unavoidable especially in novel environments where baselines cannot be adopted.  
All individuals were genotyped and individuals with the 3-Mb and the 1.5-Mb deletion were 
included. Further work could potentially explore deletion size and effects on sleep in 
individuals with 22q11.2DS. 
Possibly the most pertinent and important limitation is that I am not a trained respiratory 
clinician or neurologist, nor am I qualified to interpret sleep EEG as I do not hold sleep 
physiologist or somnologist qualifications. Therefore, I was unable to make a clinical 
assessment of any sleep-related breathing disorders, or sleep disorders in general, that could 
have been detected by the PSG. These facts need to be considered when assessing the PSG 
data. It would be important to conduct a comprehensive study in the future with the 
necessary clinical expertise involved in the study to allow for clinical conclusions to be made, 
especially as they could have real-life effects on the young people with 22q11.2DS.  
The following Table 26 demonstrates differences and similarities between the subjective and 
objective measures of sleep problems used in this thesis. 
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Table 26 Comparing the methods of sleep assessments - subjective vs. objective measures 
 
Subjective vs. Objective Sleep Assessments 
Similarities Differences 
Dependent on honest reporting: written for 
subjective, and wearing the equipment 
with the objective measures  
Self or parent-report can include biases 
whereas objective measures uses 
physiological changes  
There are standards to adhere to when 
analysing and interpreting the data 
Objective measures depend on 
predetermine algorithms for data 
acquisition whereas subjective measures 
can provide varied day-to-day responses 
Measures have been validated on 
appropriate population samples  
The scoring of the sleep 
electroencephalography was analysed using 
subjective interpretation whereas the 
actigraphy wasn’t, and questionnaires 
include closed questionnaires 
Can acquire a large wealth of data 
regarding sleep behaviours, patterns and 
physiology  
Questionnaires do not provide a direct 
narrative regarding sleep problems; usually 
there are boxes to tick, and scales to 
choose from whereas the objective 
measures can have a wider range of 
measured responses 
Should be acquired by trained professionals 
who are experienced in conducting the 
particular methods of measurement: 
questionnaires need to be explained and 
actigraphy interpreted for example by a 
trained individual 
Parents are involved more in the subjective 
measures whereas participants alone can 
provide the data acquired from the 
objective methods of assessment 
 Questionnaires and sleep diaries are 
historical techniques of measurement, 
whereas actigraphy and EEG are now 
becoming more common and accessible in 
research studies 
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Multiple comparisons were controlled for throughout the thesis. However, it is important that 
the work is replicated and progressed before conclusions can be made from the objective 
actigraphy and PSG data in the young people with 22q11.2DS.  
8.5 Future Work 
The work outlined in this thesis has created a foundation that can be further developed to 
explore the overlooked and important area of sleep in young people with 22q11.2DS. This 
thesis provides insight into the high prevalence of sleep problems in these young people and 
the wide-ranging impact that these can have on the individual and their family’s day-to-day 
lives. This work was instigated partly because of the frequent requests from parents of young 
people with 22q11.2DS to explore sleep in their children because of the debilitating effect on 
the child and the family. This thesis addresses the need to look more into the sleep phenotype 
of 22q11.2DS at all ages and indicates that this is likely to be a fruitful area for future work.  
Further research including longitudinal assessments and analysis can help to understand 
whether there is a biological component to the aetiology of sleep problems. Studies in other 
CNV genetic syndromes have discovered biological aetiologies (S. R. Williams et al., 2012), 
whereas others have suggested that it is the concurrent neurodevelopmental problems that 
relate to the sleep problems in that population (Robinson-Shelton and Malow, 2016).  
Furthermore, physical problems have not been identified in this study as it was not part of 
the main hypotheses. There are several physical problems such as cardiac, respiratory and 
physical limb problems. Limb pain and discomfort could have an impact on the quality of sleep 
gained and therefore, could influence sleep problems (Tudor et al., 2014).  
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Chapter 4 did not include investigation into whether sleep problems were associated with 
psychosis and it is known that individuals with 22q11.2DS are at a 25-30% risk for 
schizophrenia (Schneider et al., 2014). In the wave 1 cross-sectional assessments, there were 
a limited number of individuals reporting psychotic experiences and therefore it was not 
practical to assess this relationship. The sleep study did include individuals who were older 
and therefore psychotic symptoms could be assessed. Further work however could be done 
as part of the longitudinal ECHO Study to explore whether there is an association between 
actigraphy-derived sleep architecture parameters and psychotic symptoms.  
Persistence of sleep problems over time was suggested from the prevalence at wave 2 
(Chapter 4), and supported by the toddler and adult studies. Assessing the stability of the 
objective measures of sleep over time could help to understand how sleep problems could 
confound problems in later life and in adults with 22q11.2DS, especially in those who develop 
Parkinson’s disease. Sleep problems such as REM behavioural disorder are prevalent in 
Parkinson’s disease (Van, Boot and Bassett, 2017). Individuals with 22q11.2DS are at an 
elevated risk and it is important to identify whether sleep problems throughout life could be 
associated with this outcome. 
Assessing sleep problems over time can also add to an understanding of when it is best to 
intervene with treatments. There are currently no research studies into sleep interventions 
in individuals with 22q11.2DS but there is evidence of the effective practise of sleep hygiene 
and cognitive behavioural therapies in other chromosomal disorders and NDDs (Blackmer and 
Feinstein, 2016).  
An investigation into the relationship between the sleep of the young person with 22q11.2DS 
and their primary carer could help to better understand the bedtime behaviours and 
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potentially identify activities detrimental to establishing good quality and quantity of sleep. 
Some parents of these children experience mental health problems and poor sleep 
themselves. Examining how parental sleep could be related to the young person’s sleep could 
have benefits for the entire family and act as a whole-family project and intervention could 
work to develop the best night’s sleep for all.  
Future PSG studies in these young people should be conducted in a controlled environment. 
It is important to account for the ‘first-night effect’, the anxiety of the young people, the 
baseline night comparison to a second night and the time that is required for the young 
people to become accustomed to the equipment. Qualified and experienced sleep 
physiologists are required to help with the interpretation of the data and reliability testing. 
Work into the sleep physiology is required in the future for example waveforms during the 
sleep period. Larger samples need to be assessed using objective methods to draw 
conclusions that could help inform families, schools and clinical practice. 
8.6 Conclusions 
Sleep problems are prevalent in young people with 22q11.2DS. Sleep problems are not 
dissimilar from other aspects of the syndrome in their variability amongst individuals in their 
presentation. This thesis provides evidence for sleep problems outside of subjective 
measurement. Objective measures have suggested that there are differences between young 
people with 22q11.2DS and their unaffected siblings. This work has showed that is important 
to include both subjective and objective methods of sleep assessment to best explore the 
sleep phenotype in young people with 22q11.2DS. Evidence showing minimal agreement 
between the objective and subjective measures reflects this. However, showing agreement 
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between subjective and objective methods of sleep assessment in individuals with 22q11.2DS 
is an underrepresented area of research.  
Future work should broaden its focus on how sleep problems affect the individual with 
22q11.2DS and their surroundings including family, parents, social interactions and gene-
environment relationships. Work into sleep problems should aim to address the substantial 
impact sleep problems have on individuals with 22q11.2DS throughout their lives, and how 
these interact with their neurodevelopmental phenotype. Treatments for sleep problems in 
individuals with 22q11.2DS must be developed for the immediate wellbeing and fruitful 
futures of every single individual. 
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Appendix 1: A flow-chart of the ECHO Study and its relationship with 
the IMAGINE-ID study  
 
 
 
 
 
 
 
 
 
 
i) An individual could be recruited into the ECHO Study at wave 1. This was the first time point 
for assessments. At the same time that an individual was recruited into the ECHO Study, the 
primary carer could consent to being informed of other projects: in the case of the ECHO 
Study, it was namely the IMAGINE-ID Study. The ECHO Study worked to investigate 22q11.2 
Deletion Syndrome whereas the IMAGINE-ID Study includes 22q11.2 Deletion Syndrome in 
addition to other copy number variants including 22q11.2 Duplication, 15q11.2 Deletion and 
Duplication, 16p11.2 Deletion and Duplication and 3q29 Deletion.  
ii 
Figure 26 How the ECHO and the IMAGINE-ID Studies relate to one-another  
i 
Future 
Wave 3 
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ii) The ECHO Study commenced in 2010. The first families that were seen completed 
assessments as part of wave 1. After ~2.5 years, the same family became eligible for a follow-
up assessment and they were invited to participate in wave 2 of the ECHO Study.  
However, after the inception of the IMAGINE-ID study in 2014, young people eligible for wave 
2 follow-up in the ECHO Study were instead (if the primary carer had consented) followed-up 
as part of the IMAGINE-ID Study. This in turn resulted in some young people having 
participated in both the ECHO and IMAGINE-ID studies. It also resulted in fewer young people 
being newly recruited through the ECHO Study from 2017 onwards as the IMAGINE-ID Study 
was then responsible for the recruitment of new young people including young people with 
22q11.2 Deletion Syndrome.  
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Appendix 2: A flow-chart of the different studies and samples 
outlined in the thesis with sample sizes included 
Figure 27 A flow-chart of the different studies and samples in this thesis 
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Appendix 3: Recruitment and Ethics Protocol for the ECHO Study  
The ECHO Study 
Young people with 22q11.2DS were recruited through NHS Medical Genetics clinics in the UK, 
British 22q11.2DS charities (Max Appeal! 22qCrew and Unique), social media advertisements 
and family networks. Where available, a sibling control closest in age to the child with the 
deletion was invited to take part in the ECHO study. Carriers of the deletion and sibling 
controls were aged 6 or older and the presence (in carriers) or absence (in sibling controls) of 
the deletion was confirmed either by a Medical Genetics laboratory providing a medical 
genetics report, and/or a microarray analysis in the MRC Centre for Neuropsychiatric Genetics 
and Genomics laboratory at Cardiff University.  
Timepoint Two: wave 2 
The recruitment process for the wave 2 assessment was dependent on whether a primary 
carer had provided consent for their families to be contacted again after completing the wave 
1 assessments. If there was consent, the family were contacted and asked whether they 
would be happy to participate in the follow-up assessments. The same assessments that were 
completed at the first timepoint, were repeated at the second timepoint. Further information 
regarding the actual assessments that were undertaken can be found in Chapter 3. 
The Toddler Study 
The cross-sectional toddler study involved families with a toddler with 22q11.2DS and any 
age-matched sibling controls. The families either attended the clinic at Cardiff University or 
were visited by a psychology team in their own home, where they participated in psychiatric, 
cognitive and other assessments. These assessments were based on the assessments in the 
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ECHO Study and outlined in Chapter 3. For the purpose of this thesis, the assessments that 
are of relevance are outlined in Chapter 3. The families that participated in the Toddler study 
were recruited predominantly through social media. There were some families that had 
previously contacted the ECHO Study as they had been interested in participating. However, 
there child/ren were too young at the time. These individuals were now able to participate in 
a study. 
DEFINE: The Adult Study  
The cross-sectional adult data were collected via a similar method of in-home psychiatric and 
cognitive assessments to the ECHO and toddler studies (see Chapter 3).  
Adults with capacity consented into the study and reported on their own psychiatric 
morbidities and completed the cognitive tasks. For participants who lacked capacity an 
advocate or personal consultee completed questions on behalf of the participant with 
22q11.2DS regarding their psychiatric morbidities, but the individual, if able to, completed 
their own cognitive tasks. This ensured that the most accurate responses were provided. 
The IMAGINE-ID Study 
Young people with rare chromosomal genetic syndromes were able to participate in the 
IMAGINE-ID Study which is a collaborative project between Cardiff University, the University 
of Cambridge and University College London. The protocol that was undertaken in the 
IMAGINE-ID Study was developed in line with the assessments that are undertaken in th ECHO 
Study. This allowed for cross-comparability. The IMAGINE-ID Study included young people 
with 22q11.2DS and these were recruited through NHS Medical Genetics clinics in the UK, 
Unique, social media advertisements and family networks. Where available, a sibling control 
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closest in age to the child with the deletion was invited to take part in the ECHO study. Carriers 
of the deletion and sibling controls were aged 6 or older and the presence (in carriers) or 
absence (in sibling controls) of the deletion was confirmed either by a Medical Genetics 
laboratory providing a medical genetics report, and/or a microarray analysis in the MRC 
Centre for Neuropsychiatric Genetics and Genomics laboratory at Cardiff University. 
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Appendix 4: Example of Sleep Diaries 
Please note that the sleep diaries shown in Appendix 4 have not been included as part of the 
analyses undertaken in this thesis. This is due to the inconsistencies with recording who was 
responsible for completing the sleep diaries and therefore, there was no validation or 
reliability data available to ensure that the sleep diaries could be accurately compared to the 
objectively-derived actigraphy data. 
 The sleep diaries were developed to be implemented in the Pilot Study (Chapter 5). By testing 
the sleep diaries in the Pilot Study, changes could be made before introducing them into the 
Main Sleep Study (Chapter 6). As mentioned in the main thesis text, there were different sleep 
diaries developed for different age categories. The different sleep diaries have been included 
in this appendix to demonstrate: 
i) What was included in the sleep diaries and to observe how the data was acquired; 
ii) To identify the differences in the sleep diaries for the younger and older young 
people that participated in our study; 
iii) To demonstrate the parent diary that was developed to compliment the sleep 
diary that was given to the younger children and the young people who were not 
considered to have capacity. 
Please note that all participants and parents were informed how to complete the sleep diary 
and an example day was completed with them during the overnight sleep study. Families 
were informed about not having to be precise in their time measurements and were verbally 
advised to ensure either accuracy or rounding to the nearest 0, 5 or 10 minutes. I recognise 
that this was not written down and therefore created some discrepancies between the sleep 
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diaries and the actigraphy. This contributed to the overall decision of excluding the sleep 
diaries from the analyses in this thesis. 
The sleep diaries are included in appendices 4, a: The Child Sleep Diary; 4, b: The Teenage 
Sleep Diary and 4, c: The Parent Sleep Diary (on behalf of their child/ren).   
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Appendix 4, a: The Child Sleep Diary   
   
340 
 
 
   
341 
 
 
   
342 
 
 
 
   
343 
 
 
Appendix 4, b: The ‘Teenage’ Sleep Diary 
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This is an example for one week: three weeks were included in each diary during the study.  
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Appendix 4, c: The Parent Sleep Diary (on behalf of their child/ren) 
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This is an example for one week: three weeks were included in each diary during the study.  
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